2014 ANNUAL REPORT
Helping people express themselves on their own piece of the Earth
SHAREHOLDER INFORMATION
World Headquarters
Stock Price Range
Annual Meeting
NYSE Symbol
Stock Price Performance
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:
Transfer Agent and Registrar
Shareholders
Shareholder and Investor
Relations Contact
Publications for Shareholders
Dividends
Comparison of 5-Year Cumulative Total Return*
Among The Scotts Miracle-Gro Company, The Russell 2000 Index and The S&P Household Products Index
The Scotts Miracle-Gro Company
Russell 2000
S&P Household Products Index
$250
$200
$150
$100
$50
$0
9/09
9/10
9/11
9/12
9/13
9/14
*$100 invested on 9/30/08 in stock or index, including
reinvestment of dividends. Fiscal year ending September 30.
14111 Scottslawn RoadMarysville, Ohio 43041 (937) 644-0011 www.scottsmiraclegro.comThe annual meeting of shareholders will be held on Thursday, January 29, 2015 at 9 a.m. ET. This year’s annual meeting will be a virtual meeting and shareholders will be able to participate, vote and submit questions during the virtual meeting. A live audio webcast of the meeting will be available from the investor relations section of the Company’s corporate website at http://investor.scotts.com.The common shares of The Scotts Miracle-Gro Company trade on the New York Stock Exchange under the symbol SMG.Wells Fargo Shareowner ServicesP.O. Box 64874St. Paul, MN 55164-0856 Jim KingSenior Vice President, Chief Communications OfficerThe Scotts Miracle-Gro Company14111 Scottslawn RoadMarysville, Ohio 43041 (937) 644-0011 The Scotts Miracle-Gro Company began paying a quarterly cash dividend of $0.125 per share in the fourth quarter of fiscal 2005. In the fourth quarter of fiscal 2010, the Company increased the quarterly cash dividend to $0.25 per share. In the fourth quarter of fiscal 2011, the Company increased the quarterly cash dividend to $0.30 per share. In the fourth quarter of fiscal 2012, the Company increased the quarterly cash dividend to $0.325 per share. In the fourth quarter of fiscal 2013, the Company increased the quarterly cash dividend to $0.4375 per share. On August 11, 2014, the Company announced that its Board of Directors had further increased the quarterly cash dividend to $0.45 per share, which was first paid to shareholders in the fourth quarter of fiscal 2014.The payment of future dividends, if any, on common shares will be determined by the Board of Directors of the Company in light of conditions then existing, including the Company’s earnings, financial condition and capital requirements, restrictions in financing agreements, business conditions and other factors. The Company’s credit facility restricts future dividend payments to an aggregate of $150 million in fiscal 2014 and 2015 and $175 million for fiscal 2016 and each fiscal year thereafter if the Company’s leverage ratio, after giving effect to any such annual dividend payment, exceeds 3.00. The Company’s leverage ratio was 2.18 as of September 30, 2014. For further discussion regarding the restrictions on dividend payments, see “NOTE 10. DEBT” of the Notes to Consolidated Financial Statements included in the Company’s 2014 Annual Report on Form 10-K.See chart at bottom right for stock price performance. The Scotts Miracle-Gro Company common shares have been publicly traded since January 31, 1992.As of November 14, 2014, there were approximately 29,000 shareholders, including holders of record and The Scotts Miracle-Gro Company’s estimate of beneficial holders.In addition to this 2014 Annual Report, The Scotts Miracle-Gro Company informs shareholders about the Company through its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, its Current Reports on Form 8-K and its Notice of Annual Meeting of Shareholders and Proxy Statement.Copies of any of these documents may be obtained without charge on the Company’s investor relations website at http://investor.scotts.com or by writing to:The Scotts Miracle-Gro CompanyAttention: Investor Relations14111 Scottslawn RoadMarysville, Ohio 43041 Fiscal year ended September 30, 2014 High LowFirst Quarter $62.57 $53.57Second Quarter $63.39 $55.23Third Quarter $63.96 $55.77Fourth Quarter $61.16 $52.38Fiscal year ended September 30, 2013 High LowFirst Quarter $44.60 $39.64Second Quarter $47.60 $42.64Third Quarter $50.46 $42.01Fourth Quarter $55.99 $47.87 Statements contained in this 2014 Annual Report, other than statements of historical fact, which address activities, events and developments that the Company expects or anticipates will or may occur in the future, including, but not limited to, information regarding the future economic performance and financial condition of the Company, the plans and objectives of the Company’s management, the Company’s assumptions regarding such performance and plans, as well as the amount and timing of repurchases of the Company’s common shares are “forward-looking statements” within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. Actual results could differ materially from the forward-looking information in this 2014 Annual Report due to a variety of factors. Additional detailed information concerning a number of the important factors that could cause actual results to differ materially from the forward-looking information contained in this 2014 Annual Report is readily available in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2014, which is filed with the Securities and Exchange Commission.
Table of Contents
(Mark One)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________
Form 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended September 30, 2014
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 1-11593
______________________________________________________________
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
Ohio
(State or other jurisdiction of
incorporation or organization)
14111 Scottslawn Road,
Marysville, Ohio
(Address of principal executive offices)
31-1414921
(I.R.S. Employer
Identification No.)
43041
(Zip Code)
Registrant’s telephone number, including area code:
937-644-0011
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Common Shares, without par value
Name of Each Exchange on Which Registered
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act:
None
______________________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes
No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes
No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). Yes
No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of
this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Accelerated filer
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
No
The aggregate market value of Common Shares (the only common equity of the registrant) held by non-affiliates (for this purpose, executive officers
and directors of the registrant are considered affiliates) as of March 28, 2014 (the last business day of the most recently completed second quarter) was
approximately $2,702,677,743.
There were 60,823,568 Common Shares of the registrant outstanding as of November 14, 2014.
______________________________________________________________
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of the definitive Proxy Statement for the registrant’s 2015 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report
on Form 10-K.
Table of Contents
ITEM 1.
BUSINESS
Company Description and Development of the Business
PART I
The discussion below provides a brief description of the business conducted by The Scotts Miracle-Gro Company (“Scotts
Miracle-Gro” and, together with its subsidiaries, the “Company,” “we” or “us”), including general developments in the Company’s
business during the fiscal year ended September 30, 2014 (“fiscal 2014”). For additional information on recent business
developments, see “ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS” of this Annual Report on Form 10-K.
We are a leading manufacturer and marketer of branded consumer lawn and garden products. Our products are marketed
under some of the most recognized brand names in the industry. In North America, key brands include Scotts® and Turf Builder®
lawn and grass seed products; Miracle-Gro®, Nature's Care®, Scotts®, Liquafeed® and Osmocote®1 gardening and landscape
products; and Ortho®, Roundup®2
, Home Defense® and Tomcat® branded insect control, weed control and rodent control products.
In the United Kingdom, key brands include Miracle-Gro® plant fertilizers; Roundup®2, Weedol® and Pathclear® herbicides;
EverGreen® lawn fertilizers; and Levington® gardening and landscape products. Other significant brands in Europe include
Roundup®2, KB® and Fertiligène® in France; Roundup®2, Celaflor®, Nexa Lotte® and Substral® in Germany and Austria; and
Roundup®2, ASEF®, KB® and Substral® in Belgium, the Netherlands and Luxembourg. We also operate the Scotts LawnService®
business, which provides residential and commercial lawn care, tree and shrub care and pest control services in the United States.
Our heritage is tied to the 1995 merger of The Scotts Company, which traces its roots to a company founded by O.M. Scott
in Marysville, Ohio in 1868, and Stern’s Miracle-Gro Products, Inc., which was formed by Horace Hagedorn and Otto Stern on
Long Island, New York in 1951. Scotts Miracle-Gro is an Ohio corporation.
We are dedicated to delivering strong, long-term financial results and outstanding shareholder returns by providing products
of superior quality and value to enhance consumers’ lawn and garden environments. In fiscal 2014, we advanced a number of
key initiatives which focused on: (1) margin improvement and savings initiatives in the core business; and (2) investment in growth
opportunities adjacent to the core business as well as expansion into the urban and indoor consumer category. After a late start to
the lawn and garden season which negatively impacted our first half results, improved consumer engagement and our initiatives
came together in the second half of the year to lift full year results. We also continued our long-term focus on innovation and
global expansion.
Business Segments
We divide our business into the following reportable segments:
•
•
Global Consumer
Scotts LawnService®
This division of reportable segments is consistent with how the segments report to and are managed by our Chief Executive
Officer (the chief operating decision-maker of the Company). Financial information about these segments for each of the three
fiscal years ended September 30, 2014, 2013, and 2012 is presented in “NOTE 21. SEGMENT INFORMATION” of the Notes
to Consolidated Financial Statements included in this Annual Report on Form 10-K.
________________________
1 Osmocote® is a registered trademark of Everris International B.V., a subsidiary of Israel Chemicals Ltd.
2 Roundup® is a registered trademark of Monsanto Technology LLC, a company affiliated with Monsanto Company
(“Monsanto”)
2
Table of Contents
Principal Products and Services
Global Consumer
In our Global Consumer segment, we manufacture and market consumer lawn and garden products in the following categories:
Lawn Care: The lawn care category is designed to help consumers obtain and enjoy the lawn they want. In the United
States, products within this category include lawn fertilizer products under the Scotts® and Turf Builder® brand names; grass seed
products under the Scotts®, Turf Builder®, EZ Seed®, Water Smart® and PatchMaster® brand names; and lawn-related weed, pest
and disease control products primarily under the Scotts® brand name, including sub-brands such as GrubEx®. A similar range of
products is marketed in Europe under a variety of brands such as EverGreen®, Fertiligène®, Substral®, Miracle-Gro Patch Magic®,
Weedol®, Pathclear®, KB® and Celaflor®. The lawn care category also includes spreaders and other durables under the Scotts®
brand name, including Turf Builder® EdgeGuard® spreaders, Snap® spreaders and Handy Green®II handheld spreaders. In addition,
in 2015, we will begin to market outdoor cleaners under the Scotts® OxiClean®3 brand name.
Gardening and Landscape: The gardening and landscape category is designed to help consumers grow and enjoy
flower and vegetable gardens and beautify landscaped areas. In the United States, products within this category include a complete
line of water soluble plant foods under the Miracle-Gro® brand and sub-brands such as LiquaFeed®, continuous-release plant foods
under the Miracle-Gro®, Scotts® and Osmocote® brands and sub-brands of Miracle-Gro® such as Shake ‘N Feed®; potting mixes
and garden soils under the Miracle-Gro®, Scotts®, Hyponex®, Earthgro® and SuperSoil® brand names; mulch and decorative
groundcover products under the Scotts® brand, including the sub-brands Nature Scapes®, Earthgro® and Hyponex by Scotts®;
landscape weed prevention products under the Ortho® brand; plant-related pest and disease control products under the Ortho®
brand; organic garden products under the Miracle-Gro Organic Choice®, Nature's Care®, Scotts® and Whitney Farms® brand
names; and live goods and seeding solutions under the Miracle-Gro® brand and Gro-ables® sub-brand. Internationally, similar
products are marketed under the Miracle-Gro®, Fertiligène®, Substral®, KB®, Celaflor®, ASEF®, Scotts®, Scotts EcoSense®,
Naturen®, and Miracle-Gro Organic Choice® brand names.
Controls: The controls category is designed to help consumers protect their homes from pests and maintain external
home areas. In the United States, insect control products are marketed under the Ortho® brand name, including Ortho Max®,
Home Defense Max® and Bug B Gon Max® sub-brands; rodent control products are marketed under the Tomcat® and Ortho®
brands; selective weed control products are marketed under the Ortho® Weed B Gon® sub-brand; and non-selective weed control
products are marketed under the Roundup® and Groundclear® brand names. Internationally, products within this category are
marketed under the Nexa Lotte®, Fertiligène®, KB®, Home Defence®, Weedol®, Pathclear® and Roundup® brands.
Since 1999, we have served as Monsanto’s exclusive agent for the marketing and distribution of consumer Roundup® products
in the consumer lawn and garden market within the United States and other specified countries, including Australia, Austria,
Belgium, Canada, France, Germany, the Netherlands and the United Kingdom. Under the terms of the Amended and Restated
Exclusive Agency and Marketing Agreement (the “Marketing Agreement”) between the Company and Monsanto, we are jointly
responsible with Monsanto for developing global consumer and trade marketing programs for consumer Roundup®. We have
responsibility for manufacturing conversion (in North America), distribution and logistics, and selling and marketing support for
consumer Roundup®. Monsanto continues to own the consumer Roundup® business and provides significant oversight of the
brand. In addition, Monsanto continues to own and operate the agricultural Roundup® business. For additional details regarding
the Marketing Agreement, see “ITEM 1A. RISK FACTORS — If Monsanto were to terminate the Marketing Agreement for
consumer Roundup® products, we would lose a substantial source of future earnings and overhead expense absorption” of this
Annual Report on Form 10-K and “NOTE 6. MARKETING AGREEMENT” of the Notes to Consolidated Financial Statements
included in this Annual Report on Form 10-K.
Scotts LawnService®
The Scotts LawnService® segment provides residential and commercial lawn care, tree and shrub care and pest control
services in the United States through periodic applications of fertilizer and control products. As of September 30, 2014, Scotts
LawnService® had 84 Company-operated locations as well as 95 locations operated by independent franchisees. Also, on October
16, 2014, Scotts LawnService® entered into a definitive agreement to acquire the assets of Action Pest Control, Inc. (“Action
Pest”), a residential pest control provider in the Midwest.
________________________
OxiClean® is a registered trademark of Church & Dwight Co., Inc.
3
3
Table of Contents
Acquisitions and Divestitures
On October 14, 2013, we acquired the Tomcat® consumer rodent control business from Bell Laboratories, Inc., located in
Madison, Wisconsin, for $60.0 million in an all-cash transaction. The acquisition included the Tomcat® brand, as well as a long-
term partnership to bring innovative technologies to the consumer rodent control market. Tomcat® consumer products are sold at
home centers and mass retailers, as well as grocery, drug and general merchandise stores across the United States and Canada, in
addition to Europe and Australia.
During the fourth quarter of fiscal 2014, we obtained control of the operations of AeroGrow International, Inc. (“AeroGrow”)
through our increased involvement, influence, and working capital loan of $4.5 million provided in July 2014. AeroGrow is a
developer, marketer, direct-seller, and wholesaler of advanced indoor garden systems designed for consumer use in gardening,
cooking, healthy eating, and home and office décor markets. AeroGrow operates primarily in the United States and Canada, as
well as select countries in Europe, Asia and Australia.
During the fourth quarter of fiscal 2014, we also completed an acquisition of the U.K. based Solus Garden and Leisure
Limited (“Solus”) within our Global Consumer segment for $7.4 million. Solus is a supplier of garden and leisure products,
offering a diverse mix of brands.
On September 30, 2014, our wholly-owned subsidiary, Scotts Canada Ltd., acquired Fafard & Brothers Ltd. (“Fafard”) for
$59.8 million. In continuous operation since 1940 and based in Saint-Bonaventure, Quebec, Canada, Fafard is a producer of peat
moss and growing media products for consumer and professional markets, including peat-based and bark-based mixes, composts
and premium soils. Fafard serves customers primarily across Ontario, Quebec and New Brunswick.
On October 16, 2014, our Scotts LawnService® business entered into a definitive agreement to acquire the assets of Action
Pest, a residential and commercial pest control provider in the Midwest for $22.7 million. The transaction, which is expected to
close by January 2015, would represent our first acquisition of a home pest control business.
In addition, over the past five years we have completed several smaller acquisitions within our controls, growing media and
Scotts LawnService® business.
During the past five years, we have completed several divestitures including the wind down of our Smith & Hawken business
completed in the first quarter of fiscal 2010 and the February 28, 2011 sale of our Global Professional (“Global Pro”) business to
Israel Chemicals Ltd. (“ICL”) for $270 million. In the fourth quarter of fiscal 2012, we completed the wind down of our professional
seed business. In the second quarter of fiscal 2014, we completed the sale of our wild bird food business in the United States and
Canada for $4.1 million in cash and an estimated $1.0 million in future earn-out payments. We have classified our results of
operations for all periods presented in this Annual Report of Form 10-K to reflect these businesses as discontinued operations
during the applicable periods. See “NOTE 2. DISCONTINUED OPERATIONS” of the Notes to Consolidated Financial
Statements included in this Annual Report on Form 10-K for additional information.
Principal Markets and Methods of Distribution
We sell our consumer products primarily to home centers, mass merchandisers, warehouse clubs, large hardware chains,
independent hardware stores, nurseries, garden centers and food and drug stores through both a direct sales force and our network
of brokers and distributors. In addition, during fiscal 2014, we employed approximately 2,200 full-time and seasonal in-store
associates within the United States to help our retail partners merchandise their lawn and garden departments directly to consumers
of our products.
The majority of shipments to customers are made via common carriers or through distributors in the United States and
through a network of public warehouses and distributors in Europe. We primarily utilize third parties to manage the key distribution
centers for our Global Consumer business in North America, which are strategically located across the United States and Canada.
The primary distribution centers for our Global Consumer business internationally are located in the United Kingdom, France,
Germany, Austria and Australia and are also managed by third-party logistics providers. Growing media products are generally
shipped direct-to-store without passing through a distribution center.
Raw Materials
We purchase raw materials for our products from various sources. We are subject to market risk as a result of the fluctuating
prices of raw materials such as urea and other fertilizer inputs, resins, diesel, gasoline, natural gas, sphagnum peat, bark and grass
seed. Our objectives surrounding the procurement of these materials are to ensure continuous supply, minimize costs and improve
predictability. We seek to achieve these objectives through negotiation of contracts with favorable terms directly with vendors.
When appropriate, we commit to purchase a certain percentage of our needs in advance of the season to secure pre-determined
4
Table of Contents
prices. We also hedge certain commodities, particularly diesel, gasoline and urea, to improve predictability and control costs.
Sufficient raw materials were available during fiscal 2014.
Trademarks, Patents and Licenses
We consider our trademarks, patents and licenses to be key competitive advantages. We pursue a vigorous trademark
protection strategy consisting of registration and maintenance of key trademarks and proactive monitoring and enforcement
activities to protect against infringement. The Scotts®, Miracle-Gro®, Ortho®, Scotts LawnService®, Tomcat®, Hyponex® and
Earthgro® brand names and logos, as well as a number of product trademarks, including Turf Builder®, EZ Seed®, Snap®, Organic
Choice®, Nature's Care®, Home Defense Max®, Nature Scapes® and Weed B Gon Max®, are registered in the United States and/
or internationally and are considered material to our business.
In addition, we actively develop and maintain an extensive portfolio of utility and design patents covering subject matters
such as fertilizer, chemical and growing media compositions and processes; grass seed varieties; and mechanical dispensing devices
such as applicators, spreaders and sprayers. Our utility patents provide protection generally extending to 20 years from the date
of filing, and many of our patents will continue well into the next decade. We also hold exclusive and non-exclusive patent licenses
and supply arrangements, permitting the use and sale of additional patented fertilizers, pesticides and mechanical devices. Although
our portfolio of patents and patent licenses is important to our success, no single patent or group of related patents is considered
significant to either of our business segments or the business as a whole.
Seasonality and Backlog
Our business is highly seasonal, with more than 75% of our annual net sales occurring in our second and third fiscal quarters
combined. Our annual sales are further concentrated in our second and third fiscal quarters by retailers who rely on our ability to
deliver products closer to when consumers buy our products, thereby reducing retailers’ pre-season inventories.
We anticipate significant orders for the upcoming spring season will start to be received late in the winter and continue
through the spring season. Historically, substantially all orders have been received and shipped within the same fiscal year with
minimal carryover of open orders at the end of the fiscal year.
Significant Customers
Approximately 89.8% of our worldwide net sales in fiscal 2014 were made by our Global Consumer segment. Our three
largest customers are reported within the Global Consumer segment and are the only customers that individually represent more
than 10% of reported consolidated net sales. Approximately 68% of our Global Consumer segment net sales in fiscal 2014 were
made to Home Depot, Lowe’s and Walmart. We face strong competition for the business of these significant customers. The loss
of any of these customers or a substantial decrease in the volume or profitability of our business with any of these customers could
have a material effect on our financial condition, results of operations or cash flows.
Competitive Marketplace
The markets in which we sell our products are highly competitive. In the United States lawn and garden and pest control
markets, our products compete against private-label as well as branded products. Primary competitors include Spectrum Brands
Holdings, Inc., Bayer AG, Central Garden & Pet Company, Enforcer Products, Inc., Kellogg Garden Products, Oldcastle Retail,
Inc. and Lebanon Seaboard Corporation. In addition, we face competition from regional competitors who compete primarily on
the basis of price for commodity growing media products.
Internationally, we face strong competition in the lawn and garden market, particularly in Europe. Our competitors in the
European Union include Bayer AG, Compo AcquiCo SARL, Westland Horticulture and a variety of local companies.
We have the second largest market share position in the fragmented U.S. lawn care service market. We compete against
TruGreen®, which has a substantially larger share of this market than Scotts LawnService®, as well as numerous regional and local
lawn care service operations and national and regional franchisors.
Research and Development
We continually invest in research and development, both in the laboratory and at the consumer level, to improve our products,
manufacturing processes, packaging and delivery systems. Spending on research and development was $48.4 million, $46.4
million and $50.1 million in fiscal 2014, fiscal 2013 and fiscal 2012, respectively, including product registration costs of $12.6
million, $12.4 million and $14.0 million, respectively. In addition to the benefits of our own research and development, we actively
seek ways to leverage the research and development activities of our suppliers and other business partners.
5
Table of Contents
Regulatory Considerations
Local, state, federal and foreign laws and regulations affect the manufacture, sale and application of our products in several
ways. For example, in the United States, products containing pesticides must comply with the Federal Insecticide, Fungicide, and
Rodenticide Act of 1947, as amended (“FIFRA”), and be registered with the U.S. Environmental Protection Agency (the
“U.S. EPA”) and similar state agencies before they can be sold or distributed. Fertilizer and growing media products are subject
to state and foreign labeling regulations. Our manufacturing operations are subject to waste, water and air quality permitting and
other regulatory requirements of federal, state and foreign agencies. Our grass seed products are regulated by the Federal Seed
Act and various state regulations. Most states require our Scotts LawnService® business locations and/or technicians to comply
with strict licensing requirements prior to applying many of our products. The failure to comply with any of these laws or regulations
could have an adverse effect on our business.
In addition, the use of certain pesticide and fertilizer products is regulated by various local, state, federal and foreign
environmental and public health agencies. These regulations may include requirements that only certified or professional users
apply the product or that certain products be used only on certain types of locations (such as “not for use on sod farms or golf
courses”), may require users to post notices on properties to which products have been or will be applied, may require notification
to individuals in the vicinity that products will be applied in the future or may ban the use of certain ingredients.
State, federal and foreign authorities generally require growing media facilities to obtain permits (sometimes on an annual
basis) in order to harvest peat and to discharge storm water run-off or water pumped from peat deposits. The permits typically
specify the condition in which the property must be left after the peat is fully harvested, with the residual use typically being
natural wetland habitats combined with open water areas. We are generally required by these permits to limit our harvesting and
to restore the property consistent with the intended residual use. In some locations, these facilities have been required to create
water retention ponds to control the sediment content of discharged water.
For more information regarding how compliance with federal, state, local and foreign laws and regulations may affect us,
see “ITEM 1A. RISK FACTORS — Compliance with environmental and other public health regulations or changes in such
regulations or regulatory enforcement priorities could increase our costs of doing business or limit our ability to market all of our
products” of this Annual Report on Form 10-K.
Regulatory Matters
We are subject to various environmental proceedings, the majority of which are for site remediation. At September 30,
2014, $5.4 million was accrued for such environmental matters. During fiscal 2014, fiscal 2013 and fiscal 2012, we expensed
$3.1 million, $0.4 million and $0.8 million, respectively, for such environmental matters. We had no material capital expenditures
during the last three fiscal years related to environmental or regulatory matters.
Employees
As of September 30, 2014, we employed approximately 6,700 employees. During peak sales and production periods, we
employ approximately 8,550 employees, including seasonal and temporary labor.
Financial Information About Geographic Areas
For certain information concerning our international revenues and long-lived assets, see “NOTE 21. SEGMENT
INFORMATION” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
General Information
We maintain a website at http://investor.scotts.com (this uniform resource locator, or URL, is an inactive textual reference
only and is not intended to incorporate our website into this Annual Report on Form 10-K). We file reports with the Securities
and Exchange Commission (the “SEC”) and make available, free of charge, on or through our website, our annual reports on
Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as well as our proxy and information
statements, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC
maintains a website that contains electronic filings by Scotts Miracle-Gro and other issuers at www.sec.gov. In addition, the public
may read and copy any materials Scotts Miracle-Gro files with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E.,
Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC
at 1-800-SEC-0330.
6
Table of Contents
ITEM 1A. RISK FACTORS
Cautionary Note Regarding Forward-Looking Statements
This Annual Report on Form 10-K, including the exhibits hereto and the information incorporated by reference herein, as
well as our 2014 Annual Report to Shareholders (our “2014 Annual Report”), contain “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, which are subject to risks and uncertainties. Other than statements of historical fact, information regarding activities,
events and developments that we expect or anticipate will or may occur in the future, including, but not limited to, information
relating to our future growth and profitability targets and strategies designed to increase total shareholder value, are forward-
looking statements based on management’s estimates, assumptions and projections. Forward-looking statements also include, but
are not limited to, statements regarding our future economic and financial condition and results of operations, the plans and
objectives of management and our assumptions regarding our performance and such plans and objectives, as well as the amount
and timing of repurchases of the common shares of Scotts Miracle-Gro (the “Common Shares”). Forward-looking statements
generally can be identified through the use of words such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,”
“estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should”
and other similar words and variations.
Forward-looking statements contained in this Annual Report on Form 10-K and our 2014 Annual Report are predictions
only and actual results could differ materially from management’s expectations due to a variety of factors, including those described
below. All forward-looking statements attributable to us or persons working on our behalf are expressly qualified in their entirety
by such risk factors.
The forward-looking statements that we make in this Annual Report on Form 10-K and our 2014 Annual Report are based
on management’s current views and assumptions regarding future events and speak only as of their dates. We disclaim any
obligation to update developments of these risk factors or to announce publicly any revisions to any of the forward-looking
statements that we make, or to make corrections to reflect future events or developments, except as required by the federal securities
laws.
Compliance with environmental and other public health regulations or changes in such regulations or regulatory
enforcement priorities could increase our costs of doing business or limit our ability to market all of our products.
Local, state, federal and foreign laws and regulations relating to environmental matters affect us in several ways. In the
United States, all products containing pesticides must comply with FIFRA and be registered with the U.S. EPA and similar state
agencies before they can be sold or distributed. The inability to obtain or maintain such compliance, or the cancellation of any
such registration, could have an adverse effect on our business, the severity of which would depend on the products involved,
whether another product could be substituted and whether our competitors were similarly affected. We attempt to anticipate
regulatory developments and maintain registrations of, and access to, substitute active ingredients, but there can be no assurance
that we will be able to avoid or reduce these risks. In the European Union (the “EU”), the European Parliament has adopted
various forms of regulation which may substantially restrict or eliminate our ability to market and sell certain of our consumer
pesticide products in their current form in the EU. In addition, in Canada, regulations have been adopted by several provinces
that substantially restrict our ability to market and sell certain of our consumer pesticide products.
Under the Food Quality Protection Act, enacted by the U.S. Congress in 1996, food-use pesticides are evaluated to determine
whether there is reasonable certainty that no harm will result from the cumulative effects of pesticide exposures. Under this Act,
the U.S. EPA is evaluating the cumulative and aggregate risks from dietary and non-dietary exposures to pesticides. The pesticides
in our products, certain of which may be used on crops processed into various food products, are typically manufactured by
independent third parties and continue to be evaluated by the U.S. EPA as part of this exposure risk assessment. The U.S. EPA or
the third-party registrant may decide that a pesticide we use in our products will be limited or made unavailable to us. We cannot
predict the outcome or the severity of the effect of continuing evaluations.
In addition, the use of certain pesticide and fertilizer products is regulated by various local, state, federal and foreign
environmental and public health agencies. These regulations may include requirements that only certified or professional users
apply the product or that certain products be used only on certain types of locations, may require users to post notices on properties
to which products have been or will be applied, may require notification to individuals in the vicinity that products will be applied
in the future or may ban the use of certain ingredients. Most states require our Scotts LawnService® business locations and/or
technicians to comply with strict licensing requirements prior to applying many of our products. Even if we are able to comply
with all such regulations and obtain all necessary registrations and licenses, we cannot provide assurance that our products,
particularly pesticide products, will not cause injury to the environment or to people under all circumstances. The costs of
compliance, remediation or products liability have adversely affected operating results in the past and could materially adversely
affect future quarterly or annual operating results.
7
Table of Contents
The harvesting of peat for our growing media business has come under increasing regulatory and environmental scrutiny.
In the United States, state regulations frequently require us to limit our harvesting and to restore the property to an agreed-upon
condition. In some locations, we have been required to create water retention ponds to control the sediment content of discharged
water. In Canada and the United Kingdom, our peat extraction efforts are also the subject of regulation.
In addition to the regulations already described, local, state, federal and foreign agencies regulate the disposal, transport,
handling and storage of waste, remediation of contaminated sites, air and water discharges from our facilities, and workplace
health and safety.
Under certain environmental laws, we may be liable for the costs of investigation and remediation of the presence of certain
regulated materials, as well as related costs of investigation and remediation of damage to natural resources, at various properties,
including our current and former properties as well as offsite waste handling or disposal sites that we have used. Liability may
be imposed upon us without regard to whether we knew of or caused the presence of such materials and, under certain circumstances,
on a joint and several basis. There can be no assurances that the presence of such regulated materials at any such locations, or
locations that we may acquire in the future, will not result in liability to us under such laws or expose us to third-party actions
such as tort suits based on alleged conduct or environmental conditions.
The adequacy of our current non-FIFRA compliance-related environmental reserves and future provisions depends upon
our operating in substantial compliance with applicable environmental and public health laws and regulations, as well as the
assumptions that we have both identified all of the significant sites that must be remediated and that there are no significant
conditions of potential contamination that are unknown to us. A significant change in the facts and circumstances surrounding
these assumptions or in current enforcement policies or requirements, or a finding that we are not in substantial compliance with
applicable environmental and public health laws and regulations, could have a material adverse effect on future environmental
capital expenditures and other environmental expenses, as well as our financial condition, results of operations or cash flows.
Damage to our reputation could have an adverse effect on our business.
Maintaining our strong reputation with both consumers and our retail customers is a key component in our success. Product
recalls, our inability to ship, sell or transport affected products and governmental investigations may harm our reputation and
acceptance of our products by consumers and our retail customers, which may materially and adversely affect our business
operations, decrease sales and increase costs.
In addition, perceptions that the products we produce and market are not safe could adversely affect us and contribute to the
risk we will be subjected to legal action. We manufacture and market a variety of products, such as fertilizers, growing media,
herbicides and pesticides. On occasion, allegations are made that some of our products have failed to perform up to expectations
or have caused damage or injury to individuals or property. Based on reports of contamination at a third-party supplier’s vermiculite
mine, the public may perceive that some of our products manufactured in the past using vermiculite are or may be contaminated.
Public perception that our products are not safe, whether justified or not, could impair our reputation, involve us in litigation,
damage our brand names and have a material adverse effect on our business.
Our marketing activities may not be successful.
We invest substantial resources in advertising, consumer promotions and other marketing activities in order to maintain,
extend and expand our brand image. There can be no assurances that our marketing strategies will be effective or that the amount
we invest in advertising activities will result in a corresponding increase in sales of our products. If our marketing initiatives are
not successful, we will have incurred significant expenses without the benefit of higher revenues.
Our success depends upon the retention and availability of key personnel and the effective succession of senior management.
Our success largely depends on the performance of our management team and other key personnel. Our future operations
could be harmed if we are unable to attract and retain talented, highly qualified senior executives and other key personnel. In
addition, if we are unable to effectively provide for the succession of senior management, including our chief executive officer,
our business, prospects, results of operations, financial condition or cash flows may be materially adversely affected.
Disruptions in availability or increases in the prices of raw materials or fuel could adversely affect our results of operations.
We source many of our commodities and other raw materials on a global basis. The general availability and price of those
raw materials can be affected by numerous forces beyond our control, including political instability, trade restrictions and other
government regulations, duties and tariffs, price controls, changes in currency exchange rates and weather.
A significant disruption in the availability of any of our key raw materials could negatively impact our business. In addition,
increases in the prices of key commodities and other raw materials could adversely affect our ability to manage our cost structure.
8
Table of Contents
Market conditions may limit our ability to raise selling prices to offset increases in our raw material costs. Our proprietary
technologies can limit our ability to locate or utilize alternative inputs for certain products. For certain inputs, new sources of
supply may have to be qualified under regulatory standards, which can require additional investment and delay bringing a product
to market.
We utilize hedge agreements periodically to fix the prices of a portion of our urea and fuel needs. The hedge agreements
are designed to mitigate the earnings and cash flow fluctuations associated with the costs of urea and fuel. In periods of declining
urea and fuel prices, utilizing hedge agreements may effectively increase our expenditures for these raw materials.
Our hedging arrangements expose us to certain counterparty risks.
In addition to commodity hedge agreements, we utilize interest rate swap agreements as a means to hedge our variable
interest rate exposure on debt instruments as well as foreign currency forward contracts to manage the exchange rate risk associated
with certain intercompany loans with foreign subsidiaries. Utilizing these hedge agreements exposes us to certain counterparty
risks. The failure of one or more of these counterparties to fulfill their obligations under the hedge agreements, whether as a result
of weakening financial stability or otherwise, could adversely affect our financial condition, results of operations or cash flows.
Economic conditions could adversely affect our business.
Uncertain global economic conditions could adversely affect our business. Negative global economic trends, such as
decreased consumer and business spending, high unemployment levels, reduced rates of home ownership and housing starts, high
foreclosure rates and declining consumer and business confidence, pose challenges to our business and could result in declining
revenues, profitability and cash flow. Although we continue to devote significant resources to support our brands, unfavorable
economic conditions may negatively affect consumer demand for our products. Consumers may reduce discretionary spending
during periods of economic uncertainty, which could reduce sales volumes of our products or result in a shift in our product mix
from higher margin to lower margin products.
The highly competitive nature of our markets could adversely affect our ability to maintain or grow revenues.
Each of our operating segments participates in markets that are highly competitive. Our products compete against national
and regional products and private label products produced by various suppliers. Many of our competitors sell their products at
prices lower than ours. Our most price sensitive customers may trade down to lower priced products during challenging economic
times or if current economic conditions worsen. We compete primarily on the basis of product innovation, product quality, product
performance, value, brand strength, supply chain competency, field sales support, in-store sales support, the strength of our
relationships with major retailers and advertising. Some of our competitors have significant financial resources. The strong
competition that we face in all of our markets may prevent us from achieving our revenue goals, which may have a material adverse
effect on our financial condition, results of operations or cash flows. Our inability to continue to develop and grow brands with
leading market positions, maintain our relationships with key retailers and deliver high quality products on a reliable basis at
competitive prices could have a material adverse effect on us.
We may not successfully develop new product lines and products or improve existing product lines and products or maintain
our effectiveness in reaching consumers through rapidly evolving communication vehicles.
Our future success depends, in part, upon our ability to improve our existing product lines and products and to develop,
manufacture and market new product lines and products to meet evolving consumer needs, as well as our ability to leverage new
mediums such as digital media and social networks to reach existing and potential consumers. We cannot be certain that we will
be successful in the development, manufacturing and marketing of new product lines and products or product innovations which
satisfy consumer needs or achieve market acceptance, or that we will develop and market new product lines and products or
product innovations in a timely manner. If we fail to successfully develop, manufacture and market new product lines and products
or develop product innovations, or if we fail to reach existing and potential consumers, our ability to maintain or grow our market
share may be adversely affected, which in turn could materially adversely affect our business, financial condition and results of
operations. In addition, the development and introduction of new product lines and products and product innovations require
substantial research, development and marketing expenditures, which we may be unable to recoup if such new products or
innovations do not achieve market acceptance.
Many of the products we manufacture and market contain active ingredients that are subject to regulatory approval. The
need to obtain such approval could delay the launch of new products or product innovations that contain active ingredients or
otherwise prevent us from developing and manufacturing certain products and product innovations, further exacerbating the risks
to our business.
9
Table of Contents
Our ongoing investment in new product lines and products and technologies is inherently risky, and could disrupt our
ongoing businesses.
We have invested and expect to continue to invest in new product lines, products, and technologies. Such endeavors may
involve significant risks and uncertainties, including distraction of management from current operations, insufficient revenues to
offset liabilities assumed and expenses associated with these new investments, inadequate return of capital on our investments,
and unidentified issues not discovered in our due diligence of such strategies and offerings. Because these new ventures are
inherently risky, no assurance can be given that such strategies and offerings will be successful and will not adversely affect our
reputation, financial condition, and operating results.
Because of the concentration of our sales to a small number of retail customers, the loss of one or more of, or a significant
reduction in orders from, our top customers could adversely affect our financial results.
Global Consumer net sales represented approximately 89.8% of our worldwide net sales in fiscal 2014. Our top three retail
customers together accounted for 68% of our Global Consumer segment fiscal 2014 net sales and 55% of our outstanding accounts
receivable as of September 30, 2014. The loss of, or reduction in orders from, our top three retail customers, Home Depot, Lowe’s,
Walmart, or any other significant customer could have a material adverse effect on our business, financial condition, results of
operations or cash flows, as could customer disputes regarding shipments, fees, merchandise condition or related matters. Our
inability to collect accounts receivable from one of our major customers, or a significant deterioration in the financial condition
of one of these customers, including a bankruptcy filing or a liquidation, could also have a material adverse effect on our financial
condition, results of operations or cash flows.
We do not have long-term sales agreements with, or other contractual assurances as to future sales to, any of our major retail
customers. In addition, continued consolidation in the retail industry has resulted in an increasingly concentrated retail base, and
as a result, we are significantly dependent upon key retailers whose bargaining strength is strong. To the extent such concentration
continues to occur, our net sales and income from operations may be increasingly sensitive to deterioration in the financial condition
of, or other adverse developments involving our relationship with, one or more of our customers. In addition, our business may
be negatively affected by changes in the policies of our retailers, such as inventory destocking, limitations on access to shelf space,
price demands and other conditions.
Our reliance on third-party manufacturers could harm our business.
We rely on third-party service providers to manufacture certain of our products. This reliance generates a number of risks,
including decreased control over the production process, which could lead to production delays or interruptions, and inferior
product quality control. In addition, performance problems at these third-party providers could lead to cost overruns, shortages
or other problems, which could increase our costs of production or result in service delays to our customers.
If one or more of our third-party manufacturers becomes insolvent or unwilling to continue to manufacture products of
acceptable quality, at acceptable costs, in a timely manner, our ability to deliver products to our retail customers could be significantly
impaired. Substitute manufacturers might not be available or, if available, might be unwilling or unable to manufacture the products
we need on acceptable terms. Moreover, if customer demand for our products increases, we may be unable to secure sufficient
additional capacity from our current third-party manufacturers, or others, on commercially reasonable terms, or at all.
Our reliance on a limited base of suppliers may result in disruptions to our business and adversely affect our financial
results.
Although we continue to implement risk-mitigation strategies for single-source suppliers, we continue to rely on a limited
number of suppliers for certain of our raw materials, product components and other necessary supplies, including certain active
ingredients used in our products. If we are unable to maintain supplier arrangements and relationships, if we are unable to contract
with suppliers at the quantity and quality levels needed for our business, or if any of our key suppliers becomes insolvent or
experiences other financial distress, we could experience disruptions in production, which could have a material adverse effect
on our financial condition, results of operations or cash flows.
10
Table of Contents
A significant interruption in the operation of our or our suppliers’ facilities could impact our capacity to produce products
and service our customers, which could adversely affect revenues and earnings.
Operations at our and our suppliers’ facilities are subject to disruption for a variety of reasons, including fire, flooding or
other natural disasters, disease outbreaks or pandemics, acts of war, terrorism, government shut-downs and work stoppages. A
significant interruption in the operation of our or our suppliers’ facilities could significantly impact our capacity to produce products
and service our retail customers in a timely manner, which could have a material adverse effect on our revenues, earnings and
financial position. This is especially true for those products that we manufacture at a limited number of facilities, such as our
fertilizer and liquid products in both the United States and Europe.
Adverse weather conditions could adversely impact financial results.
Weather conditions in North America and Europe can have a significant impact on the timing of sales in the spring selling
season and overall annual sales. An abnormally wet and/or cold spring throughout North America or Europe, abnormally dry
periods or droughts, and other severe weather conditions or events could adversely affect fertilizer, pesticide and insecticide sales
and, therefore, our financial condition, results of operations or cash flows.
Our indebtedness could limit our flexibility and adversely affect our financial condition.
As of September 30, 2014, we had $784.3 million of debt. Our inability to meet restrictive financial and non-financial
covenants associated with that debt could adversely affect our financial condition.
Our ability to make payments on our indebtedness, fund planned capital expenditures and acquisitions, pay dividends and
make repurchases of our Common Shares depends on our ability to generate cash in the future. This, to some extent, is subject
to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. We cannot ensure
that our business will generate sufficient cash flow from operating activities or that future borrowings will be available to us under
our credit facility in amounts sufficient to enable us to pay our indebtedness or to fund our other liquidity needs.
Our credit facility and the indenture governing our 6.625% Senior Notes due 2020 (the “6.625% Senior Notes”) contain
restrictive covenants and cross-default provisions. In addition, our credit facility requires us to maintain specified financial ratios.
Our ability to comply with those covenants and satisfy those financial ratios can be affected by events beyond our control. A
breach of any of those financial ratio covenants or other covenants could result in a default. Upon the occurrence of such an event
of default, the lenders could elect to declare all of the outstanding indebtedness immediately due and payable and terminate all
commitments to extend further credit. We cannot ensure that our lenders would waive a default or that we could pay the indebtedness
in full if it were accelerated.
Subject to compliance with certain covenants under our credit facility and the indenture governing our 6.625% Senior Notes,
we may incur additional debt in the future. If we incur additional debt, the risks described above could intensify.
Changes in credit ratings issued by nationally recognized statistical rating organizations could adversely affect our cost of
financing and the market price of our 6.625% Senior Notes.
Credit rating agencies rate the 6.625% Senior Notes and the Company based on factors that include our operating results,
actions that we take, their view of the general outlook for our industry and their view of the general outlook for the economy.
Actions taken by the rating agencies can include maintaining, upgrading or downgrading the current rating or placing us on a
watch list for possible future downgrading. Downgrading the credit rating of our 6.625% Senior Notes or placing us on a watch
list for possible future ratings actions could increase our cost of financing, limit our access to the capital markets and have an
adverse effect on the market price of the 6.625% Senior Notes.
Our postretirement-related costs and funding requirements could increase as a result of volatility in the financial markets,
changes in interest rates and actuarial assumptions.
We sponsor a number of defined benefit pension plans associated with our U.S. and international businesses, as well as a
postretirement medical plan in the U.S. for certain retired associates and their dependents. The performance of the financial
markets and changes in interest rates impact the funded status of these plans and cause volatility in our postretirement-related
costs and future funding requirements. If the financial markets do not provide the expected long-term returns on invested assets,
we could be required to make significant pension contributions. Additionally, changes in interest rates and legislation enacted by
governmental authorities can impact the timing and amounts of contribution requirements.
We utilize third-party actuaries to evaluate assumptions used in determining projected benefit obligations and the fair value
of plan assets for our pension and other postretirement benefit plans. In the event we determine that our assumptions should be
revised, such as the discount rate, the expected long-term rate or expected return on assets, our future pension and postretirement
11
Table of Contents
benefit expenses could increase or decrease. The assumptions we use may differ from actual results, which could have a significant
impact on our pension and postretirement liabilities and related costs and funding requirements.
Our international operations make us susceptible to the costs and risks associated with operating internationally.
We currently operate manufacturing, sales and service facilities outside of the United States, particularly in Canada, France,
the United Kingdom and Germany. In fiscal 2014, sales outside of the United States accounted for 18.1% of our total net sales.
Accordingly, we are subject to risks associated with operating in foreign countries, including:
•
•
•
•
•
•
•
•
•
•
fluctuations in currency exchange rates;
limitations on the remittance of dividends and other payments by foreign subsidiaries;
additional costs of compliance with local regulations;
historically, in certain countries, higher rates of inflation than in the United States;
changes in the economic conditions or consumer preferences or demand for our products in these markets;
restrictive actions by multi-national governing bodies, foreign governments or subdivisions thereof;
changes in foreign labor laws and regulations affecting our ability to hire and retain employees;
changes in U.S. and foreign laws regarding trade and investment;
less robust protection of our intellectual property under foreign laws; and
difficulty in obtaining distribution and support for our products.
In addition, our operations outside the United States are subject to the risk of new and different legal and regulatory
requirements in local jurisdictions, potential difficulties in staffing and managing local operations and potentially adverse tax
consequences. The costs associated with operating our international business could adversely affect our results of operations,
financial condition or cash flows in the future.
Unanticipated changes in our tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities
could affect our profitability and cash flows.
We are subject to income and other taxes in the United States federal jurisdiction and various state, local and foreign
jurisdictions. Our effective tax rate in the future could be adversely affected by changes to our operating structure, changes in the
mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets (such as net operating
losses and tax credits) and liabilities, changes in tax laws and the discovery of new information in the course of our tax return
preparation process. In particular, the carrying value of deferred tax assets, which are predominantly related to our operations in
the United States, is dependent on our ability to generate future taxable income of the appropriate character in the relevant
jurisdiction.
From time to time, tax proposals are introduced or considered by the U.S. Congress or the legislative bodies in state, local
and foreign jurisdictions that could also affect our tax rate, the carrying value of our deferred tax assets, or our other tax liabilities.
Our tax liabilities are also affected by the amounts we charge for inventory, services, licenses, funding and other items in
intercompany transactions. We are subject to ongoing tax audits in various jurisdictions such as the current IRS examination of
our federal tax return for the fiscal year ended September 30, 2011. Regarding the foreign jurisdictions, an audit is currently
underway in France for fiscal years 2010 through 2012. In regard to the U.S. state and local audits, the tax periods under examination
are limited to fiscal years 2009 through 2012. In connection with these audits, tax authorities may disagree with our intercompany
charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. We regularly assess the likely outcomes
of these audits in order to determine the appropriateness of our tax provision. As a result, the ultimate resolution of these tax audits,
changes in tax laws or tax rates, and the ability to utilize our deferred tax assets could materially affect our tax provision, net
income and cash flows in future periods.
Our operations may be impaired if our information technology systems fail to perform adequately or if we are the subject
of a data breach or cyber attack.
We rely on information technology systems in order to conduct business, including communicating with employees and our
key retail customers, ordering and managing materials from suppliers, shipping products to retail customers and analyzing and
reporting results of operations. While we have taken steps to ensure the security of our information technology systems, our
12
Table of Contents
systems may nevertheless be vulnerable to computer viruses, security breaches and other disruptions from unauthorized users. If
our information technology systems are damaged or cease to function properly for an extended period of time, whether as a result
of a significant cyber incident or otherwise, our ability to communicate internally as well as with our retail customers could be
significantly impaired, which may adversely impact our business. Additionally, an operational failure or breach of security from
increasingly sophisticated cyber threats could lead to the loss or disclosure of both our and our retail customers' financial, product,
and other confidential information, as well as personally identifiable information about our employees or customers, result in
regulatory or other legal proceedings, and have a material adverse effect on our business and reputation.
We may not be able to adequately protect our intellectual property and other proprietary rights that are material to our
business.
Our ability to compete effectively depends in part on our rights to service marks, trademarks, tradenames and other intellectual
property rights we own or license, particularly our registered brand names and issued patents. We have not sought to register
every one of our marks either in the United States or in every country in which such mark is used. Furthermore, because of the
differences in foreign trademark, patent and other intellectual property or proprietary rights laws, we may not receive the same
protection in other countries as we would in the United States with respect to the registered brand names and issued patents we
hold. If we are unable to protect our intellectual property, proprietary information and/or brand names, we could suffer a material
adverse effect on our business, financial condition or results of operations.
Litigation may be necessary to enforce our intellectual property rights and protect our proprietary information, or to defend
against claims by third parties that our products or services infringe their intellectual property rights. Any litigation or claims
brought by or against us could result in substantial costs and diversion of our resources. A successful claim of trademark, patent
or other intellectual property infringement against us, or any other successful challenge to the use of our intellectual property,
could subject us to damages or prevent us from providing certain products or services, or providing certain products or services
under our recognized brand names, which could have a material adverse effect on our business, financial condition or results of
operations.
If Monsanto were to terminate the Marketing Agreement for consumer Roundup® products, we would lose a substantial
source of future earnings and overhead expense absorption.
If we were to commit a serious default under the Marketing Agreement with Monsanto for consumer Roundup® products,
Monsanto may have the right to terminate the Marketing Agreement. If Monsanto were to terminate the Marketing Agreement
for cause, we would not be entitled to any termination fee. Monsanto may also be able to terminate the Marketing Agreement
within a given region, including North America, without paying us a termination fee if unit volume sales to consumers in that
region decline: (i) over a cumulative three-fiscal-year period; or (ii) by more than 5% for each of two consecutive years. If the
Marketing Agreement was terminated for any reason, we would also lose all, or a substantial portion, of the significant source of
earnings and overhead expense absorption the Marketing Agreement provides. For additional information regarding the Marketing
Agreement, see “NOTE 6. MARKETING AGREEMENT” of the Notes to Consolidated Financial Statements included in this
Annual Report on Form 10-K.
Hagedorn Partnership, L.P. beneficially owns approximately 26% of our Common Shares and can significantly influence
decisions that require the approval of shareholders.
Hagedorn Partnership, L.P. beneficially owned approximately 26% of our outstanding Common Shares on a fully diluted
basis as of November 14, 2014. As a result, it has sufficient voting power to significantly influence the election of directors and
the approval of other actions requiring the approval of our shareholders, including the entering into of certain business combination
transactions. In addition, because of the percentage of ownership and voting concentration in Hagedorn Partnership, L.P., elections
of our board of directors will generally be within the control of Hagedorn Partnership, L.P. While all of our shareholders are
entitled to vote on matters submitted to our shareholders for approval, the concentration of our Common Shares and voting control
presently lies with Hagedorn Partnership, L.P. As such, it would be difficult for shareholders to propose and have approved
proposals not supported by Hagedorn Partnership, L.P. Hagedorn Partnership, L.P.'s interests could differ from, or be in conflict
with, the interests of other shareholders.
While we have, over the past few years, increased the rate of cash dividends on, and engaged in repurchases of, our Common
Shares, any future decisions to reduce or discontinue paying cash dividends to our shareholders or repurchasing our Common
Shares pursuant to our previously announced repurchase program could cause the market price for our Common Shares to
decline.
Our payment of quarterly cash dividends on and repurchase of our Common Shares pursuant to our stock purchase program
are subject to, among other things, our financial position and results of operations, available cash and cash flow, capital requirements,
and other factors. We have, over the past few years, increased the rate of cash dividends on, and repurchased shares of, our
13
Table of Contents
Common Shares. For example, in the fourth quarter of fiscal 2010, we doubled the amount of our quarterly cash dividend, and
our Board of Directors authorized the repurchase of up to $500 million of Common Shares through September 30, 2014. In fiscal
2011, we increased the amount of our quarterly cash dividend by an additional 20% and our Board of Directors authorized the
repurchase of up to an additional $200 million of our Common Shares through September 30, 2014. We increased the amount of
our quarterly cash dividend again in fiscal 2012. In the fourth quarter of fiscal 2013, we increased the amount of our quarterly
cash dividend by an additional 35%. In the fourth quarter of fiscal 2014, we announced a special one-time cash dividend of $2
per share on the Company's Common Shares; a new share repurchase authorization, expiring by the end of fiscal 2019, to repurchase
up to $500 million of the Company’s Common Shares, which replaced the then existing authorization, which expired on September
30, 2014; and a 3% increase in the Company’s recurring quarterly cash dividend to $0.45 per share.
We may further increase or decrease the rate of cash dividends on, and the amount of repurchases of, our Common Shares
in the future. Any reduction or discontinuance by us of the payment of quarterly cash dividends or repurchases of our Common
Shares pursuant to our current share repurchase authorization program could cause the market price of our Common Shares to
decline. Moreover, in the event our payment of quarterly cash dividends on or repurchases of our Common Shares are reduced
or discontinued, our failure or inability to resume paying cash dividends or repurchasing Common Shares at historical levels could
result in a lower market valuation of our Common Shares.
Acquisitions and investments could result in operating difficulties, dilution, and other harmful consequences that may
adversely impact our business and results of operations.
Acquisitions are an important element of our overall corporate strategy and use of capital, and these transactions could be
material to our financial condition and results of operations. We expect to continue to evaluate and enter into discussions regarding
a wide array of potential strategic transactions. The process of integrating an acquired company, business, or product has created,
and will continue to create, unforeseen operating difficulties and expenditures. The areas where we face risks include:
•
•
•
•
•
•
•
•
•
•
Diversion of management time and focus from operating our business to acquisition integration challenges.
Failure to successfully further develop the acquired business or product lines.
Implementation or remediation of controls, procedures, and policies at the acquired company.
Integration of the acquired company’s accounting, human resource, and other administrative systems, and coordination
of product, engineering, and sales and marketing functions.
Transition of operations, users, and customers onto our existing platforms.
Failure to obtain required approvals on a timely basis, if at all, from governmental authorities, or conditions placed
upon approval, under competition and antitrust laws which could, among other things, delay or prevent us from
completing a transaction, or otherwise restrict our ability to realize the expected financial or strategic goals of an
acquisition.
In the case of foreign acquisitions, the need to integrate operations across different cultures and languages and to address
the particular economic, currency, political, and regulatory risks associated with specific countries.
Cultural challenges associated with integrating employees from the acquired company into our organization, and
retention of employees from the businesses we acquire.
Liability for activities of the acquired company before the acquisition, including patent and trademark infringement
claims, violations of laws, commercial disputes, tax liabilities, and other known and unknown liabilities.
Litigation or other claims in connection with the acquired company, including claims from terminated employees,
customers, former shareholders, or other third parties.
Our failure to address these risks or other problems encountered in connection with our past or future acquisitions and
investments could cause us to fail to realize the anticipated benefits of such acquisitions or investments, incur unanticipated
liabilities, and harm our business generally.
Our acquisitions could also result in dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities
or amortization expenses, or impairment of goodwill and purchased long-lived assets, and restructuring charges, any of which
could harm our financial condition or results. Also, the anticipated benefits of many of our acquisitions may not materialize.
14
Table of Contents
A failure to dispose of assets or businesses in a timely manner may cause the results of the Company to suffer.
The Company evaluates as necessary the potential disposition of assets and businesses that may no longer help it meet its
objectives. When the Company decides to sell assets or a business, it may encounter difficulty in finding buyers or alternative
exit strategies on acceptable terms in a timely manner, which could delay the accomplishment of its strategic objectives.
Alternatively, the Company may dispose of a business at a price or on terms that are less than it had anticipated. After reaching
an agreement with a buyer or seller for the disposition of a business, the Company is subject to satisfaction of pre-closing conditions,
which may prevent the Company from completing the transaction. Dispositions may also involve continued financial involvement
in the divested business, such as through continuing equity ownership, guarantees, indemnities or other financial obligations.
Under these arrangements, performance by the divested businesses or other conditions outside the Company’s control could affect
its future financial results.
We are involved in a number of legal proceedings and, while we cannot predict the outcomes of such proceedings and
other contingencies with certainty, some of these outcomes could adversely affect our business, financial condition and
results of operations.
We are involved in legal proceedings and are subject to investigations, inspections, audits, inquiries and similar actions by
governmental authorities, arising in the course of our business (see the discussion of Legal Proceedings in Part I, Item 3 of this
Annual Report on Form 10-K). Legal proceedings, in general, can be expensive and disruptive. Some of these suits may purport
or may be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts of damages, including
punitive or exemplary damages, and may remain unresolved for several years. From time to time, the Company is also involved
in legal proceedings as a plaintiff involving contract, intellectual property and other matters. We cannot predict with certainty the
outcomes of these legal proceedings and other contingencies, and the costs incurred in litigation can be substantial, regardless of
the outcome. Substantial unanticipated verdicts, fines and rulings do sometimes occur. As a result, we could from time to time
incur judgments, enter into settlements or revise our expectations regarding the outcome of certain matters, and such developments
could have a material adverse effect on our results of operations in the period in which the amounts are accrued and/or our cash
flows in the period in which the amounts are paid. The outcome of some of these legal proceedings and other contingencies could
require us to take, or refrain from taking, actions which could negatively affect our operations. Additionally, defending against
these legal proceedings may involve significant expense and diversion of management’s attention and resources.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 2.
PROPERTIES
Our corporate headquarters are located in Marysville, Ohio, where we own approximately 616 acres of land and lease
approximately 114 acres of land. We lease a property in Ecully, France which serves as the headquarters of our European operations.
In addition, we own and lease numerous industrial, commercial and office properties located in North America, Europe, Australia
and Asia that support the management, manufacturing, distribution and research and development of our products and services.
We believe our properties are suitable and adequate to serve the needs of our business and that our leased properties are subject
to appropriate lease agreements.
Global Consumer. There are 48 Company-owned properties and 69 leased properties in our Global Consumer segment.
These properties are located in the following countries:
Location
United States.............................................................................................................................
United Kingdom .......................................................................................................................
Canada ......................................................................................................................................
France .......................................................................................................................................
Rest of world (1) ........................................................................................................................
Total..........................................................................................................................................
(1) - Rest of world includes Australia, Austria, Belgium, China, Germany, Mexico, and Poland
Owned
Leased
34
7
5
2
—
48
45
7
5
2
10
69
We own or lease 57 manufacturing properties, three distribution properties and three research and development properties
in the United States. We own or lease nine manufacturing properties in the United Kingdom, nine manufacturing properties in
Canada, two manufacturing properties in France, and one manufacturing property in China. We also lease three distribution
15
Table of Contents
properties and own one research and development property in the United Kingdom, lease one distribution property in Mexico,
and lease one research and development property in France. Most of the manufacturing properties in our Global Consumer
segment, which include growing media properties and peat harvesting properties, have production lines, warehouses, offices and
field processing areas.
Scotts LawnService®. The Company-operated Scotts LawnService® locations consist of 89 leased properties located in the
United States. Five of these properties are not operational.
ITEM 3. LEGAL PROCEEDINGS
As noted in the discussion in “ITEM 1. BUSINESS — Regulatory Considerations — Regulatory Matters” of this Annual
Report on Form 10-K, we are involved in several pending environmental and regulatory matters. We believe that our assessment
of contingencies is reasonable and that the related reserves, in the aggregate, are adequate; however, there can be no assurance
that the final resolution of these matters will not have a material effect on our financial condition, results of operations or cash
flows.
We have been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure
to asbestos-containing products, apparently based on our historic use of vermiculite in certain of our products. In many of these
cases, the complaints are not specific about the plaintiffs’ contacts with us or our products. The cases vary, but complaints in these
cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants.
We believe that the claims against us are without merit and are vigorously defending against them. It is not currently possible to
reasonably estimate a probable loss, if any, associated with the cases and, accordingly, no reserves have been recorded in our
consolidated financial statements. We are reviewing agreements and policies that may provide insurance coverage or indemnity
as to these claims and are pursuing coverage under some of these agreements and policies, although there can be no assurance of
the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of
significant defense costs, will not have a material adverse effect on our financial condition, results of operations or cash flows.
In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, we have been
named as a defendant in four putative class actions filed on and after June 27, 2012, which have now been consolidated in the
United States District Court for the Southern District of California as In re Morning Song Bird Food Litigation, Lead Case No.
3:12-cv-01592-JAH-RBB. The plaintiffs allege various statutory and common law claims associated with the Company's sale of
wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such
sales. The plaintiffs allege, among other things, a purported class action on behalf of all persons and entities in the United States
who purchased certain bird food products. The plaintiffs assert hundreds of millions of dollars in monetary damages (actual,
compensatory, consequential, punitive, and treble); reimbursement, restitution, and disgorgement for benefits unjustly conferred;
injunctive and declaratory relief; pre-judgment and post-judgment interest; and costs and attorneys' fees. The Company disputes
the plaintiffs' assertions and intends to vigorously defend the consolidated action. Given the early stages of the action, it is not
currently possible to reasonably estimate a probable loss, if any, associated with the action and, accordingly, no reserves have been
recorded in our consolidated financial statements with respect to the action. There can be no assurance that this action, whether
as a result of an adverse outcome or as a result of significant defense costs, will not have a material adverse effect on our financial
condition, results of operations or cash flows.
We are involved in other lawsuits and claims which arise in the normal course of our business. In our opinion, these claims
individually and in the aggregate are not expected to result in a material effect on our financial condition, results of operations or
cash flows.
ITEM 4. MINE SAFETY DISCLOSURE
Not Applicable.
16
Table of Contents
SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT
The executive officers of Scotts Miracle-Gro, their positions and, as of November 14, 2014, their ages and years with Scotts
Miracle-Gro (and its predecessors) are set forth below.
Name
James Hagedorn
Barry W. Sanders
Thomas R. Coleman
Michael C. Lukemire
Ivan C. Smith
Age
Position(s) Held
59 Chief Executive Officer and Chairman of the Board
50 President and Chief Operating Officer
45 Executive Vice President and Chief Financial Officer
56 Executive Vice President, North American Operations
45 Executive Vice President, General Counsel, Corporate Secretary and Chief
Compliance Officer
Denise S. Stump
60 Executive Vice President, Global Human Resources and Chief Ethics
Officer
Years with
Company
27
13
15
18
11
14
Executive officers serve at the discretion of the Board of Directors of Scotts Miracle-Gro and pursuant to executive severance
agreements or other arrangements.
The business experience of each of the individuals listed above during at least the past five years is as follows:
Mr. Hagedorn was named Chairman of the Board of Scotts Miracle-Gro’s predecessor in January 2003 and named
Chief Executive Officer of Scotts Miracle-Gro’s predecessor in May 2001. He also served as President of Scotts Miracle-Gro (or
its predecessor) from November 2006 until October 2008 and from April 2000 until December 2005. Mr. Hagedorn serves on
Scotts Miracle-Gro’s Board of Directors, a position he has held with Scotts Miracle-Gro (or its predecessor) since 1995.
Mr. Hagedorn is the brother of Katherine Hagedorn Littlefield, a director of Scotts Miracle-Gro.
Mr. Sanders was named President of Scotts Miracle-Gro in October 2010 and named Chief Operating Officer of Scotts
Miracle-Gro in January 2012. In these positions, Mr. Sanders oversees all business unit and operating functions at the Company.
Prior to his appointment as President, Mr. Sanders had served as the Executive Vice President, Global Consumer of Scotts Miracle-
Gro since June 2010. Previously, he served as Executive Vice President, North America of Scotts Miracle-Gro from October 2007
until June 2010. He served as Executive Vice President of Global Technology and Operations of Scotts Miracle-Gro from January
to October 2007, where he was responsible for the Company’s supply chain and information systems, as well as research and
development efforts. Before January 2007, he led the North American and global supply chain organizations as well as the North
American sales force.
Mr. Coleman was named Executive Vice President and Chief Financial Officer of Scotts Miracle-Gro on April 15,
2014. Prior to his appointment as Executive Vice President and Chief Financial Officer, Mr. Coleman had served as Senior Vice
President, Global Finance Operations and Enterprise Performance Management Analytics for The Scotts Company LLC (“Scotts
LLC”), a wholly-owned subsidiary of Scotts Miracle-Gro, since January 2011. Previously, Mr. Coleman served as Senior Vice
President, North America Finance of Scotts LLC from November 2007 until January 2011. Mr. Coleman also previously served
as interim principal financial officer of Scotts Miracle-Gro between February 2013 and March 2013.
Mr. Lukemire was named Executive Vice President, North American Operations of Scotts Miracle-Gro in April 2014
and is responsible for overseeing all aspects of the Company’s core North America business. Prior to this appointment, Mr.
Lukemire had served as Executive Vice President, Business Execution of Scotts Miracle-Gro since May 2013 and was responsible
for leading the Company’s global supply chain, research and development, business transformation and environmental health and
safety efforts. Previously, Mr. Lukemire served as President, U.S. Consumer Regions of Scotts Miracle-Gro from October 2011
until May 2013. Prior to October 2011, he had served as Regional President for the Southeast region since May 2009, responsible
for leading the Company's business development, marketing and sales efforts in the southeastern U.S., and eventually led the entire
North American sales function. Previously, Mr. Lukemire was Executive Vice President, Global Technology and Operations from
June 2008 until May 2009, responsible for global supply chain, global research and development and global business information
services.
Mr. Smith was named Executive Vice President, General Counsel and Corporate Secretary of Scotts Miracle-Gro in
July 2013 and Chief Compliance Officer of Scotts Miracle-Gro in October 2013. Prior to July 2013, he had served as Vice
President, Global Consumer Legal and Assistant General Counsel of Scotts LLC since October 2011. Mr. Smith served as Vice
President, North America Legal and Assistant General Counsel from April 2009 to September 2011 and as Vice President, Litigation
of Scotts LLC from October 2007 to March 2009.
17
Table of Contents
Ms. Stump was named Executive Vice President, Global Human Resources of Scotts Miracle-Gro (or its predecessor)
in February 2003 and Chief Ethics Officer of Scotts Miracle-Gro in October 2013.
18
Table of Contents
PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER
PURCHASES OF EQUITY SECURITIES
The Common Shares trade on the New York Stock Exchange under the symbol “SMG.” The quarterly high and low sale
prices for the fiscal years ended September 30, 2014 and September 30, 2013 were as follows:
FISCAL 2014
First quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Second quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Third quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Fourth quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
FISCAL 2013
First quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Second quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Third quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Fourth quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Sale Prices
High
Low
58.83
59.85
60.30
59.04
44.60
47.60
50.46
55.99
$
$
$
$
$
$
$
$
50.51
53.21
53.97
50.97
39.64
42.64
42.01
47.87
On August 9, 2012, Scotts Miracle-Gro announced that its Board of Directors had increased the quarterly cash dividend to
$0.325 per Common Share, which was paid in September of fiscal 2012 and December, March and June of fiscal 2013. On August
6, 2013, Scotts Miracle-Gro announced that its Board of Directors had increased the quarterly cash dividend to $0.4375 per
Common Share, which was paid in September of fiscal 2013 and December, March and June of fiscal 2014. On August 11, 2014,
Scotts Miracle-Gro announced that its Board of Directors had further increased the quarterly cash dividend to $0.45 per Common
Share, which was paid in September of fiscal 2014. The Board also authorized a special one-time cash dividend of $2.00 per share
on the Common Shares, which was paid on September 17, 2014. The payment of future dividends, if any, on the Common Shares
will be determined by the Board of Directors in light of conditions then existing, including the Company’s earnings, financial
condition and capital requirements, restrictions in financing agreements, business conditions and other factors. The Company’s
credit facility restricted dividend payments to an aggregate of $125 million annually through fiscal 2013 and restricts future
dividend payments to an aggregate of $150 million in fiscal 2014 and 2015 and $175 million for fiscal 2016 and each fiscal year
thereafter if our leverage ratio, after giving effect to any such annual dividend payment, exceeds 3.00. Our leverage ratio was
2.18 at September 30, 2014. See “NOTE 10. DEBT” of the Notes to Consolidated Financial Statements included in this Annual
Report on Form 10-K for further discussion regarding the restrictions on dividend payments.
As of November 14, 2014, there were approximately 29,000 shareholders, including holders of record and our estimate of
beneficial holders.
The following table shows the purchases of Common Shares made by or on behalf of Scotts Miracle-Gro or any “affiliated
purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of Scotts Miracle-Gro for
each of the three fiscal months in the quarter ended September 30, 2014:
Period
June 29 through July 26, 2014. . . . . . . . . . .
July 27 through August 23, 2014. . . . . . . . .
August 24 through September 30, 2014 . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Number
of Common
Shares
Purchased
(1)
Average Price
Paid per
Common
(2)
Share
1
164,821
331,766
496,588
$
$
$
$
54.58
57.98
57.76
57.84
Total Number
of Common
Shares Purchased
as Part of Publicly
Announced Plans
or
Programs
(3)
Approximate
Dollar Value of
Common Shares
That May Yet
be Purchased
Under the Plans
(3)
or Programs
— $
207,363,017
$
$
197,825,679
178,790,098
164,460
329,517
493,977
(1) All of the Common Shares purchased during the quarter were purchased in open market transactions. The total number
of Common Shares purchased during the quarter includes 2,610 Common Shares purchased by the trustee of the rabbi
19
Table of Contents
trust established by the Company as permitted pursuant to the terms of The Scotts Company LLC Executive Retirement
Plan (the “ERP”). The ERP is an unfunded, non-qualified deferred compensation plan which, among other things, provides
eligible employees the opportunity to defer compensation above specified statutory limits applicable to The Scotts
Company LLC Retirement Savings Plan and with respect to any Executive Management Incentive Pay (as defined in the
ERP), Performance Award (as defined in the ERP) or other bonus awarded to such eligible employees. Pursuant to the
terms of the ERP, each eligible employee has the right to elect an investment fund, including a fund consisting of Common
Shares (the “Scotts Miracle-Gro Common Stock Fund”), against which amounts allocated to such employee’s account
under the ERP, including employer contributions, will be benchmarked (all ERP accounts are bookkeeping accounts only
and do not represent a claim against specific assets of the Company). Amounts allocated to employee accounts under
the ERP represent deferred compensation obligations of the Company. The Company established the rabbi trust in order
to assist the Company in discharging such deferred compensation obligations. When an eligible employee elects to
benchmark some or all of the amounts allocated to such employee’s account against the Scotts Miracle-Gro Common
Stock Fund, the trustee of the rabbi trust purchases the number of Common Shares equivalent to the amount so
benchmarked. All Common Shares purchased by the trustee are purchased on the open market and are held in the rabbi
trust until such time as they are distributed pursuant to the terms of the ERP. All assets of the rabbi trust, including any
Common Shares purchased by the trustee, remain, at all times, assets of the Company, subject to the claims of its creditors.
The terms of the ERP do not provide for a specified limit on the number of Common Shares that may be purchased by
the trustee of the rabbi trust.
(2) The average price paid per Common Share is calculated on a settlement basis and includes commissions.
(3) On August 10, 2010, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to
$500 million of Common Shares over a four-year period through September 30, 2014. On May 5, 2011, Scotts Miracle-
Gro announced that its Board of Directors authorized the repurchase of up to an additional $200 million of Common
Shares, resulting in authority to repurchase up to a total of $700 million of Common Shares through September 30, 2014.
On August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to
$500 million of Common Shares over a five-year period (starting November 1, 2014 through September 30, 2019). The
dollar amounts in the “Approximate Dollar Value” column reflect the remaining amounts that were available for repurchase
under the $700 million authorized repurchase program, which expired on September 30, 2014.
20
Table of Contents
ITEM 6.
SELECTED FINANCIAL DATA
Five-Year Summary(1)
Year Ended September 30,
2014
2013
2012
2011
2010
(In millions, except per share amounts)
OPERATING RESULTS:
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2,841.3
1,031.4
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
314.6
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . .
165.4
Income from continuing operations . . . . . . . . . . . . . . . .
0.8
Income (loss) from discontinued operations, net of tax .
166.2
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
166.5
Net income attributable to controlling interest . . . . . . . .
$ 2,773.7
978.2
310.5
159.4
1.7
161.1
161.1
$ 2,770.5
956.6
241.2
111.6
(5.1)
106.5
106.5
$ 2,718.1
1,013.8
301.8
157.5
10.4
167.9
167.9
$ 2,789.8
1,072.6
372.9
206.7
(2.6)
204.1
204.1
ADJUSTED OPERATING RESULTS(2):
Adjusted income from operations. . . . . . . . . . . . . . . . . . $
Adjusted income from continuing operations. . . . . . . . .
Adjusted income attributable to controlling interest
from continuing operations. . . . . . . . . . . . . . . . . . . . . . .
365.6
206.0
206.3
FINANCIAL POSITION:
Working capital(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Current ratio(3). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment, net . . . . . . . . . . . . . . . . . $
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total debt to total book capitalization(4). . . . . . . . . . . . .
Total debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Total shareholders’ equity - controlling interest. . . . . . .
390.3
1.7
437.0
2,058.3
58.6%
784.3
553.7
CASH FLOWS:
Cash flows from operating activities . . . . . . . . . . . . . . . $
Investments in property, plant and equipment . . . . . . . .
Investments in acquired businesses, net of cash
acquired and payments on sellers notes . . . . . . . . . . . . .
Total cash dividends paid . . . . . . . . . . . . . . . . . . . . . . . .
Total purchases of Common Shares . . . . . . . . . . . . . . . .
PER SHARE DATA:
Earnings per common share from continuing
operations:
Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjusted diluted(2) . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends per common share(5) . . . . . . . . . . . . . . . . . . .
Stock price at year-end. . . . . . . . . . . . . . . . . . . . . . . . . .
Stock price range—High . . . . . . . . . . . . . . . . . . . . . . . .
Stock price range—Low . . . . . . . . . . . . . . . . . . . . . . . .
OTHER:
Adjusted EBITDA(6) . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Leverage ratio(6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest coverage ratio(6). . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average Common Shares outstanding . . . . . .
Common shares and dilutive potential common
shares used in diluted EPS calculation. . . . . . . . . . . . . .
240.9
87.6
114.8
230.8
120.0
2.69
2.64
3.29
3.763
55.00
60.03
50.51
412.4
2.18
9.41
61.6
62.7
$
$
$
$
$
$
$
330.8
172.6
172.6
371.2
1.7
422.3
1,937.2
44.5%
570.5
710.5
342.0
60.1
4.0
87.8
—
2.58
2.55
2.76
1.413
55.03
55.99
39.64
390.5
2.05
6.59
61.7
62.6
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
256.5
123.3
123.3
566.4
2.3
427.4
2,074.4
56.5%
782.6
601.9
153.4
69.4
7.0
75.4
17.5
1.83
1.80
1.99
1.225
43.47
55.95
35.49
302.9
2.93
4.90
61.0
62.1
346.2
187.4
187.4
523.9
2.1
394.7
2,052.2
58.7%
795.0
559.8
122.1
72.7
7.9
67.9
358.7
2.43
2.38
2.84
1.05
44.60
60.62
39.99
393.0
1.98
7.47
64.7
66.2
400.1
225.0
225.0
381.3
1.3
381.3
2,164.0
45.2%
631.7
764.5
295.9
83.4
0.6
42.6
25.0
3.12
3.06
3.33
0.625
51.73
52.56
37.50
440.1
2.00
9.40
66.3
67.6
21
Table of Contents
(1)
On July 8, 2009, we announced a plan to close our Smith & Hawken business. During our first quarter of fiscal 2010,
all Smith & Hawken stores were closed and substantially all operational activities of Smith & Hawken were discontinued.
As a result, effective in our first quarter of fiscal 2010, we classified Smith & Hawken as discontinued operations in
accordance with accounting principles generally accepted in the United States of America (“GAAP”). Smith & Hawken®
is a registered trademark of Target Brands, Inc. We sold the Smith & Hawken brand and certain intellectual property
rights related thereto to Target Brands, Inc. on December 30, 2009, and subsequently changed the name of the subsidiary
entity formerly known as Smith & Hawken, Ltd. to Teak 2, Ltd. References in this Annual Report on Form 10-K to
Smith & Hawken refer to the subsidiary entity, not the brand itself.
On February 28, 2011, we completed the sale of Global Pro to ICL. In conjunction with the transaction, Scotts LLC and
ICL entered into several product supply agreements which are generally up to five years in duration, as well as various
trademark and technology licensing agreements with varying durations. Our continuing cash inflows and outflows related
to these agreements are not considered to be significant in relation to the overall cash flows of Global Pro. Furthermore,
none of these agreements permit us to influence the operating or financial policies of Global Pro under the ownership of
ICL. Therefore, Global Pro met the criteria for presentation as discontinued operations. As such, effective in the first
quarter of fiscal 2011, we classified Global Pro as discontinued operations in accordance with GAAP.
In the fourth quarter of fiscal 2012, the Company completed the wind down of our professional seed business (“Pro
Seed”). As a result, effective in our fourth quarter of fiscal 2012, we classified Pro Seed as discontinued operations in
accordance with GAAP.
In the second quarter of fiscal 2014, we completed the sale of our wild bird food business. As a result, effective in our
second quarter of fiscal 2014, we classified the wild bird food business as discontinued operations in accordance with
GAAP.
The Selected Financial Data has been retrospectively updated to recast Smith & Hawken, Global Pro, Pro Seed, and the
wild bird food business as discontinued operations for each period presented.
The Five-Year Summary includes non-GAAP financial measures, as defined in Item 10(e) of SEC Regulation S-K, of
adjusted income from operations, adjusted income from continuing operations, adjusted income attributable to controlling
interest from continuing operations and adjusted diluted earnings per share from continuing operations, which exclude
costs or gains related to discrete projects or transactions. Items excluded during the five-year period ended September 30,
2014 consisted of charges or credits relating to refinancings, impairments, restructurings, product registration and recall
matters, discontinued operations, and other unusual items such as costs or gains related to discrete projects or transactions
that are apart from and not indicative of the results of the operations of the business. The comparable GAAP measures
are reported income from operations, reported income from continuing operations and reported diluted earnings per share
from continuing operations. Our management believes that these non-GAAP measures are the most indicative of our
earnings capabilities and that disclosure of these non-GAAP financial measures therefore provides useful information to
investors or other users of the financial statements, such as lenders. Non-GAAP financial measures should be viewed in
addition to, and not as an alternative for, the Company's reported results prepared in accordance with GAAP. A
reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is presented in the following
tables:
(2)
22
Table of Contents
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Impairment, restructuring and other charges . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . . . . .
Adjusted income from operations . . . . . . . . . . . . . . . . . . . . . $
Income from continuing operations . . . . . . . . . . . . . . . . . . . . $
Impairment, restructuring and other charges, net of tax . . . .
Costs related to refinancing, net of tax . . . . . . . . . . . . . . . . .
Product registration and recall matters, net of tax . . . . . . . . .
Adjusted income from continuing operations . . . . . . . . . . . . $
Loss attributable to noncontrolling interest(7) . . . . . . . . . . . .
Adjusted income attributable to controlling interest from
continuing operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Diluted earnings per share from continuing operations. . . . . $
Impairment, restructuring and other charges, net of tax . . . .
Costs related to refinancing, net of tax . . . . . . . . . . . . . . . . .
Product registration and recall matters, net of tax . . . . . . . . .
Adjusted diluted earnings per share from continuing
operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Year Ended September 30,
2014
2013
2012
2011
2010
(In millions, except per share data)
314.6
$
310.5
$
241.2
$
301.8
$
372.9
$
$
51.0
—
365.6
165.4
33.6
7.0
—
20.3
—
330.8
159.4
13.2
—
—
7.1
8.2
$
$
256.5
111.6
$
$
4.3
—
7.4
$
$
29.8
14.6
346.2
157.5
17.9
—
12.0
18.5
8.7
400.1
206.7
12.7
—
5.6
206.0
$
172.6
$
123.3
$
187.4
$
225.0
$
$
0.3
206.3
2.64
0.54
0.11
—
$
$
—
172.6
2.55
0.21
—
—
$
$
—
123.3
1.80
0.07
—
0.12
$
$
—
187.4
2.38
0.27
—
0.19
—
225.0
3.06
0.19
—
0.08
3.29
$
2.76
$
1.99
$
2.84
$
3.33
(3)
(4)
(5)
(6)
Working capital is calculated as current assets minus current liabilities. Current ratio is calculated as current assets divided
by current liabilities.
The total debt to total book capitalization percentage is calculated by dividing total debt by total debt plus total shareholders’
equity - controlling interest.
Scotts Miracle-Gro began paying a quarterly dividend of $0.125 per Common Share in the fourth quarter of fiscal 2005.
On August 10, 2010, Scotts Miracle-Gro announced that its Board of Directors had increased the quarterly cash dividend
to $0.25 per Common Share, which was first paid in the fourth quarter of fiscal 2010. On August 8, 2011, Scotts Miracle-
Gro announced that its Board of Directors had increased the quarterly cash dividend to $0.30 per Common Share, which
was first paid in the fourth quarter of fiscal 2011. On August 9, 2012, Scotts Miracle-Gro announced that its Board of
Directors had increased the quarterly cash dividend to $0.325 per Common Share, which was first paid in the fourth
quarter of fiscal 2012. On August 6, 2013, Scotts Miracle-Gro announced that its Board of Directors had increased the
quarterly cash dividend to $0.4375 per Common Share, which was first paid in the fourth quarter of fiscal 2013. On
August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors had (i) further increased the quarterly cash
dividend to $0.45 per Common Share, which was paid in the fourth quarter of fiscal 2014 and (ii) a special one-time cash
dividend of $2.00 per Common Share, which was paid on September 17, 2014.
We view our credit facility as material to our ability to fund operations, particularly in light of our seasonality. Please
refer to “ITEM 1A. RISK FACTORS — Our indebtedness could limit our flexibility and adversely affect our financial
condition” of this Annual Report on Form 10-K for a more complete discussion of the risks associated with our debt and
our credit facility and the restrictive covenants therein. Our ability to generate cash flows sufficient to cover our debt
service costs is essential to our ability to maintain our borrowing capacity. We believe that Adjusted EBITDA provides
additional information for determining our ability to meet debt service requirements. The presentation of Adjusted
EBITDA herein is intended to be consistent with the calculation of that measure as used by our credit facility to calculate
a leverage ratio (maximum of 4.00 at September 30, 2014) and an interest coverage ratio (minimum of 3.50 for the year
ended September 30, 2014). Leverage ratio is calculated as average total indebtedness, as described in our credit facility,
relative to Adjusted EBITDA. Interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as
described in our credit facility, and excludes costs related to refinancings. Our leverage ratio was 2.18 at September 30,
2014 and our interest coverage ratio was 9.41 for the year ended September 30, 2014. Please refer to “ITEM 7.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS — Liquidity and Capital Resources — Borrowing Arrangements” of this Annual Report on Form 10-K
for a discussion of our credit facility.
23
Table of Contents
In accordance with the terms of our credit facility, Adjusted EBITDA is calculated as net income or loss before interest,
taxes, depreciation and amortization as well as certain other items such as the impact of the cumulative effect of changes
in accounting, costs associated with debt refinancing and other non-recurring, non-cash items affecting net income. Our
calculation of Adjusted EBITDA does not represent and should not be considered as an alternative to net income or cash
flows from operating activities as determined by GAAP. We make no representation or assertion that Adjusted EBITDA
is indicative of our cash flows from operating activities or results of operations. We have provided a reconciliation of
Adjusted EBITDA to income from continuing operations solely for the purpose of complying with SEC regulations and
not as an indication that Adjusted EBITDA is a substitute measure for income from continuing operations.
A numeric reconciliation of Adjusted EBITDA to income from continuing operations is as follows:
Income from continuing operations . . . . . . . . . . . . . . . . . . . . $
Income tax expense from continuing operations . . . . . . . . . .
Income (loss) from discontinued operations, net of tax
(excluding Global Pro sale) . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax expense (benefit) from discontinued operations .
Costs related to refinancings . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense from discontinued operations . . . . . . . . . . .
Depreciation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on investment of unconsolidated affiliate(8) . . . . . . . . .
Loss on impairment and other charges . . . . . . . . . . . . . . . . .
Product registration and recall matters, non-cash portion . . .
Mark-to-market adjustments on derivatives . . . . . . . . . . . . .
Smith & Hawken closure process, non-cash portion . . . . . . .
Adjusted EBITDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Year Ended September 30,
2014
2013
2012
2011
2010
(In millions, except per share data)
165.4
$
159.4
$
111.6
$
157.5
$
91.2
0.8
0.9
10.7
47.3
—
50.6
13.8
(3.3)
33.7
—
1.3
—
91.9
1.7
0.7
—
59.2
—
54.9
11.2
—
11.2
—
0.3
—
67.8
92.1
(3.4)
(1.2)
—
61.8
—
51.5
10.9
—
4.7
0.2
(1.0)
—
(29.1)
(16.6)
1.2
51.0
1.7
50.3
11.4
—
64.3
8.7
0.5
—
412.4
$
390.5
$
302.9
$
393.0
$
206.7
123.0
(2.6)
3.6
—
43.2
3.7
48.5
10.9
—
18.5
1.0
—
(16.4)
440.1
(7)
(8)
Amount represents the earnings attributable to the noncontrolling interest of AeroGrow which was consolidated in the
fourth quarter of fiscal 2014.
Amount represents a gain on our investment in AeroGrow recognized during the fourth quarter of 2014 as a result of our
consolidation of the business. Excluded from this amount is $2.4 million of earnings on AeroGrow's unconsolidated
results for fiscal year 2014 recorded within “Other income, net” in the Consolidated Statements of Operations.
24
Table of Contents
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The purpose of this discussion is to provide an understanding of our financial condition and results of operations by focusing
on changes in certain key measures from year-to-year. Management’s Discussion and Analysis (“MD&A”) is divided into the
following sections:
•
•
•
•
•
•
Executive summary
Results of operations
Segment results
Liquidity and capital resources
Regulatory matters
Critical accounting policies and estimates
Executive Summary
We are dedicated to delivering strong, long-term financial results and outstanding shareholder returns by providing products
of superior quality and value to enhance consumers’ lawn and garden environments. We are a leading manufacturer and marketer
of consumer branded products for lawn and garden care in North America and Europe. We are Monsanto’s exclusive agent for
the marketing and distribution of consumer Roundup® non-selective herbicide products within the United States and other
contractually specified countries. We have a presence in similar consumer branded products in Australia, the Far East and Latin
America. We also operate Scotts LawnService®, the second largest U.S. lawn care service business. Our operations are divided
into the following reportable segments: Global Consumer and Scotts LawnService®.
In fiscal 2014, we advanced a number of key initiatives which focused on: (1) margin improvement and savings initiatives
in the core business and (2) investment in growth opportunities adjacent to the core business through our recent acquisitions of
Tomcat®, Fafard, and Solus, as well as expansion into the urban and indoor consumer category through investments in AeroGrow
and our newly formed subsidiary The Hawthorne Gardening Company (“Hawthorne”). After a late start to the lawn and garden
season which negatively impacted our first half results, improved consumer engagement and our initiatives came together in the
second half of the year to lift full year results. During the year, we returned over $350 million to shareholders through quarterly
cash dividends, a special one-time cash dividend and share repurchases.
As a leading consumer branded lawn and garden company, our product development and marketing efforts are largely
focused on providing innovative and differentiated products and on continually increasing brand and product awareness to inspire
consumers and create retail demand. We have applied this model for a number of years by focusing on research and development
and investing approximately 5% of our annual net sales in advertising to support and promote our products and brands. We
continually explore new and innovative ways to communicate with consumers. We believe that we receive a significant return
on these expenditures and anticipate a similar commitment to research and development, advertising and marketing investments
in the future, with the continuing objective of driving category growth and profitably increasing market share.
Our net sales in any one year are susceptible to weather conditions in the markets in which our products are sold and our
services are offered. For instance, periods of abnormally wet or dry weather can adversely impact the sale of certain products,
while increasing demand for other products, or delay the timing our provision of certain services. We believe that our diversified
product line and our broad geographic diversification reduce this risk, although to a lesser extent in a year in which unfavorable
weather is geographically wide-spread and extends across a significant portion of the lawn and garden season. We also believe
that weather conditions in any one year, positive or negative, do not materially alter longer-term category growth trends.
Due to the nature of the lawn and garden business, significant portions of our products ship to our retail customers during
our second and third fiscal quarters, as noted in the chart below. Our annual net sales are further concentrated in the second and
third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products, thereby
reducing retailers’ pre-season inventories.
25
Table of Contents
Percent of Net Sales from Continuing
Operations by Quarter
2014
2013
2012
First Quarter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Second Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fourth Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6.7%
38.0%
39.3%
16.0%
7.0%
36.4%
41.0%
15.6%
6.7%
41.7%
37.5%
14.1%
Management focuses on a variety of key indicators and operating metrics to monitor the financial condition and performance
of the continuing operations of our business. These metrics include consumer purchases (point-of-sale data), market share, category
growth, net sales (including unit volume, pricing, and foreign exchange movements), gross profit margins, advertising to net sales
ratios, income from operations, income from continuing operations, net income and earnings per share. To the extent applicable,
these measures are evaluated with and without impairment, restructuring and other charges as well as product registration and
recall matters, which management believes are not indicative of the earnings capabilities of our businesses. We also focus on
measures to optimize cash flow and return on invested capital, including the management of working capital and capital
expenditures.
In August 2010, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to $500 million of our Common
Shares over a four-year period through September 30, 2014. In May 2011, the Scotts Miracle-Gro Board of Directors authorized
the repurchase of up to an additional $200 million of the Common Shares, resulting in authority to repurchase up to a total of up
to $700 million of our Common Shares through September 30, 2014. Since the inception of the share repurchase program in the
fourth quarter of fiscal 2010 through its expiration on September 30, 2014, Scotts Miracle-Gro repurchased 9.9 million Common
Shares for $521.2 million to be held in treasury.
On August 11, 2014, we announced that the Scotts Miracle-Gro Board of Directors approved the following:
• A special one-time cash dividend of $2.00 per Common Share that was paid on September 17, 2014;
• An increase in our quarterly cash dividend from $0.4375 to $0.45 per Common Share; and
• A new share repurchase authorization effective November 1, 2014, which will expire on September 30, 2019,
to repurchase up to $500 million of our Common Shares. This replaces the previous authorization which expired
on September 30, 2014.
The decision to increase the amount of cash we intend to return to our shareholders reflects our continued confidence in the
business.
Results of Operations
We classified our wild bird food business and our professional seed business as discontinued operations, for all periods
presented, beginning in our second quarter of fiscal 2014 and our fourth quarter of fiscal 2013, respectively. As a result, and unless
specifically stated, all discussions regarding results for the fiscal years ended September 30, 2014, 2013 and 2012 reflect results
from our continuing operations.
26
Table of Contents
The following table sets forth the components of income and expense as a percentage of net sales:
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales—impairment, restructuring and other. . . . . . . . . . . . . . .
Cost of sales—product registration and recall matters. . . . . . . . . . . . .
Gross profit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other. . . . . . . . . . . . . . . . . . . . . . . . . . .
Product registration and recall matters. . . . . . . . . . . . . . . . . . . . . . . . .
Other income, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Costs related to refinancing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations before income taxes . . . . . . . . . .
Income tax expense from continuing operations . . . . . . . . . . . . . . . . .
Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from discontinued operations, net of tax . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net Sales
Year Ended September 30,
2014
2013
2012
100.0%
63.7
—
—
36.3
24.0
1.8
—
(0.5)
11.0
0.4
1.7
8.9
3.2
5.7
—
5.7%
100.0%
64.6
0.1
—
35.3
23.8
0.7
—
(0.4)
11.2
—
2.1
9.1
3.3
5.8
0.1
5.9%
100.0%
65.5
—
—
34.5
25.4
0.3
0.3
(0.1)
8.6
—
2.2
6.4
2.4
4.0
(0.2)
3.8%
Net sales for fiscal 2014 increased 2.4% to $2.84 billion from $2.77 billion in fiscal 2013. Net sales for fiscal 2013 increased
0.1% from $2.77 billion in fiscal 2012. The changes in net sales compared to the previous year were attributable to the following:
Year Ended September 30,
2014
2013
Volume. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pricing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign exchange rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisitions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(0.1)%
0.9
0.2
1.4
2.4 %
(1.5)%
1.6
(0.2)
0.2
0.1 %
The increase in net sales for fiscal 2014 was primarily driven by:
•
•
•
the addition of net sales from the Tomcat® acquisition within our Global Consumer segment;
a favorable impact of increased pricing in the Global Consumer segment, primarily in the United States; and
a favorable impact of foreign exchange rates as a result of the slight weakening of the U.S. dollar relative to other
currencies;
• which were partially offset by a slight decline in volumes within our Global Consumer segment, driven by a decline in
sales within the United States of plant fertilizers and controls products, partially offset by increased sales of mulch products
in the United States and increased net sales in Europe.
27
Table of Contents
The increase in net sales for fiscal 2013 was primarily driven by:
•
•
the favorable impact of increased pricing in the Global Consumer segment, primarily in the United States; and
increased volume within our Scotts LawnService® segment driven by higher customer counts and a weather driven delay
of sales from the fourth quarter of fiscal 2012 to the first quarter of fiscal 2013.
which were partially offset by:
•
•
•
•
decreased volume in our Global Consumer segment, driven by a decrease in sales within the United States of fertilizers
and controls partially offset by increases in sales within the United States of mulch and grass seed products;
a decline in net sales attributable to reimbursements associated with our Marketing Agreement with Monsanto;
decreased sales in Corporate and Other related to ICL supply agreements, which were entered into in connection with
the sale of Global Pro in 2011; and
an unfavorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to other
currencies.
Cost of Sales
The following table shows the major components of cost of sales:
Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Manufacturing labor and overhead. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Distribution and warehousing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Roundup® reimbursements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . . . . . . . . . . . . . .
$
Year Ended September 30,
2014
2013
(In millions)
2012
1,073.5
324.3
349.1
63.0
1,809.9
—
—
1,809.9
$
$
1,100.0
310.0
321.3
62.0
1,793.3
2.2
—
1,795.5
$
$
1,105.9
311.7
316.3
79.6
1,813.5
—
0.4
1,813.9
Factors contributing to the change in cost of sales are outlined in the following table:
Material costs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Volume and product mix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Roundup® reimbursements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign exchange rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Year Ended September 30,
2014
2013
(In millions)
(23.2) $
35.1
1.0
3.7
16.6
(2.2)
—
14.4
$
(8.2)
10.3
(17.6)
(4.7)
(20.2)
2.2
(0.4)
(18.4)
28
Table of Contents
The increase in cost of sales, excluding impairment, restructuring and other charges, and product registration and recall matters
for fiscal 2014 was primarily driven by:
•
•
unfavorable product mix due to increased sales of our mulch products and higher distribution costs in our Global Consumer
segment; and
an unfavorable impact of foreign exchange rates as a result of a weakening of the U.S. dollar relative to other currencies;
• which were partially offset by a decline in material costs in our Global Consumer and Scotts LawnService® segments
due to product cost-out initiatives including growing media material costs and packaging and decreased prices of fertilizer
inputs.
The decrease in cost of sales, excluding impairment, restructuring and other charges, and product registration and recall matters
for fiscal 2013 was primarily driven by:
•
•
lower reimbursements attributable to our Marketing Agreement with Monsanto;
a decline in our growing media material costs due to our product cost-out initiatives, partially offset by increased costs
of fertilizer inputs and packaging; and
•
a favorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to other currencies;
• which were partially offset by unfavorable product mix due to increased sales of our mulch products in the United States
within our Global Consumer segment.
Gross Profit
As a percentage of net sales, our gross profit rate was 36.3% for fiscal 2014 compared to 35.3% for fiscal 2013. As a
percentage of net sales, our gross profit rate was 35.3% for fiscal 2013 compared to 34.5% for fiscal 2012. Factors contributing
to the change in gross profit rate are outlined in the following table:
Pricing
Material costs
Product mix and volume:
Roundup® commissions and reimbursements
Corporate & Other
Scotts LawnService®
Global Consumer mix and volume
Impairment, restructuring and other
Change in gross profit rate
Year Ended September 30,
2014
2013
0.6%
0.8
0.1
0.1
0.2
(0.8)
1.0
—
1.0%
1.0%
0.3
0.2
0.1
0.1
(0.8)
0.9
(0.1)
0.8%
The increase in our gross profit rate, excluding impairment, restructuring and other charges, for fiscal 2014, was primarily driven
by:
•
decreased material costs within our Global Consumer segment due to product cost-out initiatives including growing
media material costs and packaging costs and decreased prices of fertilizer inputs; and
•
a favorable impact of increased pricing for the Global Consumer segment, primarily in the United States;
• which were partially offset by unfavorable product mix within our Global Consumer segment due to increased sales of
our mulch products and higher distribution costs.
29
Table of Contents
The increase in our gross profit rate, excluding impairment, restructuring and other charges and product registration and recall
matters, for fiscal 2013 was primarily driven by:
•
•
•
a favorable impact of increased pricing for the Global Consumer segment, primarily in the United States;
decreased material costs in our Global Consumer segment due to a decline in growing media material costs resulting
from product cost-out initiatives, partially offset by increased costs for fertilizer inputs; and
the impact of zero margin dollar reimbursements, attributable to our Marketing Agreement with Monsanto;
• which were partially offset by decreased volume in our Global Consumer segment resulting in reduced leverage of fixed
manufacturing and warehousing costs.
Selling, General and Administrative Expenses
The following table shows the major components of Selling, General and Administrative expenses (“SG&A”):
Advertising . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Advertising as a percentage of net sales . . . . . . . . . . . . . . . . . . .
Share-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research and development . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other selling, general and administrative . . . . . . . . . . . . . . . . . .
$
Year Ended September 30,
2014
2013
2012
(In millions, except percentage figures)
143.6
$
142.2
$
5.1%
11.1
48.4
10.2
467.2
680.5
$
5.1%
10.3
46.4
8.2
452.5
659.6
$
168.9
6.1%
12.5
50.8
8.2
462.9
703.3
Advertising expense increased $1.4 million or 1.0% to $143.6 million in fiscal 2014 compared to $142.2 million in fiscal
2013 due to increased spending on Tomcat® branded products. Advertising expense in fiscal 2013 decreased $26.7 million compared
to fiscal 2012, driven by our planned reduction in media investment, reduced spending due to the delay in the fiscal 2013 lawn
and garden season and media purchasing efficiencies within the Global Consumer segment.
Share-based compensation expense increased $0.8 million or 7.8% to $11.1 million in fiscal 2014 compared to $10.3 million
in fiscal 2013 and in fiscal 2013 share-based compensation expense declined $2.2 million compared to fiscal 2012. These changes
were primarily due to the forfeiture of shares-based awards associated with the departure of certain key executives in fiscal 2013.
Amortization expense was $10.2 million in fiscal 2014, compared to $8.2 million in each of fiscal 2013 and fiscal 2012.
The increase in fiscal 2014 was driven by the amortization of intangible assets we acquired in connection with our acquisition of
the Tomcat® business.
Other SG&A increased $14.7 million or 3.2% in fiscal 2014 compared to fiscal 2013. The primary drivers of the increase
were increased marketing spending including package design costs and the startup of Hawthorne, which is focused on urban and
indoor gardening, and diligence and integration costs of our acquisitions of Solus and Fafard. In fiscal 2013, Other SG&A spending
decreased $10.4 million compared to fiscal 2012. This decrease was primarily due to a decline in outside consulting expenses,
selling and marketing expenditures due to cost productivity initiatives, partially offset by higher compensation expense, including
incentive compensation, heath care and severance.
Impairment, Restructuring and Other (included in SG&A)
The following table shows the breakdown of Impairment, Restructuring and Other Charges (included in SG&A):
Restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Property, plant and equipment impairments . . . . . . . . . . . . . . . .
Goodwill and intangible asset impairments . . . . . . . . . . . . . . . .
$
30
Year Ended September 30,
2014
2013
(In millions)
2012
17.3
—
33.7
51.0
$
$
2.2
—
15.9
18.1
$
$
1.8
2.1
3.2
7.1
Table of Contents
During the third quarter of fiscal 2014, as a result of the financial performance, the Company recognized an impairment
charge for a non-recurring fair value adjustment of $33.7 million within the Global Consumer segment related to the Ortho® brand.
The fair value was calculated based upon the evaluation of the historical performance and future growth expectations of the Ortho®
business.
During fiscal 2014, we recognized $12.5 million in restructuring costs related to termination benefits provided to U.S.
personnel as part of our restructuring of our U.S. administrative and overhead functions. In addition, we recognized $2.0 million
in additional ongoing monitoring and remediation expense for our turfgrass biotechnology program. We also recognized $2.8
million of international restructuring and other adjustments during fiscal 2014 for the continuation of our 2013 restructuring plan.
During the first quarter of fiscal 2013, we recognized income of $4.7 million related to the reimbursement by a vendor for
a portion of the costs incurred for the development and commercialization of products including the active ingredient MAT 28 for
the Global Consumer segment. During the first quarter of 2013, we also recognized a $4.3 million asset impairment charge as a
result of issues with the commercialization of an insect repellent technology for the Global Consumer segment. Also, as a result
of our impairment review performed in the fourth quarter of fiscal 2013, we recognized an impairment charge for a non-recurring
fair value adjustment of $11.6 million within the Global Consumer segment related to the Ortho® brand and certain sub-brands
of Ortho®. The fair value was calculated based upon the evaluation of the historical performance and future growth expectations
of the Ortho® business.
During fiscal 2013, we recognized $6.9 million in restructuring costs related to termination benefits provided to international
employees in relation to the profitability improvement initiative announced in December 2012, associated with the international
restructuring plan to reduce headcount and streamline management decision making within the Global Consumer segment.
In fiscal 2012, in continuation of the 2011 restructuring plan, we incurred an additional $1.6 million in restructuring costs
related to termination benefits provided to employees who accepted voluntary retirement and special termination benefits provided
to certain employees upon future separation as well as $0.2 million related to curtailment charges for our U.S. defined benefit
pension and U.S. retiree medical plans. Additionally, we recognized a $5.3 million asset impairment charge as a result of issues
with commercialization of products including the active ingredient MAT 28 for the Global Consumer segment. Further, we have
previously expensed product development and marketing costs associated with the previously planned launch of products containing
MAT 28 and are evaluating our options for recovering those costs.
Product Registration and Recall Matters (included in SG&A)
As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012, in fiscal 2012,
we resolved the previously disclosed U.S. EPA and U.S. Department of Justice (“U.S. DOJ”) investigations into pesticide product
registration issues. Product registration and recall costs were $7.8 million in fiscal 2012. For fiscal 2014 and fiscal 2013, there
were no product registration and recall costs. Fiscal 2012 costs included additional reserves established in connection with the
fiscal 2012 settlement of the previously disclosed U.S. EPA and U.S. DOJ investigations, as well as third-party compliance review,
legal and consulting fees associated with these investigations. We do not expect to incur any additional costs related to these
investigations, as they were settled in the fourth quarter of fiscal 2012.
Other Income, net
Other income is comprised of activities outside our normal business operations, such as royalty income from the licensing
of certain of our tradenames, franchise fee income from our Scotts LawnService® business, foreign exchange gains/losses and
gains/losses from the sale of non-inventory assets. Other income, net, was $14.7 million, $10.0 million and $2.8 million in fiscal
2014, fiscal 2013 and fiscal 2012, respectively. The increase in other income, net, for fiscal 2014 was primarily due to $5.8 million
of gains related to our investment in AeroGrow. The increase in other income, net, for fiscal 2013 was primarily due to the sale
of peat bog land in fiscal 2013 in the United Kingdom for a gain of $2.3 million and a non-recurring impairment charge of $4.4
million incurred in fiscal 2012 resulting from the revaluation of our corporate aircraft.
Income from Operations
Income from operations in fiscal 2014 was $314.6 million compared to $310.5 million in fiscal 2013, an increase of $4.1
million, or 1.3%. Excluding impairment, restructuring and other charges, income from operations increased by $34.8 million, or
10.5%, in fiscal 2014, primarily driven by higher gross profit and an increase in other income, net, partially offset by an increase
in SG&A.
Income from operations in fiscal 2013 was $310.5 million compared to $241.2 million in fiscal 2012, an increase of $69.3
million, or 28.7%. Excluding impairment, restructuring and other charges and product registration and recall costs, income from
operations increased by $74.3 million, or 29.0%, in fiscal 2013, primarily driven by higher gross profit and lower SG&A spending.
31
Table of Contents
Costs Related to Refinancing
Costs related to refinancing were $10.7 million for fiscal 2014. The costs incurred were associated with the redemption of
our 7.25% senior notes due 2018 (the “7.25% Senior Notes”).
Interest Expense
Interest expense in fiscal 2014 was $47.3 million compared to $59.2 million and $61.8 million in fiscal 2013 and fiscal
2012, respectively. The decline in fiscal 2014 was primarily due to a decrease in our weighted average interest rate of 124 basis
points compared to fiscal 2013 as a result of reduced rates under our third amended and restated credit agreement and due to the
redemption of the 7.25% Senior Notes. The decrease in fiscal 2013 was primarily due to a decrease in average borrowings, partially
offset by an increase in our weighted average interest rate of 24 basis points compared to fiscal 2012.
Income Tax Expense
A reconciliation of the federal corporate income tax rate and the effective tax rate on income from continuing operations
before income taxes is summarized below:
Year Ended September 30,
2014
2013
2012
Statutory income tax rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effect of foreign operations. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State taxes, net of federal benefit . . . . . . . . . . . . . . . . . . . . . . . .
Domestic production activities deduction permanent difference
Effect of other permanent differences . . . . . . . . . . . . . . . . . . . . .
Research and experimentation and other federal tax credits . . . .
Resolution of prior tax contingencies . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effective income tax rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
35.0%
1.5
2.7
(2.7)
0.2
(0.8)
0.2
(0.5)
35.6%
35.0%
0.8
2.9
(2.1)
0.8
(0.3)
0.2
(0.7)
36.6%
35.0%
(0.5)
3.1
(1.5)
2.4
(0.1)
(0.9)
0.3
37.8%
The effective tax rate for continuing operations was 35.6% for fiscal 2014, compared to 36.6% for fiscal 2013 and 37.8%
for fiscal 2012. Excluding reserves established for product registrations and recall matters, the effective tax rate for continuing
operations was 35.6%, 36.6% and 36.1% for fiscal 2014, fiscal 2013 and fiscal 2012, respectively.
Income and Earnings per Share from Continuing Operations
We reported income attributable to controlling interest from continuing operations of $165.7 million, or $2.64 per diluted
share, in fiscal 2014 compared to income attributable to controlling interest from continuing operations of $159.4 million, or $2.55
per diluted share, in fiscal 2013. In fiscal 2014, we incurred costs of $51.0 million, relating to impairment, restructuring and other
charges. Additionally the Company incurred $10.7 million of costs during the third quarter of 2014 related to refinancing. In
fiscal 2013, we incurred $20.3 million of impairment, restructuring and other charges. Excluding these items, adjusted income
attributable to controlling interest from continuing operations was $206.3 million in fiscal 2014 compared to $172.6 million in
fiscal 2013, an increase of $33.7 million, primarily driven by higher gross profit, increased Other Income, net, and lower interest
expense; partially offset by higher SG&A spending. Diluted weighted-average Common Shares outstanding increased from 62.6
million in fiscal 2013 to 62.7 million in fiscal 2014. The increase was primarily driven by the exercise of stock options and the
issuance of Common Shares upon the vesting of restricted share-based awards, an increase in the number of dilutive potential
Common Shares, partially offset by share repurchases. Dilutive equivalent shares for fiscal 2014 and fiscal 2013 were 1.1 million
and 0.9 million, respectively. The increase in dilutive equivalent shares was primarily driven by an increase in our average share
price, partially offset by the exercise of stock options.
We reported income attributable to controlling interest from continuing operations of $159.4 million, or $2.55 per diluted
share, in fiscal 2013 compared to income attributable to controlling interest from continuing operations of $111.6 million, or $1.80
per diluted share, in fiscal 2012. In fiscal 2013, we incurred costs of $20.3 million relating to impairment, restructuring and other
charges. In fiscal 2012, we incurred $7.1 million of impairment charges, as well as $8.2 million in pre-tax costs associated with
product registration and recall matters. Excluding these items, adjusted income from continuing operations was $172.6 million
in fiscal 2013 compared to $123.3 million in fiscal 2012, an increase of $49.3 million, primarily driven by higher gross profit and
lower SG&A spending and interest expense. Diluted weighted-average Common Shares outstanding increased from 62.1 million
in fiscal 2012 to 62.6 million in fiscal 2013. The increase was primarily driven by the exercise of stock options and issuance of
Common Shares upon the vesting of restricted share-based awards partially offset by a decrease in the number of dilutive equivalent
32
Table of Contents
shares. Dilutive equivalent shares for fiscal 2013 and fiscal 2012 were 0.9 million and 1.1 million, respectively. The decrease in
dilutive equivalent shares was primarily driven by the exercise of stock options partially offset by an increase in our average share
price.
Income (loss) from Discontinued Operations
In our second quarter of fiscal 2014, we completed the sale of our wild bird food business. As a result, we began presenting
this business within discontinued operations. In our fourth quarter of fiscal 2013, we completed the wind down of the non-European
professional seed business. As a result, we began presenting this business within discontinued operations.
Income from discontinued operations, net of tax, was $0.8 million in fiscal 2014, while income of $1.7 million and loss of
$5.1 million were recognized in fiscal 2013 and fiscal 2012, respectively. Fiscal 2014 included activity associated with the sale
of the wild bird food business. Fiscal 2013 and fiscal 2012 included activity associated with the wind down and disposal of the
non-European professional seed business.
Segment Results
Our continuing operations are divided into the following reportable segments: Global Consumer and Scotts LawnService®.
This division of reportable segments is consistent with how the segments report to and are managed by the chief operating decision
maker of the Company. Corporate & Other includes revenues and expenses associated with the Company’s supply agreements
with ICL and the amortization related to the Roundup® Marketing Agreement, as well as corporate general and administrative
expenses and certain other income/expense items not allocated to the business segments.
We evaluate segment performance based on several factors, including income from continuing operations before income
taxes, interest expense, amortization, product registration and recall costs, impairment, restructuring and other charges and costs
related to refinancing. Management uses this measure of operating profit to evaluate segment performance because we believe
this measure is the most indicative of performance trends and the overall earnings potential of each segment.
The following tables present segment information:
Net Sales by Segment
Year Ended September 30,
2014
2013
(In millions)
2012
Global Consumer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService® . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2,552.0
263.0
2,815.0
26.3
2,841.3
$
$
2,484.7
257.8
2,742.5
31.2
2,773.7
Income (Loss) from Continuing Operations before Income Taxes by Segment
Global Consumer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService® . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible asset amortization. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . .
Costs related to refinancing . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
33
Year Ended September 30,
2014
2013
(In millions)
438.8
30.2
469.0
(90.4)
(13.0)
—
(51.0)
(10.7)
(47.3)
256.6
$
$
403.7
28.7
432.4
(91.2)
(10.4)
—
(20.3)
—
(59.2)
251.3
$
$
$
$
2,483.6
245.8
2,729.4
41.1
2,770.5
2012
335.9
27.0
362.9
(96.3)
(10.1)
(8.2)
(7.1)
—
(61.8)
179.4
Table of Contents
Global Consumer
Global Consumer segment net sales increased 2.7% from $2.48 billion in fiscal 2013 to $2.55 billion in fiscal 2014. The
change in fiscal 2014 net sales was favorably impacted by the Tomcat® acquisition, favorable pricing and foreign exchange rates,
which were responsible for net sales increases of 1.6%, 1.1%, and 0.2%, respectively. These increases were partially offset by a
slight decrease in sales volume driven by a decline in sales within the United States of plant fertilizers and control products,
partially offset by increased sales of mulch products in the United States and increased net sales in Europe. Net sales in the United
States increased by 1.5%, primarily driven by the acquisition of the Tomcat® consumer rodent control business during the first
quarter of fiscal 2014 and an increase in pricing partially offset by a slight decrease in sales volume driven by a decline in sales
within the United States of plant fertilizers and control products, partially offset by increased sales of mulch products in the U.S.
Net sales outside of the United States increased 7.3% in fiscal 2014, primarily attributable to sales volume improvements in Europe
and favorable effects of foreign currency changes as a result of the weakening of the U.S. dollar relative to other currencies,
particularly the Euro. Excluding the impact of foreign currency rates, net sales outside of the United States increased 6.2%
compared to fiscal 2013.
Global Consumer segment income from continuing operations before income taxes (“segment income”) for fiscal 2014 was
$438.8 million, an increase of $35.1 million, or 8.7%, compared to fiscal 2013. Excluding the impact of foreign exchange
movements, segment income increased by $33.5 million, or 8.3%, from fiscal 2013. The increase in segment income for fiscal
2014 was primarily driven by the sales from businesses acquired in fiscal 2014, the favorable impact of pricing, and decreased
material costs, partially offset by an increase in SG&A expenses primarily related to increased marketing expense in the U.S.
Consumer business and transaction costs related to the acquisitions of Solus and Fafard.
Global Consumer segment net sales were flat in fiscal 2013 compared to fiscal 2012 at $2.48 billion. Net sales in the U.S.
increased $2.6 million or 0.1% in fiscal 2013 compared to fiscal 2012 primarily due to an increase in pricing and increases in sales
of mulch and grass seed products, partially offset by declines in reimbursements attributable to our Marketing Agreement with
Monsanto and sales of our controls products. Net sales outside of the United States decreased $1.5 million or 0.3% primarily
attributable to volume declines in Europe and unfavorable effects of foreign currency changes as a result of the strengthening of
the U.S. dollar relative to other currencies, partially offset by volume increases in Asia Pacific. Excluding the impact of foreign
currency rates, net sales outside of the United States increased 1.0% compared to fiscal 2012.
Global Consumer segment income for fiscal 2013 was $403.7 million, an increase of $67.8 million, or 20.2%, compared to
fiscal 2012. Excluding the impact of foreign exchange movements, segment income increased by $69.2 million, or 20.7%, for
fiscal 2013. The increase in segment income for fiscal 2013 was primarily driven by the favorable impact of pricing, decreased
material costs and a decrease in SG&A expenses resulting from our product cost-out initiatives.
Scotts LawnService®
Scotts LawnService® net sales increased by $5.2 million, or 2.0%, to $263.0 million in fiscal 2014, primarily due to higher
customer counts and increased volume. Scotts LawnService® segment income increased $1.5 million to $30.2 million in fiscal
2014. The improved operating results were driven by the higher net sales, lower product costs and lower incentive compensation,
partially offset by higher selling expenses.
Scotts LawnService® net sales increased by $12.0 million, or 4.9%, to $257.8 million in fiscal 2013, primarily due to increased
customer retention, the full year impact of acquisitions and new customer sales. Scotts LawnService® segment income increased
$1.7 million to $28.7 million in fiscal 2013. The improved operating results were driven by higher net sales and lower product
costs, partially offset by higher SG&A, which was primarily the outcome of higher marketing and selling expenses.
Corporate & Other
Net sales for Corporate & Other decreased $4.9 million to $26.3 million in fiscal 2014, due to a decline in sales for our ICL
supply agreements, which commenced shortly after the sale of Global Pro in our second quarter of fiscal 2011. The net expense
for Corporate & Other was flat for fiscal 2014 compared to fiscal 2013.
Net sales for Corporate & Other decreased $9.9 million to $31.2 million in fiscal 2013, primarily due to our ICL supply
agreements, which commenced shortly after the sale of Global Pro in our second quarter of fiscal 2011. Net expense for Corporate &
Other decreased by $5.1 million in fiscal 2013, driven by reduced spending on outside consulting expenses and marketing related
expenditures as part of our cost productivity initiatives, partially offset by higher employee related costs, including incentive
compensation, health care and severance.
34
Table of Contents
Liquidity and Capital Resources
Operating Activities
Cash provided by operating activities declined by $101.1 million to $240.9 million in fiscal 2014. The change in the cash
provided by our operating activities was primarily due to an increase in inventory of $38.7 million in fiscal 2014 as part of an
early build of growing media and plant food products for the fiscal 2015 lawn and garden season and a decline in expected volumes
compared to an $89.0 million decline in inventory in fiscal 2013.
Cash provided by operating activities increased by $188.6 million to $342.0 million in fiscal 2013 from $153.4 million in
fiscal 2012. The change in the cash provided by our operating activities was primarily due to an increase in net income of $54.6
million and a reduction in inventory levels over the prior year of $89.0 million as a result of improved inventory management. In
addition, income taxes paid declined in fiscal 2013 due to the receipt of an overpayment of taxes related to fiscal 2012 of $37.8
million.
The seasonal nature of our operations generally requires cash to fund significant increases in inventories during the first half
of the fiscal year. Receivables and payables also build substantially in the second quarter of the fiscal year in line with the timing
of sales to support our retailers’ spring selling season. These balances liquidate during the June through September period as the
lawn and garden season unwinds. Unlike our core Global Consumer segment, Scotts LawnService® typically has its highest
receivables balance in the fourth quarter because of the seasonal timing of customer applications and service revenues.
Investing Activities
Cash used in investing activities totaled $155.6 million and $64.2 million in fiscal 2014 and fiscal 2013, respectively. The
change in cash used in our investing activities was primarily driven by increased capital investments in property, plant and equipment
and acquisitions of $27.5 million and $110.8 million, respectively, partially offset by $35.1 million in cash proceeds received from
the sale and leaseback of an airplane as well as proceeds received from the sale of our U.S. and Canadian wild bird food business
of $7.2 million, and the sale of long-lived assets of $3.7 million. The increase in capital investments in property, plant, and equipment
includes a $35.1 million down payment on a purchase order to acquire an aircraft that was subsequently sold and leased back.
Significant capital projects during fiscal 2014 included investments in our growing media production and packaging facilities,
additional capital for supply chain optimization projects, investments in information technology, facility improvement and
maintenance, and investments in fleet vehicles for Scotts LawnService®. Further, during fiscal 2014 we completed acquisitions
of the Tomcat® consumer rodent control business from Bell Laboratories, Inc. within our Global Consumer segment for $60.0
million in the first quarter of fiscal 2014 and in the fourth quarter of fiscal 2014 we completed the acquisition of Fafard, a consumer
growing media business based in Quebec, Canada for $52.7 million in cash and contingent consideration of $7.1 million based
on future performance of the business.
Cash used in investing activities totaled $64.2 million and $75.7 million in fiscal 2013 and fiscal 2012, respectively. The
change in cash used in our investing activities was primarily driven by a reduction of capital investments in property, plant and
equipment and acquisitions of $9.3 million and $3.8 million, respectively, and cash proceeds from the sale of long-lived assets of
$3.6 million. Significant capital projects during fiscal 2013 included investments in our mulch production facilities associated
with our product cost-out initiatives, additional capital to increase capabilities in our fertilizer production facilities, improvements
to our inventory warehouse management system and investments in information technology. Further, during fiscal 2013 we
completed acquisitions of two franchisee businesses within our Scotts LawnService® segment for $3.2 million and an investment
in an unconsolidated affiliate in the indoor gardening market for $4.5 million.
For the three years ended September 30, 2014, our capital spending was allocated as follows: 66% for expansion and
maintenance of existing Global Consumer productive assets; 13% for new productive assets supporting our Global Consumer
segment; 11% to expand our information technology and transformation and integration capabilities; 3% for expansion and upgrades
of Scotts LawnService® infrastructure; and 7% for Corporate & Other assets. We expect fiscal 2015 capital expenditures to be
consistent with our recent capital spending amounts and allocations.
Financing Activities
Financing activities used cash of $124.3 million and $280.6 million in fiscal 2014 and fiscal 2013, respectively. The change
in cash used in financing activities was the result of higher net borrowings of $614.8 million under our credit facility, partially
offset by an increase in cash returned to shareholders through dividends of $143.0 million (which included $20.9 million in
recurring quarterly cash payments and $122.1 million for the special one-time cash dividend of $2.00 per share), the repayment
of our 7.25% Senior Notes of $200.0 million, and $120.0 million for repurchases of Common Shares in fiscal year 2014. Net
borrowings under our credit facilities in fiscal 2014 were $407.5 million compared to net payments of $207.3 million in fiscal
35
Table of Contents
2013. Financing activities also included an increase in cash received from the exercise of stock options of $6.7 million in fiscal
2014 compared to fiscal 2013.
Financing activities used cash of $280.6 million and $79.3 million in fiscal 2013 and fiscal 2012, respectively. An increase
in the net repayment of borrowings under our credit facility of $196.7 million and a reduction of share repurchases of $17.5 million
was partially offset by an increase of cash returned to shareholders through dividends of $12.4 million. Net repayments under
our credit facilities were $207.3 million in fiscal 2013, compared to $10.6 million in fiscal 2012. Financing activities also included
a decrease in cash received from the exercise of stock options of $4.3 million in fiscal 2013 compared to fiscal 2012.
Cash and Cash Equivalents
Our cash and cash equivalents balances of $89.3 million at September 30, 2014 and $129.8 million at September 30, 2013
were held in depository accounts with major financial institutions around the world or invested in high quality, short-term liquid
investments, with original maturities of three months or less. The cash and cash equivalents balance at September 30, 2014
included $59.9 million held by controlled foreign corporations. Our current plans do not demonstrate a need to, nor do we have
plans to, repatriate the retained earnings from these foreign corporations as the earnings are indefinitely reinvested. However, in
the future, if we determine it is necessary to repatriate these funds, or if we sell or liquidate any of these foreign corporations, we
may be required to pay associated taxes on the repatriation, sale or liquidation.
Borrowing Arrangements
Our primary sources of liquidity are cash generated by operations and borrowings under our credit facility which is guaranteed
by substantially all of our domestic subsidiaries. On December 20, 2013, Scotts Miracle-Gro and certain of our subsidiaries entered
into a third amended and restated senior secured credit agreement (the “current credit facility”), providing Scotts Miracle-Gro and
certain of our subsidiaries with a five-year senior secured revolving loan facility in the aggregate principal amount of up to $1.7
billion. Borrowings may be made in various currencies including U.S. dollars, Euros, British pounds, Australian dollars and
Canadian dollars. Under the current credit facility, we may request up to an additional $450 million in revolving and/or term
commitments, subject to certain specified conditions, including approval from the lenders. The current credit facility replaced
our second amended and restated senior secured credit agreement, which was entered into on June 30, 2011 and would have
terminated on June 30, 2016 if it had not been terminated early in connection with our entry into the current credit facility.
The terms of the current credit facility include customary representations and warranties, customary affirmative and negative
covenants, and events of default. The proceeds of borrowings under the current credit facility may be used: (i) to finance working
capital requirements and other general corporate purposes of Scotts Miracle-Gro and our subsidiaries; and (ii) to refinance the
amounts outstanding under the previous credit agreement. The current credit facility is guaranteed by substantially all of our
domestic subsidiaries.
We may use the current credit facility to obtain letters of credit up to an aggregate face amount of $75 million. The current
credit facility will terminate on December 20, 2018. At September 30, 2014, we had letters of credit in the aggregate face amount
of $23.3 million outstanding, and $1.2 billion of availability under the current credit facility.
On January 15, 2014, we redeemed all of the outstanding $200.0 million aggregate principal amount of 7.25% Senior Notes
due 2018 paying a redemption price of $214.5 million, which included $7.25 million of accrued and unpaid interest, $7.25 million
of call premium, and $200.0 million for outstanding principal amount. The $7.25 million call premium charge was recognized
within the “Costs related to refinancing” line on the Condensed Consolidated Statement of Operations in the Company's second
quarter of fiscal 2014. Additionally, we had $3.5 million in unamortized bond discount and issuance costs associated with the
7.25% Senior Notes that were written-off and recognized in the “Costs related to refinancing” line on the Condensed Consolidated
Statement of Operations in the second quarter of fiscal 2014. These amounts are reported in the aggregate in the “Costs related
to refinancing” line of the Consolidated Statement of Operations for fiscal 2014 in this Annual Report on Form 10-K.
On December 16, 2010, we issued $200.0 million aggregate principal amount of 6.625% Senior Notes due 2020. The net
proceeds of the offering were used to repay outstanding borrowings under our then existing credit facilities and for general corporate
purposes. The 6.625% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our
existing and future unsecured senior debt. The 6.625% Senior Notes have interest payment dates of June 15 and December 15 of
each year, which began on June 15, 2011, and may be redeemed prior to maturity starting December 2015 at applicable redemption
premiums. The 6.625% Senior Notes contain usual and customary covenants. The 6.625% Senior Notes mature on December
15, 2020. Substantially all of our domestic subsidiaries serve as guarantors of the 6.625% Senior Notes.
We are in compliance with the terms of all debt covenants at September 30, 2014. The current credit facility contains, among
other obligations, an affirmative covenant regarding our leverage ratio, calculated as average total indebtedness, as described in
the current credit facility, relative to the our EBITDA, as adjusted pursuant to the terms of the current credit facility (“Adjusted
36
Table of Contents
EBITDA”). Under the terms of the current credit facility, the maximum allowable leverage ratio was 4.00 as of September 30,
2014. Our leverage ratio was 2.18 at September 30, 2014. Our current credit facility also includes an affirmative covenant
regarding our interest coverage ratio. Interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as
described in the current credit facility, and excludes costs related to refinancings. Under the terms of the current credit facility,
the minimum allowable interest coverage ratio was 3.50 for the year ended September 30, 2014. Our interest coverage ratio was
9.41 for the year ended September 30, 2014. The weighted average interest rates on average debt were 5.0% and 6.2% for fiscal
2014 and fiscal 2013, respectively. Please see “ITEM 6. SELECTED FINANCIAL DATA” of this Annual Report on Form 10-
K for further details pertaining to the calculations of the foregoing ratios.
We continue to monitor our compliance with the leverage ratio, interest coverage ratio and other covenants contained in the
current credit facility and, based upon our current operating assumptions, we expect to remain in compliance with the permissible
leverage ratio and interest coverage ratio throughout fiscal 2015. However, an unanticipated charge to earnings, an increase in
debt or other factors could materially affect our ability to remain in compliance with the financial or other covenants of our current
credit facility, potentially causing us to have to seek an amendment or waiver from our lending group which could result in repricing
of our current credit facility.
At September 30, 2014, we had outstanding interest rate swap agreements with major financial institutions that effectively
converted the LIBOR index portion of variable-rate debt denominated in U.S. dollars to a fixed rate. The swap agreements had
a total U.S. dollar notional amount of $1,300.0 million at September 30, 2014. Interest payments made between the effective date
and expiration date are hedged by the swap agreements, except as noted below. The notional amount, effective date, expiration
date and rate of each of these swap agreements are shown in the table below.
Notional Amount
(in millions)
Effective
Date (a)
Expiration
Date
Fixed
Rate
$
50
(b)
(c)
(b)
(b)
(c)
(d)
(b)
(c)
(c)
150
150
50
100
150
50
200
150
50
200
2/14/2012
2/7/2012
11/16/2009
2/16/2010
2/21/2012
12/20/2011
12/6/2012
2/7/2014
2/7/2017
2/7/2017
12/20/2016
2/14/2016
5/7/2016
5/16/2016
5/16/2016
5/23/2016
6/20/2016
9/6/2017
11/7/2017
5/7/2019
5/7/2019
6/20/2019
3.78%
2.42%
3.26%
3.05%
2.40%
2.61%
2.96%
1.28%
2.12%
2.25%
2.12%
(a)
(b)
(c)
(d)
The effective date refers to the date on which interest payments were, or will be, first hedged by the applicable swap agreement.
Interest payments made during the three-month period of each year that begins with the month and day of the effective date are hedged
by the swap agreement.
Interest payments made during the six-month period of each year that begins with the month and day of the effective date are hedged
by the swap agreement.
Interest payments made during the nine-month period of each year that begins with the month and day of the effective date are hedged
by the swap agreement.
We maintain a Master Accounts Receivable Purchase Agreement (“MARP Agreement”), which is uncommitted and provides
for the discretionary sale by us, and the discretionary purchase by the banks, on a revolving basis, of accounts receivable generated
by sales to three specified account debtors in an aggregate amount not to exceed $400 million. On October 25, 2013, we signed
an amendment to the existing MARP Agreement which extended the termination date to August 29, 2014. On August 29, 2014,
we signed a further amendment to the existing MARP Agreement which extended the termination date to August 28, 2015, or
such later date as may be agreed by each bank party thereto and us. Under the terms of the MARP Agreement, the banks have the
opportunity to purchase those accounts receivable offered by us at a discount (from the agreed base value thereof) effectively
equal to the one-week LIBOR plus 0.75%. There were $84.0 million of short-term borrowings as of September 30, 2014 and
$85.3 million of short-term borrowings as of September 30, 2013 under the MARP Agreement. The carrying value of the receivables
pledged as collateral was $113.7 million and $106.7 million as of September 30, 2014 and September 30, 2013, respectively.
We believe that our cash flows from operations and our capital resources will be sufficient to meet debt service, capital
expenditures and working capital needs during fiscal 2015, and thereafter for the foreseeable future. However, we cannot ensure
that our business will generate sufficient cash flow from operations or that future borrowings will be available under our credit
facility in amounts sufficient to pay indebtedness or fund other liquidity needs. Actual results of operations will depend on
37
Table of Contents
numerous factors, many of which are beyond our control, as further discussed in “ITEM 1A. RISK FACTORS — Our indebtedness
could limit our flexibility and adversely affect our financial condition” of this Annual Report on Form 10-K.
Judicial and Administrative Proceedings
We are party to various pending judicial and administrative proceedings arising in the ordinary course of business, including,
among others, proceedings based on accidents or product liability claims and alleged violations of environmental laws. We have
reviewed these pending judicial and administrative proceedings, including the probable outcomes, reasonably anticipated costs
and expenses, and the availability and limits of our insurance coverage, and have established what we believe to be appropriate
reserves. We do not believe that any liabilities that may result from these pending judicial and administrative proceedings are
reasonably likely to have a material effect on our financial condition, results of operations, or cash flows; however, there can be
no assurance that future quarterly or annual operating results will not be materially affected by these proceedings, whether as a
result of adverse outcomes or as a result of significant defense costs.
Contractual Obligations
The following table summarizes our future cash outflows for contractual obligations as of September 30, 2014:
Contractual Cash Obligations
Payments Due by Period
Total
Less Than 1
Year
1-3 Years
4-5 Years
More Than
5 Years
Debt obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense on debt obligations . . . . . . . . . . . . . . . . . .
Operating lease obligations . . . . . . . . . . . . . . . . . . . . . . . . .
Purchase obligations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other, primarily retirement plan obligations . . . . . . . . . . . .
Total contractual cash obligations . . . . . . . . . . . . . . . . . . . .
$
784.3
167.1
173.1
208.9
93.8
$ 1,427.2
$
$
(In millions)
9.2
$
73.8
62.5
69.7
17.5
232.7
$
$
$
91.9
38.2
46.4
127.1
4.1
307.7
482.8
52.3
37.2
11.6
18.0
601.9
$
$
200.4
2.8
27.0
0.5
54.2
284.9
We have long-term debt obligations and interest payments due primarily under the 6.625% Senior Notes and our current
credit facility. Amounts in the table represent scheduled future maturities of long-term debt principal for the periods indicated.
The interest payments for our current credit facility are based on outstanding borrowings as of September 30, 2014. Actual interest
expense will likely be higher due to the seasonality of our business and associated higher average borrowings.
Purchase obligations primarily represent commitments for materials used in our manufacturing processes, as well as
commitments for warehouse services, grass seed and out-sourced information services which comprise the unconditional purchase
obligations disclosed in “NOTE 17. COMMITMENTS” of the Notes to Consolidated Financial Statements included in this Annual
Report on Form 10-K.
Other obligations include actuarially determined retiree benefit payments and pension funding to comply with local funding
requirements. Pension funding requirements beyond fiscal 2014 are based on preliminary estimates using actuarial assumptions
determined as of September 30, 2014. The above table excludes liabilities for unrecognized tax benefits and insurance accruals
as the Company is unable to estimate the timing of payments for these items.
Off-Balance Sheet Arrangements
At September 30, 2014, the Company had letters of credit in the aggregate face amount of $23.3 million outstanding. Further,
the Company has residual value guarantees on Scotts LawnService® vehicles and the corporate aircraft as disclosed in “NOTE
16. OPERATING LEASES” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
38
Table of Contents
Regulatory Matters
We are subject to local, state, federal and foreign environmental protection laws and regulations with respect to our business
operations and believe we are operating in substantial compliance with, or taking actions aimed at ensuring compliance with, such
laws and regulations. We are involved in several legal proceedings with various governmental agencies related to environmental
matters, including those described in “ITEM 3. LEGAL PROCEEDINGS” of this Annual Report on Form 10-K and “NOTE 18.
CONTINGENCIES” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K. While it
is difficult to quantify the potential financial impact of actions involving these environmental matters, particularly remediation
costs at waste disposal sites and future capital expenditures for environmental control equipment, in the opinion of management,
the ultimate liability arising from such environmental matters, taking into account established reserves, should not have a material
effect on our financial condition, results of operations or cash flows. However, there can be no assurance that the resolution of
these matters will not materially affect our future quarterly or annual results of operations, financial condition or cash flows.
Additional information on environmental matters affecting us is provided in “ITEM 1. BUSINESS — Regulatory Considerations
— Regulatory Matters” and “ITEM 3. LEGAL PROCEEDINGS” of this Annual Report on Form 10-K.
Critical Accounting Policies and Estimates
Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial
statements, which have been prepared in accordance with GAAP. Certain accounting policies are particularly significant, including
those related to revenue recognition, goodwill and intangibles, certain associate benefits and income taxes. We believe these
accounting policies, and others set forth in “NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES” of the Notes
to Consolidated Financial Statements included in this Annual Report on Form 10-K, should be reviewed as they are integral to
understanding our results of operations and financial position. Our critical accounting policies are reviewed periodically with the
Audit and Finance Committee of the Board of Directors of Scotts Miracle-Gro.
The preparation of financial statements requires management to use judgment and make estimates that affect the reported
amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing
basis, we evaluate our estimates, including those related to customer programs and incentives, product returns, bad debts,
inventories, intangible assets, income taxes, restructuring, environmental matters, contingencies and litigation. We base our
estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances.
Although actual results historically have not deviated significantly from those determined using our estimates, our results of
operations or financial condition could differ, perhaps materially, from these estimates under different assumptions or conditions.
Revenue Recognition and Promotional Allowances
Most of our revenue is derived from the sale of inventory, and we recognize revenue when title and risk of loss transfer,
generally when products are received by the customer. Provisions for payment discounts, product returns and allowances are
recorded as a reduction of sales at the time revenue is recognized based on historical trends and adjusted periodically as
circumstances warrant. Similarly, reserves for uncollectible receivables due from customers are established based on management’s
judgment as to the ultimate collectability of these balances. We offer sales incentives through various programs, consisting
principally of volume rebates, cooperative advertising, consumer coupons and other trade programs. The cost of these programs
is recorded as a reduction of sales. The recognition of revenues, receivables and trade programs requires the use of estimates.
While we believe these estimates to be reasonable based on the then current facts and circumstances, there can be no assurance
that actual amounts realized will not differ materially from estimated amounts recorded.
Income Taxes
Our annual effective tax rate is established based on our pre-tax income (loss), statutory tax rates and the tax impacts of
items treated differently for tax purposes than for financial reporting purposes. We record income tax liabilities utilizing known
obligations and estimates of potential obligations. A deferred tax asset or liability is recognized whenever there are future tax
effects from existing temporary differences and operating loss and tax credit carryforwards. Valuation allowances are used to
reduce deferred tax assets to the balances that are more likely than not to be realized. We must make estimates and judgments on
future taxable income, considering feasible tax planning strategies and taking into account existing facts and circumstances, to
determine the proper valuation allowances. When we determine that deferred tax assets could be realized in greater or lesser
amounts than recorded, the asset balance and consolidated statement of operations reflect the change in the period such
determination is made. Due to changes in facts and circumstances and the estimates and judgments that are involved in determining
the proper valuation allowances, differences between actual future events and prior estimates and judgments could result in
adjustments to these valuation allowances. We use an estimate of our annual effective tax rate at each interim period based on the
facts and circumstances available at that time, while the actual effective tax rate is calculated at year-end.
39
Table of Contents
Inventories
Inventories are stated at the lower of cost or market, principally determined by the first-in, first-out method of accounting.
Inventories include the cost of raw materials, labor, manufacturing overhead and freight and in-bound handling costs incurred to
pre-position goods in our warehouse network. Adjustments to net realizable value for excess and obsolete inventory are based on
a variety of factors, including product changes and improvements, changes in active ingredient availability and regulatory
acceptance, new product introductions and estimated future demand. The adequacy of our adjustments could be materially affected
by changes in the demand for our products or regulatory actions.
Long-lived Assets, including Property, Plant and Equipment
Property, plant and equipment are stated at cost. Depreciation of property, plant and equipment is provided on the straight-
line method and is based on the estimated useful economic lives of the assets. Intangible assets with finite lives, and therefore
subject to amortization, include technology (e.g., patents), customer relationships and certain tradenames. These intangible assets
are being amortized over their estimated useful economic lives typically ranging from 3 to 25 years. We review long-lived assets
whenever circumstances change such that the recorded value of an asset may not be recoverable and therefore impaired.
Goodwill and Indefinite-lived Intangible Assets
We have significant investments in intangible assets and goodwill. Our annual goodwill and indefinite-lived intangible asset
testing is performed as of the first day of our fiscal fourth quarter or more frequently if circumstances indicate potential impairment.
In our evaluation of goodwill and indefinite-lived intangible assets impairment, we perform either an initial qualitative or
quantitative evaluation for each of our reporting units and indefinite-lived intangible assets. Factors considered in the qualitative
test include operating results as well as new events and circumstances impacting the operations or cash flows of the reporting unit
and indefinite-lived intangible assets. For the quantitative test, the review for impairment of goodwill and indefinite-lived intangible
assets is primarily based on our estimates of discounted future cash flows, which are based upon annual budgets and longer-range
strategic plans. These budgets and plans are used for internal purposes and are also the basis for communication with outside
parties about future business trends. While we believe the assumptions we use to estimate future cash flows are reasonable, there
can be no assurance that the expected future cash flows will be realized. As a result, impairment charges that possibly would have
been recognized in earlier periods may not be recognized until later periods if actual results deviate unfavorably from earlier
estimates. An asset’s value is deemed impaired if the discounted cash flows or earnings projections generated do not substantiate
the carrying value of the asset. The estimation of such amounts requires management to exercise judgment with respect to revenue
and expense growth rates, changes in working capital, future capital expenditure requirements and selection of an appropriate
discount rate, as applicable. The use of different assumptions would increase or decrease discounted future operating cash flows
or earnings projections and could, therefore, change impairment determinations.
Fair value estimates employed in our annual impairment review of indefinite-lived tradenames and goodwill were determined
using discounted cash flow models involving several assumptions. Changes in our assumptions could materially impact our fair
value estimates. Assumptions critical to our fair value estimates were: (i) discount rates used in determining the fair value of the
reporting units and tradenames; (ii) royalty rates used in our tradename valuations; (iii) projected revenue and operating profit
growth rates used in the reporting unit and tradename models; and (iv) projected long-term growth rates used in the derivation of
terminal year values. These and other assumptions are impacted by economic conditions and expectations of management and
may change in the future based on period specific facts and circumstances.
At September 30, 2014, goodwill totaled $350.9 million, with $218.9 million and $132.0 million of goodwill for the Global
Consumer and Scotts LawnService® segments, respectively. No goodwill impairment was recognized as a result of the annual
evaluation performed as of June 29, 2014. The estimated fair value of each reporting unit was substantially in excess of its carrying
value as of the annual test date. If we were to alter our impairment testing by increasing the discount rate in the discounted cash
flow analysis by 100 basis points, there still would not be any impairment indicated for any of these reporting units. At September
30, 2014, indefinite-lived intangible assets comprised of tradenames totaled $187.3 million. With the exception of the Ortho®
tradename, each of these tradenames had an estimated fair value substantially in excess of its carrying value as of the annual test
date. During the third quarter of fiscal 2014, as a result of an impairment review, the Company recognized an impairment charge
for a non-recurring fair value adjustment of $33.7 million within the Global Consumer segment related to the Ortho® brand. The
fair value was calculated based upon the evaluation of the historical performance and future growth expectations of the Ortho®
business. Additionally, the Company performed an annual impairment review in the fourth quarter of fiscal 2014 and concluded
that the fair value of the Ortho® tradename exceeded the carrying value of the intangible asset and no further impairment was
necessary. If we were to increase the discount rate in the Ortho® brand fair value calculation by 100 basis points, the resulting
non-recurring fair value adjustment would have increased by approximately $10.3 million.
40
Table of Contents
Associate Benefits
We sponsor various post-employment benefit plans, including pension plans, both defined contribution plans and defined
benefit plans, and other post-employment benefit (“OPEB”) plans, consisting primarily of health care for retirees. For accounting
purposes, the defined benefit pension and OPEB plans are dependent on a variety of assumptions to estimate the projected and
accumulated benefit obligations and annual expense determined by actuarial valuations. These assumptions include the following:
discount rate; expected salary increases; certain employee-related factors, such as turnover, retirement age and mortality; expected
return on plan assets; and health care cost trend rates.
Assumptions are reviewed annually for appropriateness and updated as necessary. We base the discount rate assumption
on investment yields available at fiscal year-end on high-quality corporate bonds that could be purchased to effectively settle the
pension liabilities. The salary growth assumption reflects our long-term actual experience, the near-term outlook and assumed
inflation. The expected return on plan assets assumption reflects asset allocation, investment strategy and the views of investment
managers regarding the market. Retirement and mortality rates are based primarily on actual and expected plan experience. The
effects of actual results that differ from our assumptions are accumulated and amortized over future periods.
Changes in the discount rate and investment returns can have a significant effect on the funded status of our pension plans
and shareholders’ equity. We cannot predict discount rates or investment returns with certainty and, therefore, cannot determine
whether adjustments to our shareholders’ equity for pension-related activity in subsequent years will be significant. We also cannot
predict future investment returns, and therefore cannot determine whether future pension plan funding requirements could
materially affect our financial condition, results of operations or cash flows. A 100 basis point change in the discount rate would
have an immaterial effect on fiscal 2014 pension expense. A 100 basis point change in the discount rate would have a $56.6 million
change in our projected benefit obligation as of September 30, 2014.
Insurance and Self-Insurance
We maintain insurance for certain risks, including workers’ compensation, general liability and vehicle liability, and are
self-insured for employee-related health care benefits up to a specified level for individual claims. We establish reserves for losses
based on our claims experience and industry actuarial estimates of the ultimate loss amount inherent in the claims, including losses
for claims incurred but not reported. Our estimate of self-insured liabilities is subject to change as new events or circumstances
develop which might materially impact the ultimate cost to settle these losses.
Derivative Instruments
In the normal course of business, we are exposed to fluctuations in interest rates, the value of foreign currencies and the cost
of commodities. A variety of financial instruments, including forward and swap contracts, are used to manage these exposures.
Our objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow
volatility associated with changes in the applicable rates and prices. We have established policies and procedures that encompass
risk-management philosophy and objectives, guidelines for derivative-instrument usage, counterparty credit approval, and the
monitoring and reporting of derivative activity. We do not enter into derivative instruments for the purpose of speculation.
Contingencies
As described more fully in “NOTE 18. CONTINGENCIES” of the Notes to Consolidated Financial Statements included
in this Annual Report on Form 10-K, we are involved in environmental and legal proceedings which have a high degree of
uncertainty associated with them. We continually assess the likely outcome of these proceedings and the adequacy of reserves,
if any, provided for their resolution. There can be no assurance that the ultimate outcomes of these proceedings will not differ
materially from our current assessment of them, nor that all proceedings that may currently be brought against us are known by
us at this time.
Other Significant Accounting Policies
Other significant accounting policies, primarily those with lower levels of uncertainty than those discussed above, are also
critical to understanding the consolidated financial statements. The Notes to Consolidated Financial Statements included in this
Annual Report on Form 10-K contain additional information related to our accounting policies, including recent accounting
pronouncements, and should be read in conjunction with this discussion.
41
Table of Contents
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As part of our ongoing business, we are exposed to certain market risks, including fluctuations in interest rates, foreign
currency exchange rates and commodity prices. Financial derivative and other instruments are used to manage these risks. These
instruments are not used for speculative purposes.
Interest Rate Risk
We had variable rate debt instruments outstanding at September 30, 2014 and September 30, 2013 that are impacted by
changes in interest rates. As a means of managing our interest rate risk on these debt instruments, we entered into interest rate
swap agreements with major financial institutions to effectively fix the LIBOR index on certain variable-rate debt obligations.
At September 30, 2014 and September 30, 2013, we had outstanding interest rate swap agreements with a total U.S. dollar
equivalent notional value of $1,300.0 million and $1,100.0 million, respectively. The weighted average fixed rate of swap
agreements outstanding at September 30, 2014 was 2.1%.
The following table summarizes information about our derivative financial instruments and debt instruments that are sensitive
to changes in interest rates as of September 30, 2014 and 2013. For debt instruments, the table presents principal cash flows and
related weighted-average interest rates by expected maturity dates. For interest rate swap agreements, the table presents expected
cash flows based on notional amounts and weighted-average interest rates by contractual maturity dates. Weighted-average variable
rates are based on rates in effect at September 30, 2014 and September 30, 2013. A change in our variable interest rate of 100
basis points for a full twelve-month period would have a $2.5 million impact on interest expense assuming approximately $250
million of our average fiscal 2014 variable-rate debt had not been hedged via an interest rate swap agreement. The information
is presented in U.S. dollars (in millions):
2014
Long-term debt:
Fixed rate debt . . . . . . . . . . . . . . .
Average rate . . . . . . . . . . . . . . . . .
Variable rate debt . . . . . . . . . . . . .
Average rate . . . . . . . . . . . . . . . . .
Interest rate derivatives:
2015
2016
2017
2018
2019
After
Total
Expected Maturity Date
$ — $ — $ — $ — $ — $ 200.0
$ 200.0
—
$ 84.0
—
—
$ — $ — $ — $ 481.8
—
—
6.6%
6.6%
$ — $ 565.8
0.9%
—
—
—
1.8%
—
1.6%
Fair
Value
$ 212.5
—
$ 565.8
—
Interest rate swaps . . . . . . . . . . . .
Average rate . . . . . . . . . . . . . . . . .
$ — $ (11.6)
2.9%
—
$ (1.9)
3.0%
$ (0.2)
1.3%
$
2.2
2.1%
$ — $ (11.5)
2.1%
—
$ (11.5)
—
2013
Long-term debt:
2014
2015
2016
2017
2018
After
Total
Expected Maturity Date
Fixed rate debt . . . . . . . . . . . . . . .
Average rate . . . . . . . . . . . . . . . . .
Variable rate debt . . . . . . . . . . . . .
Average rate . . . . . . . . . . . . . . . . .
$ — $ — $ — $ — $ 200.0
$ 200.0
$ 400.0
—
$ 85.3
—
—
$ — $ 73.0
—
7.3%
6.6%
6.9%
$ — $ — $ — $ 158.3
1.0%
—
2.4%
—
—
—
1.7%
Fair
Value
$ 523.0
—
$ 158.3
—
Interest rate derivatives:
Interest rate swaps . . . . . . . . . . . .
Average rate . . . . . . . . . . . . . . . . .
$ — $ — $ (17.8)
3.0%
—
—
$ (2.6)
3.0%
$
3.7
2.1%
$ — $ (16.7)
2.7%
—
$ (16.7)
—
Excluded from the information provided above are $18.5 million and $12.2 million at September 30, 2014 and September 30,
2013, respectively, of miscellaneous debt instruments.
Other Market Risks
Through fiscal 2014, we had transactions that were denominated in currencies other than the currency of the country of
origin. We use foreign currency swap contracts to manage the exchange rate risk associated with intercompany loans with foreign
42
Table of Contents
subsidiaries that are denominated in local currencies. At September 30, 2014, the notional amount of outstanding foreign currency
swap contracts was $149.0 million with a negative fair value of $0.1 million. At September 30, 2013, the notional amount of
outstanding foreign currency swap contracts was $80.4 million with a negative fair value of $2.1 million.
We are subject to market risk from fluctuating prices of certain raw materials, including urea and other fertilizer inputs,
resins, diesel, gasoline, natural gas, sphagnum peat, bark and grass seed. Our objectives surrounding the procurement of these
materials are to ensure continuous supply and to control costs. We seek to achieve these objectives through negotiation of contracts
with favorable terms directly with vendors. In addition, we entered into derivatives to partially mitigate the effect of fluctuating
direct and indirect fuel costs on our Global Consumer and Scotts LawnService® businesses and hedged a portion of our fuel and
urea needs for fiscal 2014 and fiscal 2013. We had outstanding derivative contracts for 10,206,000 gallons of fuel with a negative
fair value of $1.4 million at September 30, 2014. We had outstanding derivative contracts for 7,098,000 gallons of fuel with a
negative fair value of $0.3 million at September 30, 2013. We also had outstanding derivative contracts for 58,500 and 49,500
aggregate tons of urea at September 30, 2014 and September 30, 2013, respectively. The outstanding derivative contracts for
58,500 aggregate tons at September 30, 2014 had a negative fair value of $0.5 million, while the outstanding derivative contracts
for 49,500 aggregate tons at September 30, 2013 had a negative fair value of $2.0 million.
ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The financial statements and other information required by this Item are contained in the Consolidated Financial Statements,
Notes to Consolidated Financial Statements and Schedules Supporting the Consolidated Financial Statements listed in the “Index
to Consolidated Financial Statements and Financial Statement Schedules” on page 50 of this Annual Report on Form 10-K.
ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
With the participation of the principal executive officer and the principal financial officer of The Scotts Miracle-Gro Company
(the “Registrant”), the Registrant’s management has evaluated the effectiveness of the Registrant’s disclosure controls and
procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), as of the end of the
fiscal year covered by this Annual Report on Form 10-K. Based upon that evaluation, the Registrant’s principal executive officer
and principal financial officer have concluded that the Registrant’s disclosure controls and procedures were effective as of the end
of the fiscal year covered by this Annual Report on Form 10-K.
Management’s Annual Report on Internal Control Over Financial Reporting
The “Annual Report of Management on Internal Control Over Financial Reporting” required by Item 308(a) of SEC
Regulation S-K is included on page 51 of this Annual Report on Form 10-K.
Attestation Report of Independent Registered Public Accounting Firm
The “Report of Independent Registered Public Accounting Firm” required by Item 308(b) of SEC Regulation S-K is included
on page 52 of this Annual Report on Form 10-K.
Changes in Internal Control Over Financial Reporting
No changes in the Registrant’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange
Act) occurred during the Registrant’s fiscal quarter ended September 30, 2014, that have materially affected, or are reasonably
likely to materially affect, the Registrant’s internal control over financial reporting.
ITEM 9B. OTHER INFORMATION
None.
43
Table of Contents
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
PART III
Directors, Executive Officers and Persons Nominated or Chosen to Become Directors or Executive Officers
The information required by Item 401 of SEC Regulation S-K concerning the directors of Scotts Miracle-Gro and the
nominees for election or re-election as directors of Scotts Miracle-Gro at the Annual Meeting of Shareholders to be held on
January 29, 2015 (the “2015 Annual Meeting”) is incorporated herein by reference from the disclosure which will be included
under the caption “PROPOSAL NUMBER 1 — ELECTION OF DIRECTORS” in Scotts Miracle-Gro’s definitive Proxy Statement
relating to the 2015 Annual Meeting (“Scotts Miracle-Gro’s Definitive Proxy Statement”), which will be filed pursuant to SEC
Regulation 14A not later than 120 days after the end of Scotts Miracle-Gro’s fiscal year ended September 30, 2014.
The information required by Item 401 of SEC Regulation S-K concerning the executive officers of Scotts Miracle-Gro is
incorporated herein by reference from the disclosure included under the caption “SUPPLEMENTAL ITEM. EXECUTIVE
OFFICERS OF THE REGISTRANT” in Part I of this Annual Report on Form 10-K.
Compliance with Section 16(a) of the Securities Exchange Act of 1934
The information required by Item 405 of SEC Regulation S-K is incorporated herein by reference from the disclosure which
will be included under the caption “SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE” in Scotts
Miracle-Gro’s Definitive Proxy Statement.
Procedures for Recommending Director Nominees
Information concerning the procedures by which shareholders of Scotts Miracle-Gro may recommend nominees to Scotts
Miracle-Gro’s Board of Directors is incorporated herein by reference from the disclosures which will be included under the captions
“CORPORATE GOVERNANCE — Nominations of Directors” and “MEETINGS AND COMMITTEES OF THE BOARD —
Committees of the Board — Nominating and Governance Committee” in Scotts Miracle-Gro’s Definitive Proxy Statement. These
procedures have not materially changed from those described in Scotts Miracle-Gro’s definitive Proxy Statement for the 2014
Annual Meeting of Shareholders held on January 30, 2014.
Audit and Finance Committee
The information required by Items 407(d)(4) and 407(d)(5) of SEC Regulation S-K is incorporated herein by reference from
the disclosure which will be included under the captions “MEETINGS AND COMMITTEES OF THE BOARD — Committees
of the Board” and “MEETINGS AND COMMITTEES OF THE BOARD — Committees of the Board — Audit and Finance
Committee” in Scotts Miracle-Gro’s Definitive Proxy Statement.
Committee Charters; Code of Business Conduct & Ethics; Corporate Governance Guidelines
The Board of Directors of Scotts Miracle-Gro has adopted charters for each of the Audit and Finance Committee, the
Nominating and Governance Committee, the Compensation and Organization Committee, the Innovation and Marketing
Committee, the Strategy and Business Development Committee and the Executive Committee, as well as Corporate Governance
Guidelines, as contemplated by the applicable sections of the New York Stock Exchange Listed Company Manual.
In accordance with the requirements of Section 303A.10 of the New York Stock Exchange Listed Company Manual and
Item 406 of SEC Regulation S-K, the Board of Directors of Scotts Miracle-Gro has adopted a Code of Business Conduct & Ethics
covering the members of Scotts Miracle-Gro’s Board of Directors and associates (employees) of Scotts Miracle-Gro and its
subsidiaries, including, without limitation, Scotts Miracle-Gro’s principal executive officer, principal financial officer and principal
accounting officer. Scotts Miracle-Gro intends to disclose the following events, if they occur, on its Internet website located at
http://investor.scotts.com within four business days following their occurrence: (A) the date and nature of any amendment to a
provision of Scotts Miracle-Gro’s Code of Business Conduct & Ethics that (i) applies to Scotts Miracle-Gro’s principal executive
officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, (ii) relates
to any element of the code of ethics definition enumerated in Item 406(b) of SEC Regulation S-K, and (iii) is not a technical,
administrative or other non-substantive amendment; and (B) a description of any waiver (including the nature of the waiver, the
name of the person to whom the waiver was granted and the date of the waiver), including an implicit waiver, from a provision
of the Code of Business Conduct & Ethics granted to Scotts Miracle-Gro’s principal executive officer, principal financial officer,
principal accounting officer or controller, or persons performing similar functions, that relates to one or more of the elements of
the code of ethics definition enumerated in Item 406(b) of SEC Regulation S-K. In addition, Scotts Miracle-Gro will disclose any
waivers from the provisions of the Code of Business Conduct & Ethics granted to an executive officer or a director of Scotts
44
Table of Contents
Miracle-Gro on Scotts Miracle-Gro's Internet website located at http://investor.scotts.com within four business days of the
determination to grant any such waiver.
The text of Scotts Miracle-Gro’s Code of Business Conduct & Ethics, Scotts Miracle-Gro’s Corporate Governance
Guidelines, the Audit and Finance Committee charter, the Nominating and Governance Committee charter, the Compensation and
Organization Committee charter, the Innovation and Marketing Committee charter, the Strategy and Business Development
Committee charter and the Executive Committee charter are posted under the “Corporate Governance” link on Scotts Miracle-
Gro’s Internet website located at http://investor.scotts.com. Interested persons and shareholders of Scotts Miracle-Gro may also
obtain copies of each of these documents without charge by writing to The Scotts Miracle-Gro Company, Attention: Corporate
Secretary, 14111 Scottslawn Road, Marysville, Ohio 43041. In addition, a copy of the Code of Business Conduct & Ethics, as
revised effective January 18, 2012, is incorporated by reference in Exhibit 14 to this Annual Report on Form 10-K.
ITEM 11. EXECUTIVE COMPENSATION
The information required by Item 402 of SEC Regulation S-K is incorporated herein by reference from the disclosures which
will be included under the captions “EXECUTIVE COMPENSATION,” “NON-EMPLOYEE DIRECTOR COMPENSATION,”
“EXECUTIVE COMPENSATION TABLES,” “SEVERANCE AND CHANGE IN CONTROL (CIC) ARRANGEMENTS,” and
“PAYMENTS ON TERMINATION OF EMPLOYMENT AND/OR CHANGE IN CONTROL” in Scotts Miracle-Gro’s Definitive
Proxy Statement.
The information required by Item 407(e)(4) of SEC Regulation S-K is incorporated herein by reference from the disclosure
which will be included under the caption “MEETINGS AND COMMITTEES OF THE BOARD — Compensation and Organization
Committee Interlocks and Insider Participation” in Scotts Miracle-Gro’s Definitive Proxy Statement.
The information required by Item 407(e)(5) of SEC Regulation S-K is incorporated herein by reference from the disclosure
which will be included under the caption “COMPENSATION COMMITTEE REPORT” in Scotts Miracle-Gro’s Definitive Proxy
Statement.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDER MATTERS
Ownership of Common Shares of Scotts Miracle-Gro
The information required by Item 403 of SEC Regulation S-K is incorporated herein by reference from the disclosure which
will be included under the caption “SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT”
in Scotts Miracle-Gro’s Definitive Proxy Statement.
Equity Compensation Plan Information
The information required by Item 201(d) of SEC Regulation S-K is incorporated herein by reference from the disclosure
which will be included under the caption “EQUITY COMPENSATION PLAN INFORMATION” in Scotts Miracle-Gro’s
Definitive Proxy Statement.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Certain Relationships and Related Person Transactions
The information required by Item 404 of SEC Regulation S-K is incorporated herein by reference from the disclosures which
will be included under the caption “CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS” in Scotts Miracle-Gro’s
Definitive Proxy Statement.
Director Independence
The information required by Item 407(a) of SEC Regulation S-K is incorporated herein by reference from the disclosures
which will be included under the captions “CORPORATE GOVERNANCE — Director Independence” and “MEETINGS AND
COMMITTEES OF THE BOARD” in Scotts Miracle-Gro’s Definitive Proxy Statement.
45
Table of Contents
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required by this Item 14 is incorporated herein by reference from the disclosures which will be included
under the captions “AUDIT AND FINANCE COMMITTEE MATTERS — Fees of the Independent Registered Public Accounting
Firm” and “AUDIT AND FINANCE COMMITTEE MATTERS — Pre-Approval of Services Performed by the Independent
Registered Public Accounting Firm” in Scotts Miracle-Gro’s Definitive Proxy Statement.
46
Table of Contents
PART IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a) LIST OF DOCUMENTS FILED AS PART OF THIS REPORT
1 and 2. Financial Statements and Financial Statement Schedules:
The response to this portion of Item 15 is submitted as a separate section of this Annual Report on Form 10-K.
Reference is made to the “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 50 of this
Annual Report on Form 10-K.
(b) EXHIBITS
The exhibits listed on the “Index to Exhibits” beginning on page 116 of this Annual Report on Form 10-K are filed or
furnished with this Annual Report on Form 10-K or incorporated herein by reference as noted in the “Index to Exhibits.”
(c) FINANCIAL STATEMENT SCHEDULES
The financial statement schedule filed with this Annual Report on Form 10-K is submitted in a separate section hereof. For
a description of such financial statement schedules, see “Index to Consolidated Financial Statements and Financial Statement
Schedules” on page 50 of this Annual Report on Form 10-K.
47
Table of Contents
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused
this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
THE SCOTTS MIRACLE-GRO COMPANY
By:
/s/ JAMES HAGEDORN
James Hagedorn, Chief Executive Officer and
Chairman of the Board
Dated: November 25, 2014
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following
persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature
Title
Date
/s/ ALAN H. BARRY*
Director
Alan H. Barry
November 25, 2014
/s/ THOMAS RANDAL COLEMAN Chief Financial Officer and Executive Vice President
November 25, 2014
Thomas Randal Coleman
(Principal Financial Officer and Principal Accounting Officer)
/s/ JAMES HAGEDORN
James Hagedorn
Chief Executive Officer, Chairman of the Board and Director November 25, 2014
(Principal Executive Officer)
November 25, 2014
November 25, 2014
November 25, 2014
November 25, 2014
November 25, 2014
/s/ ADAM HANFT*
Director
Adam Hanft
/s/ MICHELLE A. JOHNSON*
Director
Michelle A. Johnson
/s/ STEPHEN L. JOHNSON*
Director
Stephen L. Johnson
/s/ THOMAS N. KELLY JR.*
Director
Thomas N. Kelly Jr.
/s/ KATHERINE HAGEDORN
LITTLEFIELD*
Katherine Hagedorn Littlefield
Director
48
Table of Contents
Signature
Title
Date
/s/ JAMES F. MCCANN*
Director
November 25, 2014
James F. McCann
/s/ NANCY G. MISTRETTA*
Nancy G. Mistretta
Director
/s/ MICHAEL E. PORTER*
Director
Michael E. Porter
/s/ JOHN R. VINES*
John R. Vines
Director
November 25, 2014
November 25, 2014
November 25, 2014
*
The undersigned, by signing his name hereto, does hereby sign this Report on behalf of each of the directors of the Registrant
identified above pursuant to Powers of Attorney executed by the directors identified above, which Powers of Attorney are
filed with this Report as exhibits.
By:
/s/ THOMAS RANDAL COLEMAN
Thomas Randal Coleman, Attorney-in-Fact
49
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULES
Consolidated Financial Statements of The Scotts Miracle-Gro Company and Subsidiaries:
Annual Report of Management on Internal Control Over Financial Reporting
Reports of Independent Registered Public Accounting Firm
Consolidated Statements of Operations for the fiscal years ended September 30, 2014, 2013 and 2012
Consolidated Statements of Comprehensive Income for the fiscal years ended September 30, 2014, 2013 and
2012
Consolidated Statements of Cash Flows for the fiscal years ended September 30, 2014, 2013 and 2012
Consolidated Balance Sheets at September 30, 2014 and 2013
Consolidated Statements of Shareholders’ Equity for the fiscal years ended September 30, 2014, 2013 and 2012
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Page
51
52
54
55
56
57
58
59
Schedules Supporting the Consolidated Financial Statements:
Schedule II—Valuation and Qualifying Accounts for the fiscal years ended September 30, 2014, 2013 and 2012
115
All other financial statement schedules for which provision is made in the applicable accounting regulations of the Securities
and Exchange Commission are omitted because they are not required or are not applicable, or the required information has been
presented in the Consolidated Financial Statements or Notes thereto.
50
Table of Contents
ANNUAL REPORT OF MANAGEMENT ON INTERNAL
CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining adequate internal control over financial reporting to provide
reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external
purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over
financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of The Scotts Miracle-Gro Company and our consolidated
subsidiaries; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and
expenditures of The Scotts Miracle-Gro Company and our consolidated subsidiaries are being made only in accordance with
authorizations of management and directors of The Scotts Miracle-Gro Company and our consolidated subsidiaries, as appropriate;
and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of
the assets of The Scotts Miracle-Gro Company and our consolidated subsidiaries that could have a material effect on our consolidated
financial statements.
Management, with the participation of our principal executive officer and principal financial officer, assessed the effectiveness
of our internal control over financial reporting as of September 30, 2014, the end of our fiscal year. Management based its
assessment on criteria established in Internal Control — Integrated Framework (1992) issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Management’s assessment included evaluation of such elements as the design and
operating effectiveness of key financial reporting controls, process documentation, accounting policies and our overall control
environment. This assessment is supported by testing and monitoring performed under the direction of management. As allowed
by the SEC guidance, management excluded from the assessment the internal control over financial reporting at Fafard & Brothers
Ltd. and AeroGrow International, Inc. which were acquired in fiscal 2014. These acquisitions constituted 3.9% of total assets, 0%
and 2.1% of both, revenues and net income, respectively, included in our consolidated financial statements as of and for the fiscal
year ended September 30, 2014.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluations of effectiveness to future periods are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Accordingly, even an
effective system of internal control over financial reporting will provide only reasonable assurance with respect to financial
statement preparation.
Based on our assessment, management has concluded that our internal control over financial reporting was effective as of
September 30, 2014, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external reporting purposes in accordance with accounting principles generally accepted in the United States of
America. We reviewed the results of management’s assessment with the Audit and Finance Committee of the Board of Directors
of The Scotts Miracle-Gro Company.
Our independent registered public accounting firm, Deloitte & Touche LLP, independently audited our internal control over
financial reporting as of September 30, 2014 and has issued their attestation report which appears herein.
/s/ JAMES HAGEDORN
/s/ THOMAS RANDAL COLEMAN
James Hagedorn
Chief Executive Officer and Chairman of the Board
Thomas Randal Coleman
Executive Vice President and Chief Financial Officer
Dated: November 25, 2014
Dated: November 25, 2014
51
Table of Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company
Marysville, Ohio
We have audited the accompanying consolidated balance sheets of The Scotts Miracle-Gro Company and subsidiaries (the
“Company”) as of September 30, 2014 and 2013, and the related consolidated statements of operations, comprehensive income,
shareholders’ equity, and cash flows for each of the three years in the period ended September 30, 2014. Our audits also included
the financial statement schedules listed in the Index to Consolidated Financial Statements and Financial Statement Schedules.
These consolidated financial statements and financial statement schedules are the responsibility of the Company’s management.
Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedules based on
our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of the
Company as of September 30, 2014 and 2013, and the results of its operations and its cash flows for each of the three years in the
period ended September 30, 2014, in conformity with accounting principles generally accepted in the United States of America.
Also, in our opinion, such financial statement schedules, when considered in relation to the basic consolidated financial statements
taken as a whole, present fairly, in all material respects, the information set forth therein.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States),
the Company’s internal control over financial reporting as of September 30, 2014, based on the criteria established in Internal
Control — Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission
and our report dated November 25, 2014 expressed an unqualified opinion on the Company’s internal control over financial
reporting.
/s/ DELOITTE & TOUCHE LLP
Columbus, Ohio
November 25, 2014
52
Table of Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company
Marysville, Ohio
We have audited the internal control over financial reporting of The Scotts Miracle-Gro Company and subsidiaries (the
"Company") as of September 30, 2014, based on criteria established in Internal Control - Integrated Framework (1992) issued
by the Committee of Sponsoring Organizations of the Treadway Commission. As described in Management’s Report on Internal
Control Over Financial Reporting, management excluded from its assessment the internal control over financial reporting at the
following subsidiaries which were acquired in 2014: Fafard & Brothers Ltd. and AeroGrow International, Inc. which were acquired
in fiscal 2014. These acquisitions constituted 3.9% of total assets, 0% and 2.1% of both, revenues and net income, respectively,
included in the consolidated financial statements as of and for the fiscal year ended September 30, 2014. Accordingly, our audit
did not include the internal control over financial reporting at these subsidiaries. The Company's management is responsible for
maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over
financial reporting, included in the accompanying Annual Report of Management on Internal Control Over Financial Reporting.
Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal
control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal
control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating
effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in
the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company's internal control over financial reporting is a process designed by, or under the supervision of, the company's
principal executive and principal financial officers, or persons performing similar functions, and effected by the company's board
of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A
company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance
with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods
are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.
In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of
September 30, 2014, based on the criteria established in Internal Control - Integrated Framework (1992) issued by the Committee
of Sponsoring Organizations of the Treadway Commission.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United
States), the consolidated financial statements and financial statement schedules as of and for the year ended September 30, 2014
of the Company and our report dated November 25, 2014 expressed an unqualified opinion on those financial statements and
financial statement schedules.
/s/ DELOITTE & TOUCHE LLP
Columbus, Ohio
November 25, 2014
53
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Operations
(In millions, except per share data)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales—impairment, restructuring and other . . . . . . . . . . . . . . . . . . . .
Cost of sales—product registration and recall matters . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . . . . . . . . . . . . . .
Other income, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Costs related to refinancing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations before income taxes . . . . . . . . . . . .
Income tax expense from continuing operations . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from discontinued operations, net of tax. . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Net loss attributable to noncontrolling interest . . . . . . . . . . . . . . . . . . . . . . . .
Net income attributable to controlling interest . . . . . . . . . . . . . . . . . . . . . . . . $
Basic income per common share: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Income (loss) from discontinued operations . . . . . . . . . . . . . . . . . . . . . .
Basic net income per common share . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Diluted income per common share:
Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Income (loss) from discontinued operations . . . . . . . . . . . . . . . . . . . . . .
Diluted net income per common share . . . . . . . . . . . . . . . . . . . . . . . . . . $
Year Ended September 30,
2014
2013
2012
$
2,841.3
1,809.9
—
—
1,031.4
$
2,773.7
1,793.3
2.2
—
978.2
2,770.5
1,813.5
—
0.4
956.6
680.5
51.0
—
(14.7)
314.6
10.7
47.3
256.6
91.2
165.4
0.8
166.2
0.3
166.5
2.69
0.01
2.70
2.64
0.01
2.65
$
$
$
$
$
$
659.6
18.1
—
(10.0)
310.5
—
59.2
251.3
91.9
159.4
1.7
161.1
—
161.1
2.58
0.03
2.61
2.55
0.02
2.57
$
$
$
$
$
$
703.3
7.1
7.8
(2.8)
241.2
—
61.8
179.4
67.8
111.6
(5.1)
106.5
—
106.5
1.83
(0.08)
1.75
1.80
(0.09)
1.71
See Notes to Consolidated Financial Statements.
54
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Comprehensive Income
(In millions)
Year Ended September 30,
2014
2013
2012
$
166.2
$
161.1
$
106.5
(8.2)
(4.9)
9.5
(7.9)
(5.2)
(3.3)
8.4
5.8
3.8
9.5
$
170.6
$
2.3
(9.3)
8.4
3.6
(14.3)
(9.3)
97.2
Net income
Other comprehensive income (loss):
Net foreign currency translation adjustment
Net unrealized losses on derivative instruments, net of tax of $3.0, $2.1
and $6.2 for fiscal 2014, fiscal 2013 and fiscal 2012, respectively
Reclassification of net unrealized losses on derivatives to net income, net
of tax of $5.9, $5.4 and $5.6 for fiscal 2014, fiscal 2013 and fiscal 2012,
respectively
Net unrealized gains (loss) in pension and other post retirement benefits,
net of tax of $4.9, $2.4 and $0.4 for fiscal 2014, fiscal 2013 and fiscal
2012, respectively
Reclassification of net pension and post-retirement benefit income (loss)
to net income, net of tax of $1.9, $2.3 and $2.2 for fiscal 2014, fiscal
2013 and fiscal 2012, respectively
Total other comprehensive income (loss)
Comprehensive income
3.1
(8.4)
157.8
$
See Notes to Consolidated Financial Statements.
55
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Cash Flows
(In millions)
Year Ended September 30,
2013
2012
2014
166.2
$
161.1
$
106.5
OPERATING ACTIVITIES
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Adjustments to reconcile net income to net cash provided by operating activities:. . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Costs related to refinancing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Share-based compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss (gain) on sale of long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on sale of business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Gain) loss on investment of unconsolidated affiliate . . . . . . . . . . . . . . . . . . . . .
Changes in assets and liabilities, net of acquired businesses: . . . . . . . . . . . . . . .
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other non-current items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . . .
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from sale of business, net of transaction costs . . . . . . . . . . . . . . . . . . . . . . .
Investments in property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from sale and leaseback transaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Investment in unconsolidated affiliate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Investments in acquired businesses, net of cash acquired . . . . . . . . . . . . . . . . . . . . . .
Net cash used in investing activities . . . . . . . . . . . . . . . . . . . . . . . . .
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans . . . . . . . . . . . . .
Repayments under revolving and bank lines of credit and term loans. . . . . . . . . . . . .
Repayment of 7.25% senior notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Financing and issuance fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchase of Common Shares . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Payments on sellers notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Excess tax benefits from share-based payment arrangements . . . . . . . . . . . . . . . . . . .
Cash received from exercise of stock options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash used in financing activities . . . . . . . . . . . . . . . . . . . . . . . . .
Effect of exchange rate changes on cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net (decrease) increase in cash and cash equivalents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
SUPPLEMENTAL CASH FLOW INFORMATION
33.7
3.5
11.1
50.6
13.8
12.1
1.1
(1.4)
(5.7)
(29.4)
(38.7)
(3.2)
52.6
(22.9)
4.9
(14.6)
7.2
240.9
3.7
7.2
(87.6)
35.1
—
(114.0)
(155.6)
16.2
—
10.3
54.9
11.2
24.2
(2.1)
—
0.4
17.9
89.0
0.3
(5.2)
5.4
(8.1)
(32.6)
(0.9)
342.0
3.6
—
(60.1)
—
(4.5)
(3.2)
(64.2)
1,932.8
(1,525.3)
(200.0)
(6.1)
(230.8)
(120.0)
(0.8)
5.9
20.0
(124.3)
(1.5)
(40.5)
129.8
89.3
$
1,474.8
(1,682.1)
—
—
(87.8)
—
(0.8)
2.0
13.3
(280.6)
0.7
(2.1)
131.9
129.8
$
Interest paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Call premium on 7.25% senior notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(46.9) $
(7.3)
(55.3)
(56.6) $
—
(44.0)
See Notes to Consolidated Financial Statements.
56
5.3
—
12.5
51.5
10.9
24.2
0.1
—
—
(6.9)
(23.1)
17.3
(6.9)
(15.9)
(19.4)
(9.0)
6.3
153.4
0.7
—
(69.4)
—
—
(7.0)
(75.7)
1,684.0
(1,694.6)
—
—
(75.4)
(17.5)
—
6.6
17.6
(79.3)
2.6
1.0
130.9
131.9
(48.6)
—
(79.6)
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Balance Sheets
(In millions, except stated value per share)
ASSETS
Current assets:
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accounts receivable, less allowances of $7.5 in 2014 and $9.5 in 2013 . . . . . . . . . . . . . .
Accounts receivable pledged. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid and other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible assets, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accounts payable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Commitments and contingencies (Notes 16, 17 and 18)
Shareholders’ equity:
Common shares and capital in excess of $.01 stated value per share; shares outstanding
of 60.7 in 2014 and 62.0 in 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Treasury shares, at cost; 7.4 shares in 2014 and 6.1 shares in 2013 . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total shareholders’ equity - controlling interest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Noncontrolling interest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total equity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Total liabilities and equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
See Notes to Consolidated Financial Statements.
September 30,
2014
2013
89.3
224.0
113.7
385.1
122.9
935.0
437.0
350.9
302.7
32.7
2,058.3
91.9
193.3
259.5
544.7
692.4
254.0
1,491.1
395.3
636.9
(392.3)
(86.2)
553.7
13.5
567.2
2,058.3
$
$
$
$
$
129.8
206.6
106.7
324.9
113.0
881.0
422.3
315.1
284.4
34.4
1,937.2
92.4
137.7
279.7
509.8
478.1
238.8
1,226.7
397.5
703.4
(312.6)
(77.8)
710.5
—
710.5
1,937.2
57
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Shareholders’ Equity
(In millions, except per share data)
Common Shares
Shares
Amount
Capital in
Excess of
Stated
Value
Retained
Earnings
Treasury Shares
Shares
Amount
Accumulated
Other
Comprehensive
Income (loss)
Non-
controlling
Interest
Total
Total
Balance at September 30, 2011. . . . . .
68.1
$
0.3
$
426.8
$
Net income . . . . . . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . . . . . .
Share-based compensation . . . . . . . . .
Dividends declared ($1.225 per
share). . . . . . . . . . . . . . . . . . . . . . . . . .
Treasury share purchases . . . . . . . . . .
Treasury share issuances. . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at September 30, 2012. . . . . .
68.1
0.3
Net income . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income . . . . . . .
Share-based compensation . . . . . . . . .
Dividends declared ($1.4125 per
share). . . . . . . . . . . . . . . . . . . . . . . . . .
Treasury share issuances. . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . .
12.5
(31.2)
0.2
408.3
10.3
(21.4)
Balance at September 30, 2013. . . . . .
68.1
0.3
397.2
Net income (loss) . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . . . . . .
Share-based compensation . . . . . . . . .
Dividends declared ($3.7625 per
share). . . . . . . . . . . . . . . . . . . . . . . . . .
Treasury share purchases . . . . . . . . . .
Treasury share issuances. . . . . . . . . . .
Investment in noncontrolling interest .
11.1
(13.3)
599.2
106.5
(75.4)
(0.1)
630.2
161.1
(87.8)
(0.1)
703.4
166.5
(233.0)
7.5
$ (388.5) $
(78.0) $ 559.8
$
— $ 559.8
(9.3)
106.5
(9.3)
12.5
(75.4)
(17.5)
25.2
0.1
0.4
(1.1)
(17.5)
56.4
6.8
(349.6)
(87.3)
601.9
—
9.5
161.1
9.5
10.3
(87.8)
15.6
(0.1)
(0.7)
37.0
106.5
(9.3)
12.5
(75.4)
(17.5)
25.2
0.1
601.9
161.1
9.5
10.3
(87.8)
15.6
(0.1)
6.1
(312.6)
(77.8)
710.5
—
710.5
(8.4)
166.5
(8.4)
11.1
(233.0)
(120.0)
27.0
(0.3)
166.2
(8.4)
11.1
(233.0)
(120.0)
27.0
13.8
13.8
2.1
(0.8)
(120.0)
40.3
Balance at September 30, 2014. . . . . .
68.1
$
0.3
$
395.0
$
636.9
7.4
$ (392.3) $
(86.2) $ 553.7
$
13.5
$ 567.2
See Notes to Consolidated Financial Statements.
58
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, together with Scotts Miracle-
Gro, the “Company”) are engaged in the manufacturing, marketing and sale of consumer branded products for lawn and garden
care. The Company’s primary customers include home centers, mass merchandisers, warehouse clubs, large hardware chains,
independent hardware stores, nurseries, garden centers and food and drug stores. The Company’s products are sold primarily in
North America and the European Union. The Company also operates the Scotts LawnService® business, which provides residential
and commercial lawn care, tree and shrub care and pest control services in the United States.
In March 2014, the Company completed the sale of its U.S. and Canadian wild bird food business. As a result of the sale,
effective in the Company’s second quarter of fiscal 2014, the Company classified its results of operations for all periods presented
to reflect the wild bird food business as a discontinued operation. In the fourth quarter of fiscal 2012, the Company completed the
wind down of the Company's professional seed business ("Pro Seed"). As a result, effective in its fourth quarter of fiscal 2012, the
Company classified Pro Seed as a discontinued operation.
In fiscal 2012, the Company incurred product registration and recall costs of $8.2 million. Fiscal 2012 costs include reserves
that were established in connection with the previously disclosed U.S. Environmental Protection Agency (the “U.S. EPA”) and
U.S. Department of Justice (the “U.S. DOJ”) investigations into pesticide product registration issues, which, as previously disclosed
in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2012, were settled in the fourth quarter
of fiscal year 2012. The Company does not expect to incur any additional costs related to these investigations.
Due to the nature of the consumer lawn and garden business, the majority of sales to customers occur in the Company’s
second and third fiscal quarters. On a combined basis, net sales for the second and third quarters of the last three fiscal years
represented in excess of 75% of annual net sales.
Organization and Basis of Presentation
The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted
in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and
its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation
criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and
determination of effective management control. AeroGrow International, Inc. (“AeroGrow”), in which the Company owns
controlling interest, is consolidated with the equity owned by other shareholders shown as noncontrolling interest in the consolidated
balance sheets, and the other shareholders' portion of net earnings and other comprehensive income is shown as net earnings or
comprehensive income attributable to noncontrolling interest in the consolidated statements of earnings and consolidated statements
of comprehensive income, respectively.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are
based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results
ultimately may differ from the estimates.
Revenue Recognition
Revenue is recognized when title and risk of loss transfer, which generally occurs when products or services are received
by the retail customer. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on
historical rates and are periodically adjusted for known changes in return levels. Outbound shipping and handling costs are included
in cost of sales.
Under the terms of the Amended and Restated Exclusive Agency and Marketing Agreement (the “Marketing Agreement”)
between the Company and Monsanto Company (“Monsanto”), the Company, in its role as exclusive agent, performs certain
functions, primarily manufacturing conversion (in North America), distribution and logistics, and selling and marketing support
on behalf of Monsanto in the conduct of the consumer Roundup® business. The actual costs incurred by the Company on behalf
of the consumer Roundup® business are recovered from Monsanto through the terms of the Marketing Agreement. The
reimbursement of costs for which the Company is considered the primary obligor is included in net sales.
59
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Promotional Allowances
The Company promotes its branded products through, among other things, cooperative advertising programs with retailers.
Retailers may also be offered in-store promotional allowances and rebates based on sales volumes. Certain products are promoted
with direct consumer rebate programs and special purchasing incentives. Promotion costs (including allowances and rebates)
incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals
for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets.
Advertising
Advertising costs incurred during the year by our Global Consumer segment are expensed to interim periods in relation to
revenues. All advertising costs, except for external production costs, are expensed within the fiscal year in which such costs are
incurred. External production costs for advertising programs are deferred until the period in which the advertising is first aired.
The costs deferred at September 30, 2014 were $1.9 million. There were no costs deferred at September 30, 2013.
Scotts LawnService® promotes its service offerings through direct mail and direct selling campaigns. External costs associated
with these campaigns that qualify as direct response advertising costs are deferred and recognized as advertising expense in
proportion to revenues over a period not beyond the end of the immediately following calendar year. Costs that do not qualify as
direct response advertising costs are expensed within the fiscal year incurred on a monthly basis in proportion to net sales. The
costs deferred at September 30, 2014 were $1.3 million. There were no costs deferred at September 30, 2013.
Advertising expenses were $143.6 million in fiscal 2014, $142.2 million in fiscal 2013 and $168.9 million in fiscal 2012.
Research and Development
All costs associated with research and development are charged to expense as incurred. Expenses for fiscal 2014, fiscal
2013 and fiscal 2012 were $48.4 million, $46.4 million and $50.1 million, respectively, including product registration costs of
$12.6 million, $12.4 million and $14.0 million, respectively.
Environmental Costs
The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can
be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental
contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance
carriers.
Share-Based Compensation Awards
The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three
years, except in cases where employees are eligible for accelerated vesting based on having satisfied retirement requirements
relating to age and years of service. Performance-based awards are expensed over the requisite service period based on achievement
of performance criteria. The Company uses a binomial model to determine the fair value of its option grants. The Company
classifies share-based compensation expense within selling, general and administrative expenses to correspond with the same line
item as cash compensation paid to employees.
Earnings per Common Share
Basic earnings per Common Share is computed based on the weighted-average number of Common Shares outstanding each
period. Diluted earnings per Common Share is computed based on the weighted-average number of Common Shares and dilutive
potential Common Shares (stock options, stock appreciation rights, performance shares, restricted stock and restricted stock unit
awards) outstanding each period.
Cash and Cash Equivalents
The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash
equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance
available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any
potential credit loss is minimal.
60
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Accounts Receivable and Allowances
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts
reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or
customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s
risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables
are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable
will not be recovered.
Inventories
Inventories are stated at the lower of cost or market, principally determined by the first in, first out method of accounting.
Inventories include the cost of raw materials, labor, manufacturing overhead and freight and in-bound handling costs incurred to
pre-position goods in the Company’s warehouse network. The Company makes provisions for obsolete or slow-moving inventories
as necessary to properly reflect inventory at the lower of cost or market value. Adjustments to reflect inventories at net realizable
values were $18.4 million and $19.7 million at September 30, 2014 and 2013, respectively.
Long-lived Assets
Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $0.4
million, $0.8 million and $0.9 million during fiscal 2014, fiscal 2013 and fiscal 2012, respectively. Expenditures for maintenance
and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the
related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income from
operations.
Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful
economic lives of the assets as follows:
Land improvements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Machinery and equipment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10 –25 years
10 –40 years
3 –15 years
6 –10 years
3 – 8 years
Intangible assets subject to amortization include technology, such as patents, customer relationships, non-compete
agreements and certain tradenames. These intangible assets are being amortized over their estimated useful economic lives, which
typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be
tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If
an evaluation of recoverability was required, the estimated undiscounted future cash flows associated with the asset would be
compared to the asset’s carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the
carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as
“Impairment, restructuring and other charges” within “Operating expenses” in the Consolidated Statements of Operations.
The Company had noncash investing activities of $7.0 million, $7.3 million and $17.3 million during fiscal 2014, fiscal
2013 and fiscal 2013, respectively, representing unpaid liabilities incurred during each fiscal year to acquire property, plant and
equipment.
Internal Use Software
The costs of internal use software are expensed or capitalized depending on whether they are incurred in the preliminary
project stage, application development stage or the post-implementation/operation stage. As of September 30, 2014 and
September 30, 2013, the Company had $21.8 million and $17.5 million, respectively, in unamortized capitalized internal use
computer software costs. Amortization of these costs was $8.3 million, $7.3 million and $8.0 million during fiscal 2014, fiscal
2013 and fiscal 2012, respectively.
61
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Goodwill and Indefinite-lived Intangible Assets
Goodwill and indefinite-lived intangible assets are not subject to amortization. Goodwill and indefinite-lived intangible
assets are reviewed for impairment by applying a fair-value based test on an annual basis, as of the first day of the Company’s
fiscal fourth quarter, or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the
Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative
test include reporting unit specific operating results as well as new events and circumstances impacting the operations of the
reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its
reporting units to their respective fair values and reviewing the Company’s market value of invested capital. A reporting unit is
defined as an operating segment or one level below an operating segment. The Company has identified six reporting units. The
Company determines the fair value of its reporting units under the income-based approach utilizing discounted cash flows and
incorporates assumptions it believes marketplace participants would utilize. The Company also uses a comparative market-based
approach using market multiples and other factors to corroborate the discounted cash flow results used.
With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for
each of its indefinite-lived intangible assets. Factors considered in the qualitative test include indefinite-lived intangible asset
specific operating results as well as new events and circumstances impacting the cash flows of the indefinite-lived intangible assets.
For the quantitative test, the value of all indefinite-lived tradenames was determined using a royalty savings methodology similar
to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.
If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value
of the asset exceeds its estimated fair value and classified as “Impairment, restructuring and other charges” within “Operating
expenses” in the Consolidated Statements of Operations.
Insurance and Self-Insurance
The Company maintains insurance for certain risks, including workers’ compensation, general liability and vehicle liability,
and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues
for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors
and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially
determined estimate of claims incurred but not yet reported.
Income Taxes
The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized
for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective
tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon
available evidence. A valuation allowance is established when management believes that it is more likely than not that some
portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the
Company’s tax provision in the period of change.
The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position
will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available
or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized
tax benefits within income tax expense.
U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely
reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income
or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed
earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes
and foreign withholding taxes attributable to the anticipated remittance.
Translation of Foreign Currencies
The functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these
subsidiaries are translated at the exchange rate in effect at each year-end. Income and expense accounts are translated at the average
rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from
period to period are included in accumulated other comprehensive income (loss) within shareholders’ equity. Foreign currency
transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in
the Consolidated Statements of Operations.
62
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Derivative Instruments
In the normal course of business, the Company is exposed to fluctuations in interest rates, the value of foreign currencies
and the cost of commodities. A variety of financial instruments, including forward and swap contracts, are used to manage these
exposures. These financial instruments are recognized at fair value on the Consolidated Balance Sheets, and all changes in fair
value are recognized in net income or shareholders’ equity through accumulated other comprehensive income (loss). The Company’s
objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility
associated with changes in the applicable rates and prices.
The Company has established policies and procedures that encompass risk-management philosophy and objectives,
guidelines for derivative-instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity.
The Company does not enter into derivative instruments for the purpose of speculation.
The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying
exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial
instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure.
Fluctuations in the value of these instruments generally are offset by changes in the cash flows of the underlying exposures being
hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument.
GAAP requires all derivative instruments to be recognized as either assets or liabilities at fair value in the Consolidated Balance
Sheets. The Company designates commodity hedges as cash flow hedges of forecasted purchases of commodities and interest
rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Any ineffective portion of a change
in the fair value of a qualifying instrument is immediately recognized in earnings.
RECENT ACCOUNTING PRONOUNCEMENTS
Revenue Recognition from Contracts with Customers
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No.
2014-09, Revenue from Contracts with Customers. This guidance requires companies to recognize revenue in a manner that
depicts the transfer of promised goods or services to customers in amounts that reflect the consideration to which a company
expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about
the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The provisions are
effective for the Company's financial statements for the fiscal year beginning October 1, 2017. The standard allows for either a
full retrospective or a modified retrospective transition method. The Company is currently evaluating the impact of this standard
on its consolidated results of operations, financial position and cash flows.
Balance Sheet Offsetting
In December 2011, the FASB issued an amendment to accounting guidance on the presentation of offsetting of derivatives,
and financial assets and liabilities. The amended guidance requires quantitative disclosures regarding the gross amounts and their
location within the consolidated balance sheets. The provisions were effective for the Company's financial statements for the
fiscal year beginning October 1, 2013. The adoption of the amended guidance did not have a significant impact on the Company's
financial statements and related disclosures.
Discontinued Operations Reporting
In April 2014, the FASB issued an accounting standard update that amends the accounting guidance related to discontinued
operations. This amendment defines discontinued operations as a component or group of components that is disposed of or is
classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial
results. This amendment also introduces new disclosures for disposals that do not meet the criteria of discontinued operations.
The provisions are effective for fiscal years beginning after December 15, 2014 and apply to new disposals and new classifications
of disposal groups as held for sale after the effective date. The adoption of the amended guidance impacts presentation and
disclosure and will not have a significant impact on the Company's consolidated financial position, results of operations or cash
flows.
63
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 2. DISCONTINUED OPERATIONS
Wild Bird Food
In March 2014, the Company completed the sale of its U.S. and Canadian wild bird food business, including intangible
assets, certain on-hand inventory and fixed assets, for $4.1 million in cash and an estimated $1.0 million in future earn-out payments.
As a result, effective in the second quarter of fiscal 2014, the Company classified its results of operations for all periods presented
to reflect the wild bird food business as a discontinued operation. In addition, in the third quarter of fiscal 2014, the Company
received $3.1 million for the sale of the remaining wild bird food manufacturing facilities resulting in a gain of $1.2 million.
Pro Seed
In the fourth quarter of fiscal 2012, the Company completed the wind down of the Company's professional seed business.
As a result, effective in its fourth quarter of fiscal 2012, the Company classified its results of operations for all periods presented
to reflect the professional seed business as a discontinued operation. In fiscal 2013, the Company recorded a $0.1 million loss
related to the wind-down of the professional seed business. The Company recorded restructuring and other charges of $0.1 million
and $3.4 million in fiscal 2013 and fiscal 2012, respectively, related to termination benefits provided to employees and other
restructuring charges. The Company also recorded a $0.5 million impairment charge related to the investment in Turf-Seed (Europe)
Limited in fiscal 2012.
The following table summarizes the results of the wild bird food and Pro Seed businesses as discontinued operations:
Year Ended September 30,
2014
2013
2012
(In millions)
Net sales. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Operating costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on sale of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other (income) expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from discontinued operations before income taxes . . . . . . . . .
Income tax expense from discontinued operations . . . . . . . . . . . . . . . . . . . . .
Income (loss) from discontinued operations, net of tax . . . . . . . . . . . . . . . . . $
18.1
17.6
—
(1.2)
—
1.7
0.9
0.8
$
$
42.8
40.4
—
—
—
2.4
0.7
1.7
$
$
82.3
85.9
0.6
—
0.3
(4.5)
0.6
(5.1)
NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER
Activity described herein is classified within the “Impairment, restructuring and other” lines in the Consolidated Statements
of Operations.
The following table details impairment, restructuring and other charges during fiscal 2014, fiscal 2013 and fiscal 2012:
Restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Property, plant and equipment impairments . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill and intangible asset impairments . . . . . . . . . . . . . . . . . . . . . . . . . .
Total impairment, restructuring and other. . . . . . . . . . . . . . . . . . . . . . . . . . . . $
17.3
$
—
33.7
51.0
$
4.4
—
15.9
20.3
$
$
1.8
2.1
3.2
7.1
Year Ended September 30,
2014
2013
2012
(In millions)
64
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table summarizes the activity related to liabilities associated with the restructuring and other charges during
fiscal 2014, fiscal 2013 and fiscal 2012:
Year Ended September 30,
2014
2013
2012
(In millions)
Amounts reserved for restructuring and other at beginning of year . . . . . . . . $
Restructuring and other charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring and other in discontinued operations . . . . . . . . . . . . . . . . . . . .
Payments and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amounts reserved for restructuring and other at end of year . . . . . . . . . . . . . $
11.1
17.3
—
(12.4)
16.0
$
$
10.2
$
9.1
—
(8.2)
11.1
$
29.6
1.8
0.1
(21.3)
10.2
Included in the restructuring reserves as of September 30, 2014, is $2.8 million that is classified as long-term. Payments against
the long-term reserves will be incurred as the employees covered by the restructuring plan retire. The remaining amounts reserved
will be paid out over the course of the next twelve months.
Fiscal 2014
During the third quarter of fiscal 2014, as a result of financial performance, the Company recognized an impairment charge
for a non-recurring fair value adjustment of $33.7 million within the Global Consumer segment related to the Ortho® brand. The
fair value was calculated based upon the evaluation of the historical performance and future growth expectations of the Ortho®
business.
During fiscal 2014, the Company recognized $12.5 million in restructuring costs related to termination benefits provided to
U.S. personnel as part of the Company's restructuring of its U.S. administrative and overhead functions. The Company also
recognized $2.8 million of international restructuring and other adjustments during fiscal 2014 for the continuation of the 2013
international restructuring plan. In addition, during fiscal 2014, the Company recognized $2.0 million in additional ongoing
monitoring and remediation costs for the Company's turfgrass biotechnology program.
Fiscal 2013
During the first quarter of fiscal 2013, the Company recognized income of $4.7 million related to the reimbursement by a
vendor for a portion of the costs incurred for the development and commercialization of products including the active ingredient
MAT 28 for the Global Consumer segment. During the first quarter of 2013, the Company also recognized a $4.3 million asset
impairment charge as a result of issues with the commercialization of an insect repellent technology for the Global Consumer
segment. Also, as a result of the Company's annual impairment review performed in the fourth quarter of fiscal 2013, the Company
recognized an impairment charge for a non-recurring fair value adjustment of $11.6 million within the Global Consumer segment
related to the Ortho® brand and certain sub-brands of Ortho®. The fair value was calculated based upon the evaluation of the
historical performance and future growth expectations of the Ortho® business.
During fiscal 2013, the Company recognized $9.1 million in restructuring costs related to termination benefits provided to
international employees in relation to the profitability improvement initiative announced in December 2012, associated with the
international restructuring plan to reduce headcount and streamline management decision making within the Global Consumer
segment.
Fiscal 2012
During fiscal 2012, in continuation of the 2011 restructuring plan, the Company incurred an additional $1.6 million in
restructuring costs related to termination benefits provided to employees who accepted voluntary retirement and special termination
benefits provided to certain employees upon future separation as well as $0.2 million related to curtailment charges for its U.S.
defined benefit pension and U.S. retiree medical plans.
For the fiscal year ended September 30, 2012, the Company recognized a $5.3 million asset impairment charge as a result
of issues with respect to the commercialization of products including the active ingredient MAT 28 for the Global Consumer
segment.
65
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 4. GOODWILL AND INTANGIBLE ASSETS, NET
The following table displays a rollforward of the carrying amount of goodwill by reportable segment, as well as Corporate &
Other:
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accumulated impairment losses . . . . . . . . . . . . . . . .
Balance at September 30, 2012
Acquisitions, net of purchase price adjustments . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accumulated impairment losses . . . . . . . . . . . . . . . .
Balance at September 30, 2013
Acquisitions, net of purchase price adjustments . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accumulated impairment losses . . . . . . . . . . . . . . . .
Balance at September 30, 2014
$
The following table presents intangible assets, net:
Global
Consumer
Scotts
LawnService
®
Corporate &
Other
Total
(In millions)
$
127.3
$
—
127.3
4.7
$
24.6
(24.6)
—
—
$
132.0
$
— $
—
132.0
—
132.0
—
132.0
$
$
$
$
—
—
—
— $
—
— $
244.9
(62.8)
182.1
1.0
245.9
(62.8)
183.1
35.8
281.7
(62.8)
218.9
396.8
(87.4)
309.4
5.7
377.9
(62.8)
315.1
35.8
413.7
(62.8)
350.9
September 30, 2014
September 30, 2013
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
(In millions)
$
70.3
74.2
69.0
99.2
(56.0) $
(47.2)
(12.7)
(81.4)
$
14.3
27.0
56.3
17.8
115.4
187.3
302.7
$
$
61.8
81.2
47.0
103.9
(53.8) $
(65.0)
(24.8)
(88.2)
$
8.0
16.2
22.2
15.7
62.1
222.3
284.4
Finite-lived intangible assets:
Technology. . . . . . . . . . . . . . . . . . . . . $
Customer accounts . . . . . . . . . . . . . . .
Tradenames . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . .
Total finite-lived intangible assets,
net. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Indefinite-lived tradenames. . . . . . . . . . . .
Total intangible assets, net. . . . . . . . .
Fiscal 2014
During the third quarter of 2014, the Company completed an impairment review and recognized an impairment charge for
a non-recurring fair value adjustment of $33.7 million, within the Global Consumer segment related to the Ortho® brand. The fair
value was calculated based upon the evaluation of the historical performance and future growth expectations of the Ortho®
business.The impact of the fair value adjustment was to reduce the carrying value of the indefinite-lived Ortho® brand and sub-
brands from $126.0 million to $92.3 million. The impairment charge is discussed further in “NOTE 3. IMPAIRMENT,
RESTRUCTURING AND OTHER CHARGES.” As a result of the annual impairment review, the Company also determined that
no other charges for impairment of goodwill or intangible assets were required. The estimated fair value of each reporting unit
was substantially in excess of its carrying value as of the annual test date. Each of the indefinite-lived tradenames had an estimated
fair value substantially in excess of its carrying value as of the annual test date, with the exception of the Ortho® brand.
Fiscal 2013
During the first quarter of 2013, the Company recognized a $4.3 million asset impairment charge as a result of issues with
the commercialization of an insect repellent technology for the Global Consumer segment. During the fourth quarter of fiscal
66
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
2013, the Company completed its annual impairment review and recognized an impairment charge for a non-recurring fair value
adjustment of $11.6 million, which included $11.1 million for indefinite-lived tradenames and $0.5 million for finite-lived
tradenames, within the Global Consumer segment related to the Ortho® brand and certain sub-brands of Ortho®. The impact of
the fair value adjustment was to reduce the carrying value of the indefinite-lived Ortho® brand and sub-brands from $137.1 million
to $126.0 million. The impairment charge is discussed further in “NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER
CHARGES.” As a result of the annual impairment review, the Company also determined that no other charges for impairment of
goodwill or intangible assets were required. The estimated fair value of each reporting unit was substantially in excess of its
carrying value as of the annual test date. Each of the indefinite-lived tradenames had an estimated fair value substantially in excess
of its carrying value as of the annual test date, with the exception of the Ortho® brand.
Fiscal 2012
The Company recognized a $3.2 million impairment charge related to an intangible asset associated with the active ingredient
MAT 28. The impairment charge is discussed further in “NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER
CHARGES.”
During the fourth quarter of fiscal 2012, the Company completed its annual impairment analysis and determined that no
additional charges for impairment of goodwill or intangible assets were required. The estimated fair value of each reporting unit
was substantially in excess of its carrying value as of the annual test date. Each of the indefinite-lived tradenames had an estimated
fair value substantially in excess of its carrying value as of the annual test date, with the exception of the Ortho® tradename and
French tradenames of KB® and Fertiligene®. The carrying value of the Ortho® tradename and French tradenames (KB® and
Fertiligene®) at September 30, 2012 were $137.1 million and $17.7 million, respectively. The excess fair value over the carrying
value of Ortho® tradename and French tradenames was 7.4% and 14.1%, respectively.
Total amortization expense for the years ended September 30, 2014, 2013, and 2012 was $13.8 million, $11.2 million and
$10.9 million, respectively. Amortization expense is estimated to be as follows for the years ending September 30 (in millions):
2015. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2016. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NOTE 5. DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS
The following is detail of certain financial statement accounts:
September 30,
2014
2013
(In millions)
INVENTORIES:
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Work-in-progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Raw materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PREPAID AND OTHER ASSETS:
Deferred tax asset. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accounts receivable, non-trade . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
217.5
46.2
121.4
385.1
72.2
12.7
38.0
122.9
$
$
$
$
12.5
10.8
9.7
8.4
7.0
182.6
42.7
99.6
324.9
67.1
12.9
33.0
113.0
67
79.6
216.3
508.7
39.7
116.7
15.1
19.6
995.7
(573.4)
422.3
66.6
103.0
110.1
279.7
96.5
96.2
46.1
238.8
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
September 30,
2014
2013
(In millions)
PROPERTY, PLANT AND EQUIPMENT, NET:
Land and improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Buildings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Machinery and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Software. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Aircraft . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Construction in progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: accumulated depreciation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
87.1
218.8
536.2
40.5
123.8
6.7
21.1
1,034.2
(597.2)
437.0
$
$
OTHER CURRENT LIABILITIES:
Payroll and other compensation accruals . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Advertising and promotional accruals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OTHER NON-CURRENT LIABILITIES:
Accrued pension and postretirement liabilities . . . . . . . . . . . . . . . . . . . . . . . . $
Deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
ACCUMULATED OTHER COMPREHENSIVE LOSS:
Unrecognized loss on derivatives, net of tax of $4.3, $7.1 and $10.6
Pension and other postretirement liabilities, net of tax of $38.6, $31.4 and
$36.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation adjustment. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
$
September 30,
2014
2013
(In millions)
79.0
64.1
116.4
259.5
93.8
120.4
39.8
254.0
$
$
$
$
September 30,
2014
2013
2012
(In millions)
(6.9) $
(11.5) $
(16.6)
(62.4)
(16.9)
(86.2) $
(58.0)
(8.3)
(77.8) $
(67.6)
(3.1)
(87.3)
NOTE 6. MARKETING AGREEMENT
The Company is Monsanto’s exclusive agent for the marketing and distribution of consumer Roundup® herbicide products
(with additional rights to new products containing glyphosate or other similar non-selective herbicides) in the consumer lawn and
garden market within the United States and other specified countries, including Australia, Austria, Belgium, Canada, France,
Germany, the Netherlands and the United Kingdom. Under the terms of the Marketing Agreement, the Company is entitled to
receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The annual
gross commission under the Marketing Agreement is calculated as a percentage of the actual earnings before interest and income
taxes of the consumer Roundup® business in the markets covered by the Marketing Agreement and is based on the achievement
of two earnings thresholds, as defined in the Marketing Agreement. The Marketing Agreement also requires the Company to make
68
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
annual payments to Monsanto as a contribution against the overall expenses of the consumer Roundup® business. The annual
contribution payment is defined in the Marketing Agreement as $20 million.
In consideration for the rights granted to the Company under the Marketing Agreement for North America, the Company
was required to pay a marketing fee of $32 million to Monsanto. The Company has deferred this amount on the basis that the
payment will provide a future benefit through commissions that will be earned under the Marketing Agreement. The economic
useful life over which the marketing fee is being amortized is 20 years, with a remaining amortization period of less than four
years as of September 30, 2014.
Under the terms of the Marketing Agreement, the Company performs certain functions, primarily manufacturing conversion
(in North America), distribution and logistics, and selling and marketing support, on behalf of Monsanto in the conduct of the
consumer Roundup® business. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The
Company records costs incurred under the Marketing Agreement for which the Company is the primary obligor on a gross basis,
recognizing such costs in “Cost of sales” and the reimbursement of these costs in “Net sales,” with no effect on gross profit dollars
or net income.
The gross commission earned under the Marketing Agreement, the contribution payments to Monsanto and the amortization
of the initial marketing fee paid to Monsanto are included in the calculation of net sales in the Company’s Consolidated Statements
of Operations. The elements of the net commission and reimbursements earned under the Marketing Agreement and included in
“Net sales” were as follows:
Year Ended September 30
2014
2013
2012
(In millions)
Gross commission. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Contribution expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of marketing fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net commission income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reimbursements associated with Marketing Agreement . . . . . . . . . . . . . . .
Total net sales associated with Marketing Agreement. . . . . . . . . . . . . . $
85.2
(20.0)
(0.8)
64.4
63.0
127.4
$
$
81.8
(20.0)
(0.8)
61.0
62.0
123.0
$
$
81.3
(20.0)
(0.8)
60.5
79.6
140.1
The Marketing Agreement has no definite term except as it relates to the European Union countries (the “EU term”). The
EU term extends through September 30, 2015. Thereafter, the Marketing Agreement provides that the parties may agree to renew
the EU term for an additional three years.
The Marketing Agreement provides Monsanto with the right to terminate the Marketing Agreement upon an event of default
(as defined in the Marketing Agreement) by the Company, a change in control of Monsanto or the sale of the consumer Roundup®
business. The Marketing Agreement provides the Company with the right to terminate the Marketing Agreement in certain
circumstances, including an event of default by Monsanto or the sale of the consumer Roundup® business. Unless Monsanto
terminates the Marketing Agreement due to an event of default by the Company, Monsanto is required to pay a termination fee to
the Company that varies by program year. The termination fee is calculated as a percentage of the value of the Roundup® business
exceeding a certain threshold, but in no event will the termination fee be less than $16 million absent termination for cause. If
Monsanto were to terminate the Marketing Agreement for cause, the Company would not be entitled to any termination fee.
Monsanto may also be able to terminate the Marketing Agreement within a given region, including North America, without paying
a termination fee if unit volume sales to consumers in that region decline: (1) over a cumulative three-fiscal-year period; or (2) by
more than 5% for each of two consecutive years. If the Marketing Agreement was terminated for any reason, the Company would
also lose all, or a substantial portion, of the significant source of earnings and overhead expense absorption the Marketing Agreement
provides.
Under the Marketing Agreement, Monsanto must provide the Company with notice of any proposed sale of the consumer
Roundup® business, allow the Company to participate in the sale process and negotiate in good faith with the Company with
respect to any such proposed sale. In the event the Company acquires the consumer Roundup® business in such a sale, the Company
would receive as a credit against the purchase price the amount of the termination fee that would have been paid to the Company
if Monsanto had exercised its right to terminate the Marketing Agreement in connection with a sale to another party. If Monsanto
decides to sell the consumer Roundup® business to another party, the Company must let Monsanto know whether the Company
intends to terminate the Marketing Agreement and forfeit any right to a termination fee. For additional details regarding the
Marketing Agreement, see “ITEM 1A. RISK FACTORS - If Monsanto were to terminate the Marketing Agreement for consumer
69
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Roundup® products, we would lose a substantial source of future earnings and overhead expense absorption” of this Annual Report
on Form 10-K.
NOTE 7. ACQUISITIONS
Fiscal 2014
During the first quarter of fiscal 2014, in an effort to expand the rodenticide product offerings, the Company completed the
$60.0 million all-cash acquisition of the assets of the Tomcat® consumer rodent control business from Bell Laboratories, Inc.
located in Madison, Wisconsin. Tomcat® consumer products are sold at home centers, mass retailers, and grocery, drug and general
merchandise stores across the United States, Canada, Europe and Australia. During the second quarter of fiscal 2014, the valuation
of the acquired assets was updated based on actual results, which resulted in the reallocation of approximately $1.7 million to
finite-lived intangibles from goodwill. The revised valuation of the acquired assets included finite-lived identifiable intangible
assets of $39.8 million, and tax deductible goodwill of $18.2 million. Also, the Company received a $2.0 million credit toward
the purchase of finished goods in the months subsequent to acquisition date. Identifiable intangible assets included tradename,
technology, customer relationships, product registrations and non-compete agreements with useful lives ranging between 10 to
30 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which
includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to
present value using an appropriate rate of return. Net sales for the Tomcat® rodent control business included within the Global
Consumer segment for fiscal 2014 were $33.6 million.
During the fourth quarter of fiscal 2014, the Company obtained control of the operations of AeroGrow International, Inc
(“AeroGrow”) through its increased involvement, influence, and working capital loan of $4.5 million provided in July of 2014.
AeroGrow is a developer, marketer, direct-seller, and wholesaler of advanced indoor garden systems designed for consumer use
in gardening, cooking, healthy eating, and home and office décor markets. AeroGrow operates primarily in the United States and
Canada, as well as select countries in Europe, Asia and Australia. The preliminary valuation of acquired assets included finite-
lived identifiable intangible assets of $13.7 million, and goodwill of $11.6 million. Identifiable intangible assets included tradename
and customer relationships with useful lives ranging between 9 to 20 years. The estimated fair values of the identifiable intangible
assets were determined using an income-based approach, which includes market participant expectations of cash flows that an
asset will generate over the remaining useful life discounted to present value using an appropriate rate of return. Net sales for
AeroGrow included in the Global Consumer segment for fiscal 2014 were $1.7 million.
The Company completed an acquisition of the assets of the U.K. based Solus Garden and Leisure Limited (“Solus”) in the
fourth quarter of fiscal 2014 within its Global Consumer segment for $7.4 million, $1.1 million of which was paid in cash and
$6.3 million of which was paid through the forgiveness of outstanding accounts receivable owed by Solus to the Company. Solus
is a supplier of garden and leisure products and offers a diverse mix of brands.
On September 30, 2014, Scotts Miracle-Gro's wholly-owned subsidiary, Scotts Canada Ltd., acquired Fafard & Brothers
Ltd. (“Fafard”) for $59.8 million. In continuous operation since 1940 and based in Saint-Bonaventure, Quebec, Canada, Fafard
is a producer of peat moss and growing media products for the consumer and professional markets, including peat-based and bark-
based mixes, composts and premium soils. The acquisition of Fafard increases the Company's presence within Canada as Fafard
serves customers primarily across Ontario, Quebec and New Brunswick. The preliminary valuation of acquired assets included
working capital of $18.0 million, property, plant, and equipment of $23.7 million, finite-lived identifiable intangible assets of
$13.6 million, and tax deductible goodwill of $6.0 million. Working capital included accounts receivable of $5.2 million, inventory
of $17.3 million, and accounts payable of $4.5 million. Identifiable intangible assets included tradename, customer relationships,
non-compete agreements, and peat harvesting rights with useful lives ranging between 5 to 25 years. The estimated fair values
of the identifiable intangible assets were determined using an income-based approach, which includes market participant
expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate
rate of return. Included in the purchase price of Fafard is $7.1 million of contingent consideration, the payment of which will
depend on the performance of the business over the next two years.
The Consolidated Financial Statements include the results of operations from these businesses from the date of each
acquisition.
On October 16, 2014, Scotts LawnService® entered into a definitive agreement to acquire the assets of Action Pest Control,
Inc. (“Action Pest”), a residential and commercial pest control provider in the Midwest for $22.7 million. The initial purchase
price accounting for the Action Pest acquisition will be determined during the first quarter of fiscal 2015.
70
Table of Contents
Fiscal 2013 and 2012
During fiscal 2013 and 2012, the Company completed several acquisitions within its controls, growing media and Scotts
LawnService® businesses that individually and in the aggregate were not significant. The aggregate purchase price of these
acquisitions was $7.2 million and $6.7 million in fiscal 2013 and fiscal 2012, respectively. The Consolidated Financial Statements
include the results of operations from these business combinations from the date of each acquisition.
NOTE 8. RETIREMENT PLANS
The Company sponsors a defined contribution 401(k) plan for substantially all U.S. associates. The Company matches
150% of associates’ initial 4% contribution and 50% of their remaining contribution up to 6%. The Company may make additional
discretionary profit sharing matching contributions to eligible employees on their initial 4% contribution. The Company recorded
charges of $13.8 million, $13.1 million and $12.9 million under the plan in fiscal 2014, fiscal 2013 and fiscal 2012, respectively.
The Company sponsors two defined benefit pension plans for certain U.S. associates. Benefits under these plans have been
frozen and closed to new associates since 1997. The benefits under the primary plan are based on years of service and the associates’
average final compensation or stated amounts. The Company’s funding policy, consistent with statutory requirements and tax
considerations, is based on actuarial computations using the Projected Unit Credit method. The second frozen plan is a non-
qualified supplemental pension plan. This plan provides for incremental pension payments so that total pension payments equal
amounts that would have been payable from the Company’s pension plan if it were not for limitations imposed by the income tax
regulations. In connection with the restructuring plans discussed in “NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER
CHARGES,” the Company recognized a plan curtailment gain of $0.5 million in fiscal 2013 for a change in the benefit obligations
associated with these plans.
The Company sponsors defined benefit pension plans associated with its international businesses in the United Kingdom,
Germany, France and the Netherlands. These plans generally cover all associates of the respective businesses, with retirement
benefits primarily based on years of service and compensation levels. In fiscal 2013 the Company's remaining obligations were
settled for the defined benefit pension plan associated with its Netherlands business. On July 1, 2010, the Company froze its two
U.K. defined benefit pension plans and transferred participants to an amended defined contribution plan. Under the frozen plans,
participants are no longer credited for future service; however, future salary increases will continue to be factored into each
participant’s final pension benefit.
71
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following tables present information about benefit obligations, plan assets, annual expense, assumptions and other
information about the Company’s defined benefit pension plans. The defined benefit pension plans are valued using a September 30
measurement date.
U.S. Defined
Benefit Pension Plans
International
Defined
Benefit Pension Plans
2014
2013
2014
2013
(In millions)
106.7
$
118.8
$
190.7
$
188.0
—
4.5
5.1
(7.1)
—
—
—
—
109.2
109.2
84.3
9.2
3.4
(7.1)
—
—
—
$
$
$
—
3.9
(8.8)
(7.2)
—
—
—
—
106.7
106.7
85.3
3.4
2.8
(7.2)
—
—
—
$
$
$
89.8
$
(19.4) $
84.3
$
(22.4) $
1.2
8.3
17.7
(6.5)
—
—
(0.6)
(2.5)
208.3
200.8
148.8
16.4
$
$
$
8.9
(6.5)
—
(0.4)
(0.9)
166.3
$
(42.0) $
109.2
$
106.7
$
208.3
$
109.2
89.8
106.7
84.3
200.8
166.3
(0.2) $
(19.2)
(19.4) $
34.3
—
34.3
$
$
(0.2) $
(22.2)
(22.4) $
36.9
—
36.9
$
$
(1.1) $
(40.9)
(42.0) $
64.7
0.4
65.1
$
$
1.2
7.8
4.5
(6.1)
(0.8)
(4.6)
(1.3)
2.0
190.7
184.8
139.8
12.1
8.2
(6.1)
(4.6)
0.7
(1.3)
148.8
(41.9)
190.7
184.8
148.8
(1.0)
(40.9)
(41.9)
56.1
0.4
56.5
Change in projected benefit obligation
Benefit obligation at beginning of year . . . . . . . . . . . . . . . . . . $
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Actuarial loss (gain) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefits paid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Curtailment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation. . . . . . . . . . . . . . . . . . . . . . . . . . .
Projected benefit obligation at end of year. . . . . . . . . . . . . . . . $
Accumulated benefit obligation at end of year . . . . . . . . . . $
Change in plan assets
Fair value of plan assets at beginning of year . . . . . . . . . . . . . $
Actual return on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . .
Employer contribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benefits paid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation. . . . . . . . . . . . . . . . . . . . . . . . . . .
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fair value of plan assets at end of year . . . . . . . . . . . . . . . . . . $
Underfunded status at end of year . . . . . . . . . . . . . . . . . . . . $
Information for pension plans with an accumulated
benefit obligation in excess of plan assets
Projected benefit obligation . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accumulated benefit obligation . . . . . . . . . . . . . . . . . . . . . . . .
Fair value of plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amounts recognized in the Consolidated Balance Sheets
consist of:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Noncurrent liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total amount accrued . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Amounts recognized in accumulated other
comprehensive loss consist of:
Actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Prior service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total amount recognized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
72
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Total change in other comprehensive loss attributable to:
Pension benefit (loss) gain during the period
Reclassification of pension benefit losses to net income
Curtailment gain during the period
Foreign currency translation
Total change in other comprehensive loss
Amounts in accumulated other comprehensive loss
expected to be recognized as components of net periodic
benefit cost in fiscal 2015 are as follows:
Actuarial loss
Prior service cost
Amount to be amortized into net periodic benefit cost
Weighted average assumptions used in development of
projected benefit obligation
$
$
$
$
U.S. Defined
Benefit Pension Plans
International
Defined
Benefit Pension Plans
2014
2013
2014
2013
(In millions, except percentage figures)
(1.1)
3.7
—
—
2.6
$
$
7.1
4.8
—
—
11.9
3.3
—
3.3
$
$
$
$
(10.7)
1.4
—
0.7
(8.6)
$
$
(0.3)
1.2
(1.0)
(0.4)
(0.5)
1.8
—
1.8
Discount rate
Rate of compensation increase
3.81%
n/a
4.32%
n/a
3.73%
3.65%
4.32%
3.74%
Components of net periodic benefit cost
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected return on plan assets . . . . . . . . . . . . .
Net amortization . . . . . . . . . . . . . . . . . . . . . . . .
Net periodic benefit cost . . . . . . . . . . . . . . . . .
Curtailment loss (gain) . . . . . . . . . . . . . . . . . . .
Settlement. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Contractual termination benefits . . . . . . . . . . .
Total benefit cost . . . . . . . . . . . . . . . . . . . . . . . $
Weighted average assumptions used in
development of net periodic benefit cost
Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected return on plan assets . . . . . . . . . . . . .
Rate of compensation increase . . . . . . . . . . . . .
U.S. Defined
Benefit Pension Plans
International
Defined Benefit Pension Plans
2014
2013
2012
2014
2013
2012
(In millions, except percentage figures)
— $
4.5
(5.2)
3.7
3.0
—
—
—
3.0
$
— $
3.8
(5.2)
4.8
3.4
—
—
—
3.4
$
— $
4.6
(5.5)
5.1
4.2
0.2
—
—
4.4
$
1.2
8.3
(9.4)
1.4
1.5
—
—
0.3
1.8
$
$
1.2
7.8
(8.7)
1.2
1.5
(0.5)
(0.5)
—
0.5
$
$
1.1
8.6
(8.4)
0.8
2.1
—
—
0.3
2.4
4.32%
6.25%
n/a
3.39%
6.25%
n/a
4.29%
7.50%
n/a
4.32%
6.17%
3.7%
4.45%
6.52%
3.4%
5.46%
7.00%
3.5%
73
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
U.S. Defined
Benefit Pension Plans
International
Defined
Benefit Pension Plans
(In millions, except percentage figures)
Other information:
Plan asset allocations:
Target for September 30, 2015:
Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Debt securities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Real estate securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Insurance contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
September 30, 2014:
Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Debt securities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Real estate securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Insurance contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
September 30, 2013:
Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Debt securities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Insurance contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected Company contributions in fiscal 2015. . . . . . . . . . . . . . . . . . . . . . . . . . . $
Expected future benefit payments:
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 – 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20%
76%
4%
—%
—%
25%
69%
4%
2%
—%
33%
66%
1%
—%
0.2
7.2
7.3
7.3
7.3
7.3
36.0
$
$
46%
49%
—%
3%
2%
52%
45%
—%
1%
2%
47%
44%
—%
9%
7.3
6.4
6.6
6.9
7.3
7.6
44.5
74
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value
hierarchy:
September 30, 2014
Quoted Prices in
Active
Markets for
Identical
Assets (Level 1)
Significant Other
Observable
Inputs (Level 2)
Unobservable
Inputs
(Level 3)
Total
(In millions)
U.S. Defined Benefit Pension Plan Assets
Cash and cash equivalents. . . . . . . . . . . . . . . . . . . . $
Mutual funds—real estate . . . . . . . . . . . . . . . . . . . .
Mutual funds—equities. . . . . . . . . . . . . . . . . . . . . .
Mutual funds—fixed income . . . . . . . . . . . . . . . . .
Total
International Defined Benefit Pension Plan
Assets
Cash and cash equivalents. . . . . . . . . . . . . . . . . . . . $
Insurance contracts . . . . . . . . . . . . . . . . . . . . . . . . .
Mutual funds—equities. . . . . . . . . . . . . . . . . . . . . .
Mutual funds—fixed income . . . . . . . . . . . . . . . . .
Total
$
$
2.0
—
—
—
2.0
1.7
—
—
—
1.7
$
$
$
$
— $
3.7
22.2
61.9
87.8
$
— $
3.0
87.4
74.2
164.6
$
— $
—
—
—
— $
— $
—
—
—
— $
September 30, 2013
Quoted Prices in
Active
Markets for
Identical
Assets (Level 1)
Significant Other
Observable
Inputs (Level 2)
Unobservable
Inputs
(Level 3)
Total
(In millions)
U.S. Defined Benefit Pension Plan Assets
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . $
Mutual funds—equities . . . . . . . . . . . . . . . . . . . . . .
Mutual funds—fixed income. . . . . . . . . . . . . . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
International Defined Benefit Pension Plan
Assets
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . $
Insurance contracts . . . . . . . . . . . . . . . . . . . . . . . . .
Mutual funds—equities . . . . . . . . . . . . . . . . . . . . . .
Mutual funds—fixed income. . . . . . . . . . . . . . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
1.5
—
—
1.5
1.6
—
—
—
1.6
$
$
$
$
— $
27.5
55.3
82.8
$
— $
3.3
73.9
70.0
147.2
$
— $
—
—
— $
— $
—
—
—
— $
2.0
3.7
22.2
61.9
89.8
1.7
3.0
87.4
74.2
166.3
1.5
27.5
55.3
84.3
1.6
3.3
73.9
70.0
148.8
The fair value of the mutual funds are valued at the exchange-listed year end closing price or at the net asset value of shares
held by the fund at the end of the year. Insurance contracts are valued by discounting the related cash flows using a current year
end market rate or at cash surrender value, which is presumed to equal fair value. Funds of hedge funds are valued at the net asset
value of shares held by the fund at the end of the year.
75
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The table below sets forth a summary of changes in the fair value of the Company’s level 3 pension plan assets:
Balance, September 30, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Realized gain on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrealized gain on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchases, sales, issuances and settlements (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance, September 30, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Realized gain on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrealized gain on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchases, sales, issuances and settlements (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance, September 30, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Level 3 Assets
Insurance contracts
(In millions)
4.4
0.3
—
—
(4.7)
—
—
—
—
—
—
Investment Strategy
Target allocation percentages among various asset classes are maintained based on an individual investment policy established
for each of the various pension plans. Asset allocations are designed to achieve long-term objectives of return while mitigating
against downside risk and considering expected cash requirements necessary to fund benefit payments. However, the Company
cannot predict future investment returns and therefore cannot determine whether future pension plan funding requirements could
materially and adversely affect its financial condition, results of operations or cash flows.
Basis for Long-Term Rate of Return on Asset Assumptions
The Company’s expected long-term rate of return on asset assumptions are derived from studies conducted by third parties.
The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the
appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings
expected. While the studies give appropriate consideration to recent fund performance and historical returns, the assumptions
primarily represent expectations about future rates of return over the long term.
NOTE 9. ASSOCIATE MEDICAL BENEFITS
The Company provides comprehensive major medical benefits to certain of its retired associates and their dependents.
Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits
if they retire at age 55 or older with more than 10 years of service. The retiree medical plan requires certain minimum contributions
from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company
funds its portion of retiree medical benefits on a pay-as-you-go basis.
The following table sets forth information about the retiree medical plan for domestic associates. The retiree medical plan
is valued using a September 30 measurement date.
76
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Change in Accumulated Plan Benefit Obligation (APBO)
Benefit obligation at beginning of year
Service cost
Interest cost
Plan participants’ contributions
Actuarial gain (loss)
Benefits paid (net of federal subsidy of $0.3 and $0.3)
Plan changes
Benefit obligation at end of year
Change in plan assets
Fair value of plan assets at beginning of year
Employer contribution
Plan participants’ contributions
Gross benefits paid
Fair value of plan assets at end of year
Unfunded status at end of year
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities
Noncurrent liabilities
Total amount accrued
Amounts recognized in accumulated other comprehensive loss consist of:
Actuarial loss
Unamortized prior service cost
Total amount recognized
Total change in other comprehensive loss attributable to:
Benefit loss (gain) during the period
Net prior service cost
Net gain amortized during the year
Total change in other comprehensive loss (gain)
2014
2013
(In millions, except percentage
figures)
$
$
$
$
$
$
$
$
$
$
31.6
0.4
1.4
1.1
0.7
(2.9)
0.1
32.4
$
$
— $
2.1
1.1
(3.2)
—
(32.4)
$
(2.3)
(30.1)
(32.4)
1.3
0.1
1.4
0.9
0.1
—
1.0
$
$
$
$
$
$
36.3
0.5
1.3
1.1
(4.4)
(3.2)
—
31.6
—
2.4
1.1
(3.5)
—
(31.6)
(2.4)
(29.2)
(31.6)
0.4
—
0.4
(4.3)
—
(0.2)
(4.5)
Discount rate used in development of APBO
4.08%
4.54%
Components of net periodic benefit cost
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total postretirement benefit cost. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2014
2013
2012
0.4
1.4
—
1.8
$
$
0.5
1.3
0.1
1.9
$
$
0.6
1.6
—
2.2
Discount rate used in development of net periodic benefit cost . . . . . . . .
4.54%
3.66%
4.66%
The estimated actuarial gain that will be amortized from accumulated loss into net periodic benefit cost over the next fiscal
year is immaterial.
On December 8, 2003, the Medicare Prescription Drug, Improvement and Modernization Act (the “Act”) became law. The
Act provides for a federal subsidy to sponsors of retiree health care benefit plans that provide a prescription drug benefit that is
at least actuarially equivalent to the benefit established by the Act. The APBO at September 30, 2014, has been reduced by a
deferred actuarial gain in the amount of $0.3 million to reflect the effect of the subsidy related to benefits attributed to past service.
77
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The amortization of the actuarial gain and reduction of service and interest costs served to reduce net periodic post retirement
benefit cost for fiscal 2014, fiscal 2013 and fiscal 2012 by $0.1 million, $0.3 million and $0.2 million, respectively.
For measurement as of September 30, 2014, management has assumed that health care costs will increase at an annual rate
of 7.50% in fiscal 2015, decreasing 0.25% per year to an ultimate trend rate of 5.00% in 2025. A 1% increase in health cost trend
rate assumptions would increase the APBO by $1.1 million as of September 30, 2014. A 1% decrease in health cost trend rate
assumptions would decrease the APBO by $0.8 million as of September 30, 2014. A 1% increase or decrease in the same rate
would not have a material effect on service or interest costs.
The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years
indicated:
Gross
Benefit
Payments
Retiree
Contributions
Medicare
Part D
Subsidy
Net
Company
Payments
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 – 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
4.0
4.2
4.4
4.7
5.1
28.8
(In millions)
(1.3) $
(1.5)
(1.8)
(2.0)
(2.4)
(15.8)
(0.3) $
(0.4)
(0.4)
(0.4)
(0.5)
(2.8)
2.4
2.3
2.2
2.3
2.2
10.2
The Company also provides comprehensive major medical benefits to its associates. The Company is self-insured for certain
health benefits up to $0.6 million per occurrence per individual. The cost of such benefits is recognized as expense in the period
the claim is incurred. This cost was $33.8 million, $35.1 million and $28.7 million in fiscal 2014, fiscal 2013 and fiscal 2012,
respectively.
NOTE 10. DEBT
The components of long-term debt are as follows:
September 30,
2014
2013
(In millions)
Credit Facilities - Revolving loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Senior Notes – 7.25% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Senior Notes – 6.625% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Master Accounts Receivable Purchase Agreement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less current portions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
481.8
—
200.0
84.0
18.5
784.3
91.9
692.4
$
$
The Company’s debt matures as follows for each of the next five fiscal years and thereafter (in millions):
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
73.0
200.0
200.0
85.3
12.2
570.5
92.4
478.1
91.9
1.5
7.7
0.5
482.3
200.4
784.3
78
Table of Contents
Credit Facilities
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
On December 20, 2013, the Company entered into a third amended and restated senior secured credit agreement (the “new
credit facility”), providing Scotts Miracle-Gro and certain of its subsidiaries with a five-year senior secured revolving loan facility
in the aggregate principal amount of up to $1.7 billion. The new credit facility also provides the Company with the right to seek
to increase the revolving and/or term commitments available under the new credit facility by an aggregate amount of up to $450
million, subject to certain specified conditions, including approval from lenders. The new credit facility replaces the Company’s
second amended and restated senior secured credit agreement, which was entered into on June 30, 2011, and would have terminated
on June 30, 2016 if it had not been terminated early in connection with the entry into the new credit facility.
The terms of the new credit facility include customary representations and warranties, customary affirmative and negative
covenants, and events of default. The proceeds of borrowings under the new credit facility may be used: (i) to finance working
capital requirements and other general corporate purposes of the Scotts Miracle-Gro and its subsidiaries; and (ii) to refinance the
amounts outstanding under the previous credit agreement. The Company may use the new credit facility to obtain letters of credit
up to $75 million. The new credit facility will terminate on December 20, 2018.
Under the terms of the new credit facility, loans made under the new credit facility bear interest, at the Company’s election,
at a rate per annum equal to either the ABR or LIBOR (both as defined in the new credit facility) plus the applicable margin.
Amounts outstanding under the credit facility at September 30, 2014 were at interest rates based on LIBOR applicable to the
borrowed currencies plus 150 basis points. The new credit facility is guaranteed by substantially all of Scotts Miracle-Gro's domestic
subsidiaries, which have a carrying value of $1.6 billion. The credit facility is secured by (i) a perfected first priority security
interest in all of the accounts receivable, inventory and equipment of the Company and those of Scotts Miracle-Gro’s domestic
subsidiaries that are parties to the third amended and restated guarantee and collateral agreement and (ii) the pledge of all of the
capital stock of Scotts Miracle-Gro’s domestic subsidiaries that are parties to the third amended and restated guarantee and collateral
agreement.
As of September 30, 2014, there was $1,194.9 million of availability under the new credit facility, including availability
under letters of credit. At September 30, 2014, the Company had letters of credit in the aggregate face amount of $23.3 million
outstanding under the new credit facility.
The new credit facility contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio,
calculated as average total indebtedness, as described in the new credit facility, relative to the Company’s earnings before interest,
taxes, depreciation and amortization (“EBITDA”), as adjusted pursuant to the terms of the new credit facility (“Adjusted EBITDA”).
Under the terms of the new credit facility, the maximum leverage ratio was 4.00 as of September 30, 2014. The Company’s
leverage ratio was 2.18 at September 30, 2014. The new credit facility also includes an affirmative covenant regarding the
Company's interest coverage ratio. The interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense and
excludes costs related to refinancings. Under the terms of the new credit facility, the minimum interest coverage ratio was 3.50
for the twelve months ended September 30, 2014. The Company’s interest coverage ratio was 9.41 for the twelve months ended
September 30, 2014. The Company may make restricted payments (as defined in the third amended and restated credit agreement);
provided that if after giving effect to any such restricted payment the leverage ratio is not greater than 3.00. Otherwise, the
Company may only make restricted payments in an aggregate amount for each fiscal year not to exceed the amount set forth for
such fiscal year ($150 million for 2014 and 2015 and $175 million for 2016 and in each fiscal year thereafter).
Senior Notes- 7.25%
On January 15, 2014, the Company redeemed all of its outstanding $200.0 million aggregate principal amount of 7.25%
senior notes due 2018 (the “7.25% Senior Notes”) paying a redemption price of $214.5 million, which included $7.25 million of
accrued and unpaid interest, $7.25 million of call premium, and $200.0 million for outstanding principal amount. The $7.25
million call premium charge was recognized within the “Costs related to refinancing” line on the Condensed Consolidated Statement
of Operations in the second quarter of fiscal 2014. Additionally, the Company had $3.5 million in unamortized bond discount and
issuance costs associated with the 7.25% Senior Notes that were written-off and recognized in the “Costs related to refinancing”
line on the Condensed Consolidated Statement of Operations in the Company's second quarter of fiscal 2014. These amounts are
reported in the aggregate in the “Costs related to financing” line in the Consolidated Statement of Operation for fiscal 2014.
79
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Senior Notes- 6.625%
On December 16, 2010, Scotts Miracle-Gro issued $200 million aggregate principal amount of 6.625% Senior Notes due
2020 (the “6.625%” Senior Notes”). The net proceeds of the offering were used to repay outstanding borrowings under the
Company’s then existing credit facilities and for general corporate purposes. The 6.625% Senior Notes represent general unsecured
senior obligations of Scotts Miracle-Gro and rank equal in right of payment with the Company’s existing and future unsecured
senior debt, including, without limitation, the 7.25% Senior Notes. The 6.625% Senior Notes have interest payment dates of June
15 and December 15 of each year, which began on June 15, 2011, and may be redeemed prior to maturity starting December 2015
at applicable redemption premiums. The 6.625% Senior Notes contain usual and customary covenants. The 6.625% Senior Notes
mature on December 15, 2020. Substantially all of Scotts Miracle-Gro’s domestic subsidiaries serve as guarantors of the 6.625%
Senior Notes.
Interest Rate Swap Agreements
At September 30, 2014, the Company had outstanding interest rate swap agreements with major financial institutions that
effectively converted the LIBOR index portion of variable-rate debt denominated in U.S. dollars to a fixed rate. The swap
agreements had a total U.S. dollar notional amount of $1,300 million at September 30, 2014. Interest payments made between
the effective date and expiration date are hedged by the swap agreements, except as noted below. The notional amount, effective
date, expiration date and rate of each of these swap agreements are shown in the table below.
Notional Amount
(in millions)
Effective
Date (a)
Expiration
Date
Fixed
Rate
$
50
150 (b)
150 (c)
50 (b)
100 (b)
150 (c)
50 (d)
200
150 (b)
50 (c)
200 (c)
2/14/2012
2/7/2012
11/16/2009
2/16/2010
2/21/2012
12/20/2011
12/6/2012
2/7/2014
2/7/2017
2/7/2017
12/20/2016
2/14/2016
5/7/2016
5/16/2016
5/16/2016
5/23/2016
6/20/2016
9/6/2017
11/7/2017
5/7/2019
5/7/2019
6/20/2019
3.78%
2.42%
3.26%
3.05%
2.40%
2.61%
2.96%
1.28%
2.12%
2.25%
2.12%
(a)
(b)
(c)
(d)
The effective date refers to the date on which interest payments were, or will be, first hedged by the applicable swap
agreement.
Interest payments made during the three-month period of each year that begins with the month and day of the effective
date are hedged by the swap agreement.
Interest payments made during the six-month period of each year that begins with the month and day of the effective date
are hedged by the swap agreement.
Interest payments made during the nine-month period of each year that begins with the month and day of the effective
date are hedged by the swap agreement.
Master Accounts Receivable Purchase Agreement
The Company accounts for the sale of receivables under the Master Accounts Receivable Purchase Agreement (“MARP
Agreement”), which is uncommitted and provides for the discretionary sale by the Company, and the discretionary purchase by
the banks, on a revolving basis, of accounts receivable generated by sales to three specified account debtors in an aggregate amount
not to exceed $400 million. On August 29, 2014, the Company signed an amendment to the existing MARP Agreement which
extended the termination date to August 28, 2015, or such later date as may be agreed by each bank and the Company. Under the
amended terms of the MARP Agreement, the banks have the opportunity to purchase those accounts receivable offered by the
Company at a discount (from the agreed base value thereof) effectively equal to the one-week LIBOR plus 0.75%.
The Company accounts for the sale of receivables under its MARP Agreement as short-term debt and continues to carry the
receivables on its Consolidated Balance Sheet, primarily as a result of the Company’s right to repurchase receivables sold. There
80
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
were $84.0 million in borrowings under the MARP Agreement as of September 30, 2014 and $85.3 million in borrowings as of
September 30, 2013. The carrying value of the receivables pledged as collateral was $113.7 million as of September 30, 2014
and $106.7 million as of September 30, 2013. As of September 30, 2014, there was $27.7 million of availability under the MARP
Agreement.
Estimated Fair Values
A description of the methods and assumptions used to estimate the fair values of the Company’s debt instruments is as
follows:
Credit Facility
The interest rate currently available to the Company under its credit facility fluctuates with the applicable LIBOR rate, prime
rate or Federal Funds Effective Rate, and thus the carrying value is a reasonable estimate of fair value. The fair value measurement
for the new credit facility was classified in Level 2 of the fair value hierarchy.
7.25% Senior Notes
The 7.25% Senior Notes were redeemed by the Company in the second quarter of 2014. The fair value of the 7.25% Senior
Notes was determined based on the trading value of the 7.25% Senior Notes in the open market. The difference between the
carrying value and the fair value of the 7.25% Senior Notes on a particular date represented the premium or discount on that date.
The fair value measurement for the 7.25% Senior Notes was classified in Level 1 of the fair value hierarchy.
6.625% Senior Notes
The fair value of the 6.625% Senior Notes can be determined based on the trading value of the 6.625% Senior Notes in the
open market. The difference between the carrying value and the fair value of the 6.625% Senior Notes on a particular date represents
the premium or discount on that date. The fair value measurement for the 6.625% Senior Notes was classified in Level 1 of the
fair value hierarchy.
Accounts Receivable Pledged
The interest rate on the short-term debt associated with accounts receivable pledged under the MARP Agreement fluctuates
with the applicable LIBOR rate, and thus the carrying value is a reasonable estimate of fair value. The fair value measurement
for the MARP Agreement was classified in Level 2 of the fair value hierarchy.
The estimated fair values of the Company’s debt instruments are as follows:
Year Ended September 30,
2014
2013
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Revolving loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Senior Notes – 7.25% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Senior Notes – 6.625% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Master Accounts Receivable Purchase Agreement. . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
481.8
—
200.0
84.0
18.5
(In millions)
$
481.8
—
212.5
84.0
18.5
$
73.0
200.0
200.0
85.3
12.2
73.0
209.5
213.5
85.3
12.2
Weighted Average Interest Rate
The weighted average interest rates on average debt were 5.0% and 6.2% for the fiscal years ended September 30, 2014 and
2013, respectively.
81
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 11. SHAREHOLDERS’ EQUITY
Authorized and issued shares consisted of the following:
September 30,
2014
2013
(In millions)
Preferred shares, no par value:
Authorized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issued. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
0.2 shares
0.0 shares
0.2 shares
0.0 shares
Common shares, no par value, $.01 stated value per share
Authorized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issued. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100.0 shares
68.1 shares
100.0 shares
68.1 shares
In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30,
2014, the former shareholders of Miracle-Gro, including the Hagedorn Partnership L.P., owned approximately 26% of Scotts
Miracle-Gro’s outstanding Common Shares and, thus, have the ability to significantly influence the election of directors and other
actions requiring the approval of Scotts Miracle-Gro’s shareholders.
Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively
acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement)
representing more than 49% of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100%
of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the
last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50% of the Voting Stock
beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates
and associates.
In August 2010, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to $500 million of Common
Shares over a four-year period through September 30, 2014. On May 4, 2011, the Scotts Miracle-Gro Board of Directors authorized
the repurchase of up to an additional $200 million of Common Shares, resulting in authority to repurchase a total of up to $700 million
of Common Shares through September 30, 2014. From the inception of this share repurchase program in the fourth quarter of
fiscal 2010 through its expiration on September 30, 2014, Scotts Miracle-Gro repurchased approximately 9.9 million Common
Shares for $521.2 million to be held in treasury. Common Shares held in treasury totaling 0.8 million and 0.7 million were reissued
in support of share-based compensation awards and employee purchases under the employee stock purchase plan during fiscal
2014 and fiscal 2013, respectively.
In August 2014, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to $500 million of Common
Shares over a four-year period through September 30, 2019. The authorization provides the Company with flexibility to purchase
Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the
repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the
repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization,
which expires September 30, 2019, may be suspended or discontinued at any time, and there can be no guarantee as to the timing
or amount of any repurchases. In August 2014, the Scotts Miracle-Gro Board of Directors also authorized a special one-time cash
dividend of $2.00 per share payable on September 17, 2014. The payment of the special one-time cash dividend required Scotts
Miracle-Gro to adjust the number of Common Shares subject to stock options outstanding under the Scotts Miracle-Gro share-
based awards programs, as well as the price at which the awards may be exercised. The adjustments to the outstanding awards
resulted in an increase in the number of Common Shares subject to outstanding stock options in an aggregate amount of 0.1 million
Common Shares. The methodology used to adjust the awards was consistent with Internal Revenue Code (IRC) Section 409A
and the then-proposed regulations promulgated thereunder and IRC Section 424 and the regulations promulgated thereunder,
compliance with which was necessary to avoid adverse tax consequences for the holder of an award. Such methodology also
resulted in a fair value for the adjusted awards post-dividend equal to that of the unadjusted awards pre-dividend, with the result
that there was no additional compensation expense in accordance with the accounting for modifications to awards under ASC 718.
82
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Share-Based Awards
Scotts Miracle-Gro grants share-based awards annually to officers and certain other employees of the Company and non-
employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock, restricted
stock units, deferred stock units and performance-based awards. Stock appreciation rights (“SARs”) have been granted, though
not in recent years. SARs result in less dilution than stock options as the SAR holder receives a net share settlement upon exercise.
All of these share-based awards have been made under plans approved by the shareholders. Generally, employee share-based
awards provide for three-year cliff vesting. Vesting for non-employee director awards varies based on the length of service and
age of each director at the time of the award. Vesting of performance-based awards is dependent on service and achievement of
specified performance targets. Share-based awards are forfeited if a holder terminates employment or service with the Company
prior to the vesting date. The Company estimates that 15% of its share-based awards will be forfeited based on an analysis of
historical trends. This assumption is re-evaluated on an annual basis and adjusted as appropriate. Stock options and SAR awards
have exercise prices equal to the market price of the underlying Common Shares on the date of grant with a term of 10 years. If
available, Scotts Miracle-Gro will typically use treasury shares, or if not available, newly-issued Common Shares, in satisfaction
of its share-based awards.
A maximum of 23 million Common Shares are available for issuance under share-based award plans. At September 30,
2014, approximately 3.0 million Common Shares were not subject to outstanding awards and were available to underlie the grant
of new share-based awards.
The following is a recap of the share-based awards granted during the periods indicated:
Employees
Options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restricted stock units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Performance units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Board of Directors
Deferred stock units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options due to special $2.00 dividend. . . . . . . . . . . . . . . . . . . . .
Total share-based awards. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Aggregate fair value at grant dates (in millions) . . . . . . . . . . . . . $
Year Ended September 30,
2014
2013
2012
—
112,315
161,229
38,418
98,186
311,962
—
178,030
178,321
33,253
—
389,604
17.5
$
17.5
$
464,061
107,373
110,079
30,943
—
712,456
17.4
Total share-based compensation was as follows for the periods indicated:
Share-based compensation
Tax benefit recognized
Year Ended September 30,
2014
2013
(In millions)
2012
$
$
11.1
3.9
$
10.3
3.9
12.5
4.8
As of September 30, 2014, total unrecognized compensation cost related to non-vested share-based awards amounted to
$11.6 million. This cost is expected to be recognized over a weighted-average period of 1.8 years. The tax benefit realized from
the tax deductions associated with the exercise of share-based awards and the vesting of restricted stock totaled $15.1 million for
fiscal 2014.
83
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Stock Options/SARs
Aggregate stock option and SAR activity consisted of the following for the fiscal year ended September 30, 2014 (options/
SARs in millions):
Beginning balance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercisable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
No. of
Options/SARs
WTD.
Avg.
Exercise
Price
$
2.7
0.1
(0.8)
—
2.0
1.6
37.60
40.89
30.80
—
38.26
36.70
At September 30, 2014, the Company expects 0.3 million of the remaining unexercisable stock options (after forfeitures),
with a weighted-average exercise price of $45.36, intrinsic value of $3.4 million and average remaining term of 7.3 years, to vest
in the future. The following summarizes certain information pertaining to stock option and SAR awards outstanding and exercisable
at September 30, 2014 (options/SARs in millions):
Range of
Exercise Price
$20.59 – $28.72 . . . . . . . . . . . . . . . . . . . . . . .
$29.01 – $37.03 . . . . . . . . . . . . . . . . . . . . . . .
$37.89 – $49.19 . . . . . . . . . . . . . . . . . . . . . . .
Awards Outstanding
Awards Exercisable
No. of
Options/
SARs
WTD.
Avg.
Remaining
Life
WTD.
Avg.
Exercise
Price
No. of
Options/
SARS
WTD.
Avg.
Remaining
Life
WTD.
Avg.
Exercise
Price
0.3
0.8
0.9
2.0
3.80
2.13
6.10
4.22
$
$
20.98
35.82
45.17
38.26
0.3
0.8
0.5
1.6
3.80
2.13
5.35
3.54
$
$
20.98
35.82
45.05
36.70
The intrinsic value of the stock option and SAR awards outstanding and exercisable at September 30 were as follows (in
millions):
Outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Exercisable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014
33.3
29.8
The grant date fair value of stock option awards is estimated using a binomial model and the assumptions in the following
table. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical
volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior,
is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods
within the contractual life (normally ten years) of the stock option is based on the U.S. Treasury yield curve in effect at the time
of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding. No stock
option awards were granted in fiscal 2014 and 2013. The weighted average assumptions for awards granted in fiscal 2012 are as
follows:
Year Ended September 30,
2012
Expected market price volatility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free interest rates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected dividend yield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected life of stock options in years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Estimated weighted-average fair value per stock option. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
33.2%
1.2%
2.5%
5.96
11.50
The total intrinsic value of stock options exercised was $21.3 million, $8.1 million and $23.9 million during fiscal 2014,
fiscal 2013 and fiscal 2012, respectively. Cash received from the exercise of stock options for fiscal 2014, fiscal 2013 and fiscal
2012 was $20.0 million, $13.3 million and $17.6 million respectively.
84
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Restricted share-based awards
Restricted share-based award activity (including restricted stock, restricted stock units and deferred stock units) was as
follows:
Awards outstanding at September 30, 2011
Granted
Vested
Forfeited
Awards outstanding at September 30, 2012
Granted
Vested
Forfeited
Awards outstanding at September 30, 2013
Granted
Vested
Forfeited
Awards outstanding at September 30, 2014
No. of
Shares
WTD. Avg.
Grant Date
Fair Value
per Share
$
696,906
138,316
(301,132)
(36,891)
497,199
211,283
(251,855)
(46,976)
409,651
150,733
(81,597)
(44,895)
433,892
35.22
47.53
22.25
45.28
45.75
44.80
40.87
53.54
47.36
59.35
41.88
47.43
52.55
The total fair value of restricted stock units and deferred stock units vested was $3.4 million, $10.3 million and $3.1 million
during fiscal 2014, fiscal 2013 and fiscal 2012, respectively. The total fair value of restricted stock vested was $3.6 million during
fiscal 2012. The Company has no outstanding restricted stock as of September 30, 2014.
Performance-based awards
Performance-based award activity was as follows:
No. of
Units
WTD. Avg.
Grant Date
Fair Value
per Unit
Awards outstanding at September 30, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Awards outstanding at September 30, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Awards outstanding at September 30, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Awards outstanding at September 30, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
42,300
114,279
—
(2,670)
153,909
178,321
—
(70,313)
261,917
161,229
—
(111,897)
311,249
51.73
47.63
—
47.66
45.48
45.06
—
46.62
46.81
59.39
—
53.24
51.21
NOTE 12. EARNINGS PER COMMON SHARE
Basic income per Common Share is computed by dividing income attributable to controlling interest from continuing
operations, income (loss) from discontinued operations or net income attributable to controlling interest by the weighted average
number of Common Shares outstanding. Diluted income per Common Share are computed by dividing income attributable to
controlling interest from continuing operations, income (loss) from discontinued operations or net income attributable to controlling
interest by the weighted average number of Common Shares plus all potentially dilutive securities outstanding each period. Stock
options with exercise prices greater than the average market price of the underlying Common Shares are excluded from the
85
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
computation of diluted income per Common Share because they are out-of-the-money and the effect of their inclusion would be
anti-dilutive. There were no Common Shares covered by out-of-the-money stock options for the year ended September 30, 2014
and 0.8 million and 0.7 million for the fiscal years ended September 30, 2013 and 2012, respectively. The following table presents
information necessary to calculate basic and diluted income per Common Share.
Year Ended September 30,
2014
2013
2012
(In millions, except per share data)
Income attributable to controlling interest from continuing operations $
Income (loss) from discontinued operations . . . . . . . . . . . . . . . . . . . . .
Net income attributable to controlling interest . . . . . . . . . . . . . . . . . . . $
BASIC EARNINGS PER COMMON SHARE:
Weighted-average Common Shares outstanding
during the period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . $
Income (loss) from discontinued operations . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
DILUTED EARNINGS PER COMMON SHARE:
Weighted-average Common Shares outstanding
during the period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dilutive potential Common Shares . . . . . . . . . . . . . . . . . . . . . . . .
Weighted-average number of Common Shares
outstanding and dilutive potential Common Shares . . . . . . . . . . .
Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . $
Income (loss) from discontinued operations . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
165.7
0.8
166.5
61.6
2.69
0.01
2.70
61.6
1.1
62.7
2.64
0.01
2.65
$
$
$
$
$
$
159.4
1.7
161.1
61.7
2.58
0.03
2.61
61.7
0.9
62.6
2.55
0.02
2.57
$
$
$
$
$
$
NOTE 13. INCOME TAXES
The provision (benefit) for income taxes allocated to continuing operations consisted of the following:
Year Ended September 30,
2014
2013
(In millions)
2012
Current:
Federal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
State. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred:
Federal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
67.0
8.6
3.5
79.1
10.8
1.4
(0.1)
12.1
91.2
$
$
55.0
7.4
4.4
66.8
24.0
1.2
(0.1)
25.1
91.9
$
$
111.6
(5.1)
106.5
61.0
1.83
(0.08)
1.75
61.0
1.1
62.1
1.80
(0.09)
1.71
29.2
5.6
7.3
42.1
24.7
1.4
(0.4)
25.7
67.8
86
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The domestic and foreign components of income from continuing operations before income taxes were as follows:
Year Ended September 30,
2014
2013
(In millions)
2012
Domestic. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations before income taxes . . . . . . . $
231.0
25.6
256.6
$
$
236.5
14.8
251.3
$
$
163.7
15.7
179.4
A reconciliation of the federal corporate income tax rate and the effective tax rate on income from continuing operations
before income taxes is summarized below:
Statutory income tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effect of foreign operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State taxes, net of federal benefit. . . . . . . . . . . . . . . . . . . . . . . . . . .
Domestic Production Activities Deduction permanent difference. .
Effect of other permanent differences . . . . . . . . . . . . . . . . . . . . . . .
Research and Experimentation and other federal tax credits. . . . . .
Resolution of prior tax contingencies . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effective income tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Year Ended September 30,
2014
2013
2012
35.0%
1.5
2.7
(2.7)
0.2
(0.8)
0.2
(0.5)
35.6%
35.0%
0.8
2.9
(2.1)
0.8
(0.3)
0.2
(0.7)
36.6%
35.0%
(0.5)
3.1
(1.5)
2.4
(0.1)
(0.9)
0.3
37.8%
Included in “Effect of other permanent differences” in the effective tax rate reconciliation table above are nondeductible
fines and penalties of $0.0 million, $0.4 million and $4.8 million for the fiscal years ended September 30, 2014, 2013, and 2012
respectively, from the settlement of previously disclosed U.S. EPA and U.S. DOJ investigations. The Company does not expect
to incur additional costs related to these investigations.
87
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and
liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets
and liabilities were as follows:
DEFERRED TAX ASSETS
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Postretirement benefits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State NOL carryovers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign NOL carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign tax credit carryovers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DEFERRED TAX LIABILITIES
Property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred tax liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
September 30,
2014
2013
(In millions)
$
14.7
59.7
32.4
7.2
1.3
48.2
4.6
4.2
3.1
175.4
(48.3)
127.1
(59.2)
(106.6)
(9.5)
(175.3)
(48.2) $
13.7
59.2
33.7
7.3
1.1
51.6
8.6
6.3
6.0
187.5
(51.5)
136.0
(62.3)
(99.5)
(3.3)
(165.1)
(29.1)
The net current and non-current components of deferred income taxes recognized in the Consolidated Balance Sheets were:
Net current deferred tax assets (classified with prepaid and other assets) . . . . . . . $
Net non-current deferred tax liabilities (classified with other liabilities) . . . . . . . .
Net deferred tax liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
September 30,
2014
2013
$
(In millions)
72.2
(120.4)
(48.2) $
67.1
(96.2)
(29.1)
GAAP requires that a valuation allowance be recorded against a deferred tax asset if it is more likely than not that the tax
benefit associated with the asset will not be realized in the future. As shown in the table above, valuation allowances were recorded
against $48.3 million and $51.5 million of deferred tax assets as of September 30, 2014, and September 30, 2013, respectively.
Most of these valuation allowances relate to certain foreign net operating losses, as explained further below.
The Company has elected to treat certain foreign entities as disregarded entities for U.S. tax purposes, which results in their
net income or loss being recognized currently in the Company’s U.S. tax return. As such, the tax benefit of net operating losses
available for foreign statutory tax purposes has already been recognized for U.S. purposes. Accordingly, a full valuation allowance
is required on the tax benefit of these net operating losses on global consolidation. The foreign net operating losses of these foreign
disregarded entities were $183.3 million at September 30, 2014, the majority of which have indefinite carryforward periods. The
statutory tax benefit of these net operating loss carryovers, and related full valuation allowances thereon, amounted to $45.5 million
and $49.7 million for the fiscal years ended September 30, 2014 and September 30, 2013, respectively.
Foreign net operating losses of certain controlled foreign corporations were $11.0 million as of September 30, 2014, the
majority of which have indefinite carryforward periods. Due to a history of losses in these entities, a full valuation allowance has
also been placed against the statutory tax benefit associated with these losses amounting to $2.7 million and $1.8 million at
September 30, 2014 and September 30, 2013, respectively.
88
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
State net operating losses were $17.3 million as of September 30, 2014, with carryforward periods ranging from 5 to 20
years. Any losses not utilized within a specific state’s carryforward period will expire. Tax benefits associated with state tax
credits will expire if not utilized and amounted to $0.6 million and $0.5 million at September 30, 2014 and September 30, 2013.
No valuation allowance has been placed against these net operating losses and credits as the Company should fully utilize them
within their respective carryover periods.
Deferred taxes have not been provided on unremitted earnings of $153.0 million for certain foreign subsidiaries and foreign
corporate joint ventures as such earnings have been indefinitely reinvested. These foreign entities held cash and cash equivalents
of $59.9 million and $120.4 million at September 30, 2014 and September 30, 2013, respectively. Our current plans do not
demonstrate a need to, nor do we have plans to, repatriate the retained earnings from these subsidiaries as the earnings are indefinitely
reinvested. In the future, if we determine it is necessary to repatriate these funds, or we sell or liquidate any of these subsidiaries,
we may be required to pay associated taxes on the repatriation. We may also be required to withhold foreign taxes depending on
the foreign jurisdiction from which the funds are repatriated. The effective rate of tax on such repatriations may materially differ
from the federal statutory tax rate and could have a material impact on tax expense in the year of repatriation; however, the Company
cannot reasonably estimate the amount of such a tax event.
GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the
position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the
technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50%
likely of being realized upon settlement.
The Company had $11.2 million, $6.7 million and $7.0 million of gross unrecognized tax benefits related to uncertain tax
positions at September 30, 2014, 2013 and 2012, respectively. Included in the September 30, 2014, 2013 and 2012 balances were
$8.5 million, $6.7 million and $6.9 million, respectively, of unrecognized tax benefits that, if recognized, would have an impact
on the effective tax rate.
A reconciliation of the unrecognized tax benefits is as follows:
Year Ended September 30,
2014
2013
(In millions)
2012
Balance at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Additions for tax positions of the current year . . . . . . . . . . . . . .
Additions for tax positions of prior years . . . . . . . . . . . . . . . . . .
Reductions for tax positions of prior years . . . . . . . . . . . . . . . . .
Settlements with tax authorities. . . . . . . . . . . . . . . . . . . . . . . . . .
Expiration of statutes of limitation . . . . . . . . . . . . . . . . . . . . . . .
Balance at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
6.7
0.2
7.6
(2.7)
—
(0.6)
11.2
$
$
7.0
0.3
4.3
(3.8)
(0.4)
(0.7)
6.7
$
$
8.9
1.0
2.9
(4.1)
(0.5)
(1.2)
7.0
The Company continues to recognize accrued interest and penalties related to unrecognized tax benefits as a component of
the provision for income taxes. As of September 30, 2014, 2013 and 2012, respectively, the Company had $1.8 million, $1.8
million and $1.8 million accrued for the payment of interest that, if recognized, would impact the effective tax rate. As of
September 30, 2014, 2013 and 2012, respectively, the Company had $0.6 million, $0.7 million and $0.8 million accrued for the
payment of penalties that, if recognized, would impact the effective tax rate. For the year ended September 30, 2014, the Company
recognized $0.3 million of tax interest and tax penalties in its Consolidated Statement of Operations.
Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local
and foreign jurisdictions. With few exceptions, which are discussed below, the Company is no longer subject to examinations by
these tax authorities for fiscal years prior to fiscal 2011. The Company is currently under examination by the Internal Revenue
Service and certain foreign and U.S. state and local tax authorities. The U.S. Federal examination is limited to fiscal year 2011.
Regarding the foreign jurisdictions, an audit is currently underway in France for fiscal 2010 through fiscal 2012. In regard to the
U.S. state and local audits, the tax periods under examinations are limited to fiscal 2009 through fiscal 2012. In addition to these
aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.
The Company currently anticipates that few of its open and active audits will be resolved in the next 12 months. The
Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur.
Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate
89
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial
position, results of operations or cash flows.
Management judgment is required in determining tax provisions and evaluating tax positions. Management believes its tax
positions and related provisions reflected in the consolidated financial statements are fully supportable and appropriate. The
Company established reserves for additional income taxes that may become due if the tax positions are challenged and not sustained,
and as such, the Company’s tax provision includes the impact of recording reserves and changes thereto.
NOTE 14. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices.
To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The
utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and
other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.
Exchange Rate Risk Management
The Company uses foreign currency forward contracts to manage the exchange rate risk associated with intercompany loans
with foreign subsidiaries that are denominated in local currencies. At September 30, 2014, the notional amount of outstanding
foreign currency forward contracts was $149.0 million, with a negative fair value of $0.1 million. At September 30, 2013, the
notional amount of outstanding foreign currency forward contracts was $80.4 million, with a negative fair value of $2.1 million.
The unrealized loss on the foreign currency forward contracts approximates the unrealized gain on the intercompany loans
recognized by the Company’s lending subsidiaries. The outstanding contracts will mature over fiscal 2015.
Interest Rate Risk Management
The Company enters into interest rate swap agreements to hedge changes in cash flows attributable to interest rate risk on
debt instruments. The fair values are reflected in the Company’s Consolidated Balance Sheets. Net amounts to be received or
paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have
been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded
as elements of accumulated other comprehensive income (loss) (“AOCI”) within the Consolidated Balance Sheets except for any
ineffective portion of the change in fair value, which is immediately recorded in interest expense. The fair value of the swap
agreements is determined based on the present value of the estimated future net cash flows using implied rates in the applicable
yield curve as of the valuation date. On December 20, 2013, in conjunction with entering into the new credit facility, the Company
recognized hedge ineffectiveness of $2.0 million which was recorded to interest expense.
At September 30, 2014 and 2013, the Company had outstanding interest rate swap agreements with major financial institutions
that effectively converted a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a total U.S. dollar
equivalent notional amount of $1,300.0 million and $1,100.0 million at September 30, 2014 and 2013 respectively. Refer to
“NOTE 10. DEBT” for the terms of the swap agreements outstanding at 2014. Included in the AOCI balance at September 30,
2014 was a loss of $6.3 million related to interest rate swap agreements that is expected to be reclassified to earnings during the
next 12 months, consistent with the timing of the underlying hedged transactions.
Commodity Price Risk Management
The Company has outstanding hedging arrangements designed to fix the price of a portion of its projected future urea
requirements. The contracts are designated as hedges of the Company’s exposure to future cash flow fluctuations associated with
the cost of urea. The objective of the hedges is to mitigate the earnings and cash flow volatility attributable to the risk of changing
prices. Unrealized gains or losses in the fair value of these contracts are recorded to AOCI within the Consolidated Balance Sheets.
Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory,
the gain or loss is reclassified to cost of sales. Included in the AOCI balance at September 30, 2014 was an immaterial gain related
to urea derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the
underlying hedged transactions.
The Company also uses derivatives to partially mitigate the effect of fluctuating diesel and gasoline costs on operating
results. Any such derivatives that do not qualify for hedge accounting treatment in accordance with GAAP are recorded at fair
value, with unrealized gains and losses on open contracts and realized gains or losses on settled contracts recorded as an element
of cost of sales. Unrealized gains or losses in the fair value of contracts that do qualify for hedge accounting are recorded in AOCI,
except for any ineffective portion of the change in fair value, which is immediately recorded in earnings. For the effective portion
of the change in fair value, realized gains or losses remain as a component of AOCI until the related fuel is consumed. Upon
90
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
consumption of the fuel, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at September 30, 2014 was
a loss of $0.1 million related to fuel derivatives that is expected to be reclassified to earnings during the next 12 months. The
amounts recorded in earnings related to ineffectiveness of derivative hedges for the years ended September, 30, 2014, 2013, and
2012 were not significant.
The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:
Commodity
Urea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diesel. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gasoline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Heating Oil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
58,500 tons
5,250,000 gallons
462,000 gallons
4,494,000 gallons
49,500 tons
3,528,000 gallons
630,000 gallons
2,940,000 gallons
September 30,
2014
2013
Fair Values of Derivative Instruments
The fair values of the Company’s derivative instruments were as follows:
Assets / (Liabilities)
Derivatives Designated As Hedging Instruments
Balance Sheet Location
Interest rate swap agreements . . . . . . . . . . . . . . . . . . . . . Other assets
Other current liabilities
Other liabilities
Commodity hedging instruments . . . . . . . . . . . . . . . . . . Prepaid and other assets
Other current liabilities
Total derivatives designated as hedging instruments . . . . . . .
Derivatives Not Designated As Hedging Instruments
Balance Sheet Location
Foreign currency forward contracts . . . . . . . . . . . . . . . . Other current liabilities
Commodity hedging instruments . . . . . . . . . . . . . . . . . . Other current liabilities
Total derivatives not designated as hedging instruments. . . .
Total derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014
2013
Fair Value
(In millions)
$
$
$
$
$
$
4.0
(10.3)
(5.2)
—
(0.6)
(12.1) $
(0.1) $
(1.3)
(1.4) $
(13.5) $
3.7
(8.3)
(12.1)
0.1
(2.0)
(18.6)
(2.1)
(0.3)
(2.4)
(21.0)
The effect of derivative instruments on AOCI and the Consolidated Statements of Operations for the year ended September
30 was as follows:
Derivatives in Cash Flow Hedging Relationships
Interest rate swap agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Commodity hedging instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
Amount of Gain/(Loss)
Recognized in AOCI
2014
2013
(In millions)
(6.6) $
1.7
(4.9) $
(1.0)
(2.3)
(3.3)
91
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Derivatives in Cash Flow Hedging Relationships
Reclassified From AOCI Into
Statement of Operations
Amount of Gain/(Loss)
2014
2013
Interest rate swap agreements . . . . . . . . . . . . . . . . . . .
Commodity hedging instruments . . . . . . . . . . . . . . . . Cost of sales
Interest expense
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Derivatives not Designated As Hedging Instruments
Recognized in Statement of Operations
Foreign currency forward contracts. . . . . . . . . . . . . . . Other income, net
Commodity hedging instruments . . . . . . . . . . . . . . . . Cost of sales
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NOTE 15. FAIR VALUE MEASUREMENTS
(In millions)
(10.0) $
0.5
(9.5) $
Amount of Gain/(Loss)
2014
2013
(In millions)
(0.7) $
(1.0)
(1.7) $
(8.4)
—
(8.4)
6.7
(0.6)
6.1
$
$
$
$
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price)
in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at
the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires
entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to
measure fair value are as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities
in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of
the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant
unobservable inputs.
The following describes the valuation methodologies used for financial assets and liabilities measured at fair value on a
recurring basis, as well as the general classification within the valuation hierarchy.
Derivatives
Derivatives consist of foreign currency, interest rate and commodity derivative instruments. The fair value of foreign currency
forward contracts is determined based on changes in spot rates. Interest rate swap agreements are valued based on the present
value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Commodity
contracts are measured using observable commodity exchange prices in active markets.
These derivative instruments are classified within Level 2 of the valuation hierarchy and are included within other assets
and other liabilities in the Company's Consolidated Balance Sheets, except for amounts expected to be settled within the next
12 months, which are included within prepaid and other current assets and other current liabilities.
Cash Equivalents
Cash equivalents consist of highly liquid investments purchased with a maturity of three months or less. The carrying value
of these cash equivalents approximates fair value due to their short-term maturities.
Other
Other financial assets consist of investment securities in non-qualified retirement plan assets. These securities are valued
using observable market prices in active markets.
92
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at
September 30, 2014:
Quoted Prices in
Active
Markets for
Identical
Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
(In millions)
Total
Assets
Cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Derivatives
Interest rate swap agreements . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Liabilities
Derivatives
Interest rate swap agreements . . . . . . . . . . . . . . . $
Foreign currency forward contracts . . . . . . . . . . .
Commodity hedging instruments . . . . . . . . . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
32.0
$
— $
—
8.9
40.9
$
— $
—
—
— $
4.0
—
4.0
$
(15.5) $
(0.1)
(1.9)
(17.5) $
— $
—
—
— $
— $
—
—
— $
32.0
4.0
8.9
44.9
(15.5)
(0.1)
(1.9)
(17.5)
The following presents the Company’s non-financial assets and liabilities measured at fair value on a non-recurring basis
at September 30, 2014 and describes the valuation methodologies used for non-financial assets and liabilities measured at fair
value, as well as the general classification within the valuation hierarchy:
Quoted Prices in
Active
Markets for
Identical
Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
Total
Losses
Ortho® brands and sub-brands
$
— $
(In millions)
— $
92.3
$
33.7
As a result of the Company's impairment review performed in the third quarter of fiscal 2014, the Company recognized an
impairment charge for a non-recurring fair value adjustment of $33.7 million within the Global Consumer segment related to the
Ortho® brand. The remaining fair value of the indefinite-lived Ortho® brand and sub-brands is $92.3 million. The fair value was
calculated based upon the evaluation of the historical performance and future growth expectations of the Ortho® business using
a royalty savings methodology similar to that employed when the associated business was acquired with updated estimates of
sales, cash flow and profitability.
93
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at
September 30, 2013:
Quoted Prices in
Active
Markets for
Identical
Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
(In millions)
Total
Assets
Cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Derivatives
Interest rate swap agreements . . . . . . . . . . . . . . .
Commodity hedging instruments . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Liabilities
Derivatives
Interest rate swap agreements . . . . . . . . . . . . . . . $
Foreign currency forward contracts . . . . . . . . . . .
Commodity hedging instruments . . . . . . . . . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
83.9
$
— $
—
—
7.0
90.9
$
— $
—
—
— $
3.7
0.1
—
3.8
$
(20.4) $
(2.1)
(2.3)
(24.8) $
— $
—
—
—
— $
— $
—
—
— $
83.9
3.7
0.1
7.0
94.7
(20.4)
(2.1)
(2.3)
(24.8)
The following presents the Company’s non-financial assets and liabilities measured at fair value on a non-recurring basis
at September 30, 2013 and describes the valuation methodologies used for non-financial assets and liabilities measured at fair
value, as well as the general classification within the valuation hierarchy:
Quoted Prices in
Active
Markets for
Identical
Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
Total
Losses
Global Consumer insect repellent technology
Ortho® brands and sub-brands
$
— $
—
(In millions)
— $
—
— $
126.0
4.3
11.6
The intangible asset related to the insect repellent technology was determined to be fully impaired based on the estimated
future cash flows associated with the insect repellent technology in relation to its carrying value. Also, as a result of the Company's
annual impairment review performed in the fourth quarter of fiscal 2013, the Company recognized an impairment charge for a
non-recurring fair value adjustment of $11.6 million within the Global Consumer segment related to the Ortho® brand and certain
sub-brands of Ortho®. Certain finite-lived sub-brands of Ortho® were determined to be fully impaired. The remaining fair value
of the indefinite-lived Ortho® brand and sub-brands was $126.0 million. The fair value was calculated based upon the evaluation
of the historical performance and future growth of the Ortho® business using a royalty savings methodology similar to that employed
when the associated business was acquired with updated estimates of sales, cash flow and profitability.
94
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 16. OPERATING LEASES
The Company leases certain property and equipment from third parties under various non-cancelable operating lease
agreements. Certain lease agreements contain renewal and purchase options. The lease agreements generally require that the
Company pay taxes, insurance and maintenance expenses related to the leased assets. Future minimum lease payments for non-
cancelable operating leases at September 30, 2014, were as follows (in millions):
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total future minimum lease payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
46.4
36.2
26.3
20.1
17.1
27.0
173.1
The Company also leases certain vehicles (primarily cars and light trucks) under agreements that are cancelable after the
first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other
non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company
to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion
of the lease term. If all such vehicle leases had been canceled as of September 30, 2014, the Company’s residual value guarantee
would have approximated $6.4 million.
Other residual value guarantee amounts that apply at the conclusion of non-cancelable lease terms are as follows:
Amount of
Guarantee
(In millions)
Lease
Termination Date
Scotts LawnService® vehicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Corporate aircraft . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
0.8
30.9
2020
2016 and 2019
Included within the table above is a residual value guarantee related to a sale and leaseback transaction of a corporate aircraft
completed in the fourth quarter of fiscal 2014.
Rent expense for fiscal 2014, fiscal 2013 and fiscal 2012 totaled $71.2 million, $61.9 million and $69.0 million, respectively.
NOTE 17. COMMITMENTS
The Company has the following unconditional purchase obligations due during each of the next five fiscal years that have
not been recognized on the Consolidated Balance Sheet at September 30, 2014 (in millions):
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
127.1
50.0
19.7
4.8
6.8
0.5
208.9
Purchase obligations primarily represent commitments for materials used in the Company’s manufacturing processes, as
well as commitments for warehouse services, grass seed and out-sourced information services. In addition, the Company leases
certain property and equipment from third parties under various non-cancelable operating lease agreements. Future minimum
lease payments for non-cancelable operating leases not included above are included in “NOTE 16. OPERATING LEASES.”
95
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 18. CONTINGENCIES
Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the
normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which
the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss
estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse
development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and
other contingencies are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and
related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not
have a material effect on the Company’s financial condition, results of operations or cash flows.
Regulatory Matters
At September 30, 2014, $5.4 million was accrued in the “Other liabilities” line in the Consolidated Balance Sheet for
environmental actions, the majority of which is for site remediation. The amounts accrued are believed to be adequate to cover
such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible
that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts
is not expected to be material.
Other
The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from
exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products.
In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases
vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive)
from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against
them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no
reserves have been recorded in the Company’s Consolidated Financial Statements. The Company is reviewing agreements and
policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these
agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these
cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material adverse effect
on the Company’s financial condition, results of operations or cash flows.
In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company has
been named as a defendant in four putative class actions filed on and after June 27, 2012, which have now been consolidated in
the United States District Court for the Southern District of California as In re Morning Song Bird Food Litigation, Lead Case
No. 3:12-cv-01592-JAH-RBB. The plaintiffs allege various statutory and common law claims associated with the Company's
sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with
such sales. The plaintiffs allege, among other things, a purported class action on behalf of all persons and entities in the United
States who purchased certain bird food products. The plaintiffs assert hundreds of millions of dollars in monetary damages (actual,
compensatory, consequential, punitive, and treble); reimbursement, restitution, and disgorgement for benefits unjustly conferred;
injunctive and declaratory relief; pre-judgment and post-judgment interest; and costs and attorneys' fees. The Company disputes
the plaintiffs' assertions and intends to vigorously defend the consolidated action. Given the early stages of the action, it is not
currently possible to reasonably estimate a probable loss, if any, associated with the action and, accordingly, no reserves have been
recorded in the Company's Consolidated Financial Statements with respect to the action. There can be no assurance that this
action, whether as a result of an adverse outcome or as a result of significant defense costs, will not have a material adverse effect
on the Company's financial condition, results of operations or cash flows.
The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually
and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or
cash flows.
NOTE 19. CONCENTRATIONS OF CREDIT RISK
The Company maintains cash depository accounts with major financial institutions around the world and invests in high
quality, short-term liquid investments. Such investments are made only in investments issued by highly rated institutions. These
investments mature within three months and have not historically incurred any losses.
96
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Trade accounts receivable are exposed to a concentration of credit risk with retailers principally located in the United States.
The Company's retail customers include home centers, mass merchandisers, warehouse clubs, large hardware chains, independent
hardware stores, nurseries, garden centers and food and drug stores. Concentrations of net sales and accounts receivable by segment
in the United States as a percentage of consolidated net sales and accounts receivable at September 30 were as follows:
Percentage of Net Sales
Percentage of Gross Accounts
Receivable at September 30,
2014
2013
2012
2014
2013
Global Consumer segment. . . . . . . . . . . . . . . . . . . . . . . .
Scotts LawnService® segment . . . . . . . . . . . . . . . . . . . . .
Total Concentration in United States. . . . . . . . . . . . . . . .
72%
9%
81%
72%
9%
81%
72%
9%
81%
62%
9%
71%
63%
9%
72%
The remainder of the Company’s net sales and accounts receivable at September 30, 2014, 2013 and 2012 were generated
from customers located outside of the United States, primarily retailers, distributors and nurseries in Europe, Canada and Australia.
No concentrations of these customers or individual customers within this group accounted for more than 10% of the Company’s
net sales or accounts receivable for any period presented above.
The Company’s three largest customers are reported within the Global Consumer segment and are the only customers that
individually represent more than 10% of reported consolidated net sales and accounts receivable for each of the last three fiscal
years. These three customers accounted for the following percentages of Global Consumer segment net sales for the fiscal years
ended September 30:
Home Depot. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lowe's . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Walmart . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
36%
19%
13%
34%
18%
13%
33%
18%
13%
Accounts receivable for these three largest customers as a percentage of consolidated accounts receivable were 55% and
Percentage of Net Sales
2014
2013
2012
56% for September 30, 2014 and 2013, respectively.
NOTE 20. OTHER INCOME, NET
Other (income) expense consisted of the following:
Year Ended September 30,
2014
2013
(In millions)
2012
Royalty income, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Franchise fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign currency losses (gains) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Gain) loss on investment of unconsolidated affiliate . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
(5.6) $
(0.3)
1.0
(5.7)
(4.1)
(14.7) $
(4.7) $
(0.3)
0.4
0.4
(5.8)
(10.0) $
(4.9)
(0.3)
(0.7)
—
3.1
(2.8)
97
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 21. SEGMENT INFORMATION
The Company divides its business into the following segments — Global Consumer and Scotts LawnService®. This division
of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of
the Company. The Company has made reclassifications to prior period segment amounts as a result of the change in internal
organization structure associated with the disposal of the Company's wild bird food and professional seed businesses, which are
reported in discontinued operations. For additional information regarding the sale, refer to “NOTE 2. DISCONTINUED
OPERATIONS.”
The Global Consumer segment consists of the U.S. Consumer and International Consumer business groups. The business
groups comprising this segment manufacture, market and sell dry, granular slow-release lawn fertilizers, combination lawn fertilizer
and control products, grass seed, spreaders, water-soluble, liquid and continuous release garden and indoor plant foods, plant care
products, potting, garden and lawn soils, mulches and other growing media products, pesticide and rodenticide products. Products
are marketed to mass merchandisers, home centers, large hardware chains, warehouse clubs, distributors, garden centers and
grocers in the United States, Canada, Europe, Latin America and Australia.
The Scotts LawnService® segment provides residential and commercial lawn fertilization, disease and insect control and
other related services such as core aeration, tree and shrub fertilization and pest control services through Company-owned branches
and independent franchisees in the United States.
Segment performance is evaluated based on several factors, including income from continuing operations before
amortization, product registration and recall costs, and impairment, restructuring and other charges, which is not a GAAP measure.
Senior management of the Company uses this measure of operating profit to gauge segment performance because the Company
believes this measure is the most indicative of performance trends and the overall earnings potential of each segment. Total assets
reported for the Company’s operating segments include the intangible assets for the acquired businesses within those segments.
The accounting policies of the segments are the same as those described in the “NOTE 1. SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES.”
Corporate & Other consists of revenues and expenses associated with the Company’s supply agreements with Israel
Chemicals, Ltd. (“ICL”) and the amortization related to the Roundup® Marketing Agreement, as well as corporate, general and
administrative expenses and certain other income/expense items not allocated to the business segments. Corporate & Other assets
primarily include deferred financing and debt issuance costs and corporate intangible assets, as well as deferred tax assets.
98
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following tables present summarized financial information concerning the Company’s reportable segments for the
periods indicated:
Net sales:
Year Ended September 30,
2014
2013
2012
(In millions)
Global Consumer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService®. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Income from continuing operations before income taxes:
Global Consumer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService®. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Segment total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible asset amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Costs related to refinancing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Depreciation and amortization:
Global Consumer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService®. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capital expenditures:
Global Consumer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService®. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
2,552.0
$
2,484.7
$
263.0
2,815.0
26.3
2,841.3
438.8
30.2
469.0
(90.4)
(13.0)
—
(51.0)
(10.7)
(47.3)
256.6
48.1
3.9
12.4
64.4
83.3
3.2
1.1
$
$
$
$
$
$
257.8
2,742.5
31.2
2,773.7
403.7
28.7
432.4
(91.2)
(10.4)
—
(20.3)
—
(59.2)
251.3
48.7
4.0
13.4
66.1
53.3
3.1
3.7
$
$
$
$
$
$
$
87.6
$
60.1
$
2,483.6
245.8
2,729.4
41.1
2,770.5
335.9
27.0
362.9
(96.3)
(10.1)
(8.2)
(7.1)
—
(61.8)
179.4
44.2
4.1
14.1
62.4
64.6
1.9
2.9
69.4
Total assets:
Global Consumer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Scotts LawnService® . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate & Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
September 30,
2014
2013
(In millions)
1,690.7
191.3
176.3
2,058.3
$
$
1,564.2
189.8
183.2
1,937.2
99
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents net sales by product category for the Global Consumer segment:
Year Ended September 30,
2014
2013
2012
Net sales:
Lawn care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Growing media . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Controls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Roundup® Marketing Agreement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other, primarily gardening and landscape . . . . . . . . . . . . . . . . . . . . . . . . . . . .
34%
36
15
5
10
35%
35%
35
14
5
11
33
14
6
12
Segment total product sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100%
100%
100%
The following table presents net sales and long-lived assets (property, plant and equipment and finite-lived intangibles) by
geographic area:
Net sales:
United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
Long-lived assets:
United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
Year Ended September 30,
2014
2013
(In millions)
2012
2,328.2
513.1
2,841.3
458.8
91.1
549.9
$
$
$
$
2,295.5
478.2
2,773.7
419.9
64.5
484.4
$
$
$
$
2,290.7
479.8
2,770.5
432.0
70.2
502.2
100
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 22. QUARTERLY CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED)
The following is a summary of the unaudited quarterly results of operations.
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Full Year
(In millions, except per share data)
189.6
$ 1,081.0
$ 1,116.4
$
454.3
$ 2,841.3
FISCAL 2014
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from continuing operations . . . . . . . . . . . . . . .
Income (loss) from discontinued operations, net of tax
Net income (loss)
Income (loss) attributable to controlling interest . . . . . . . . . .
Basic income (loss) per common share:
Income (loss) from continuing operations . . . . . . . . . . . $
Income (loss) from discontinued operations, net of tax
Basic net income (loss) per common share . . . . . . . . . . $
Common shares used in basic EPS calculation
Diluted income (loss) per common share:
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of tax .
Diluted net income (loss) per common share
Common shares and dilutive potential Common Shares
used in diluted EPS calculation . . . . . . . . . . . . . . . . . . . . . . .
FISCAL 2013
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Gross profit
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of tax
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Basic income (loss) per common share:
Income (loss) from continuing operations . . . . . . . . . . . $
Income (loss) from discontinued operations
Basic net income (loss) per common share . . . . . . . . . . $
Common shares used in basic EPS calculation
Diluted income (loss) per common share:
Income (loss) from continuing operations
Income (loss) from discontinued operations. . . . . . . . . .
Diluted net income (loss) per common share
33.9
(65.8)
0.1
(65.7)
(65.7)
(1.06) $
—
(1.06) $
62.1
$
$
(1.06) $
—
(1.06) $
62.1
30.6
(68.2)
0.5
(67.7)
(1.11) $
0.01
(1.10) $
61.4
$
$
(1.11) $
0.01
(1.10) $
Common shares and dilutive potential Common Shares
used in diluted EPS calculation . . . . . . . . . . . . . . . . . . . . . . .
61.4
433.8
125.7
—
125.7
125.7
2.03
—
2.03
61.9
2.00
—
2.00
62.9
$
$
$
$
423.3
120.7
1.0
121.7
121.7
1.97
0.02
1.99
61.3
1.93
0.02
1.95
62.4
140.4
(15.2)
(0.3)
(15.5)
(15.2)
1,031.4
165.4
0.8
166.2
166.5
$
$
$
$
(0.24) $
—
(0.24) $
61.0
(0.24) $
—
(0.24) $
61.0
2.69
0.01
2.70
61.6
2.64
0.01
2.65
62.7
377.2
99.1
0.9
100.0
1.61
0.01
1.62
61.6
1.59
0.01
1.60
62.4
$
$
$
$
440.3
147.7
0.5
148.2
2.39
0.01
2.40
61.7
2.36
0.01
2.37
62.6
$
$
$
$
130.1
(19.2)
(0.2)
(19.4)
(0.31) $
—
(0.31) $
62.0
(0.31) $
—
(0.31) $
62.0
978.2
159.4
1.7
161.1
2.58
0.03
2.61
61.7
2.55
0.02
2.57
62.6
195.1
$ 1,007.9
$ 1,137.1
$
433.6
$ 2,773.7
Common share equivalents, such as share-based awards, are excluded from the diluted loss per common share calculation
in periods where there is a loss from continuing operations because the effect of their inclusion would be anti-dilutive. The
Company’s business is highly seasonal, with approximately 75% of net sales occurring in the second and third fiscal quarters.
Unusual items during fiscal 2014 consisted of impairment, restructuring and other charges. These items are reflected in the
quarterly financial information as follows: first quarter restructuring costs of $0.3 million related to termination benefits; second
101
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
quarter restructuring costs of $4.1 million related to termination benefits for U.S. and international employees, $2.0 million in
additional ongoing monitoring and remediation costs for the Company's turfgrass biotechnology program and $10.7 million in
costs related to refinancing; third quarter restructuring costs of $5.5 million related to termination benefits primarily for U.S.
employees and impairment charges of $33.7 million related to the Ortho® brand; fourth quarter restructuring costs of $5.4 million
related to termination benefits for U.S. and international employees. In March 2014, the Company completed the sale of its U.S.
and Canadian wild bird food business, including intangible assets, certain on-hand inventory and fixed assets, for $4.1 million in
cash and an estimated $1.0 million in future earn-out payments. In addition, in the third quarter of fiscal 2014, the Company
received $3.1 million for the sale of the remaining wild bird food manufacturing facilities resulting in a gain of $1.2 million.
Unusual items during fiscal 2013 consisted of impairment, restructuring and other charges. These items are reflected in the
quarterly financial information as follows: first quarter impairment, restructuring and other charges of $(0.4) million; second
quarter impairment, restructuring and other charges of $0.1 million in cost of sales and $0.1 million in SG&A; third quarter
impairment, restructuring and other charges of $1.5 million in cost of sales and $7.0 million in SG&A; and fourth quarter impairment,
restructuring and other charges of $0.6 million in cost of sales and $11.4 million in SG&A.
NOTE 23. FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS
The 6.625% Senior Notes (the “Senior Notes”) issued by Scotts Miracle-Gro on December 16, 2010 are guaranteed by
certain of its domestic subsidiaries and, therefore, the Company has disclosed condensed, consolidating financial information in
accordance with SEC Regulation S-X Rule 3-10, Financial Statements of Guarantors and Issuers of Guaranteed Securities
Registered or Being Registered. On January 15, 2014, the Company redeemed all of its outstanding $200 million aggregate
principal amount of the 7.25% Senior Notes which were previously guaranteed by certain of its domestic subsidiaries. The guarantees
are “full and unconditional,” as those terms are used in Regulation S-X Rule 3-10, except that a subsidiary’s guarantee will be
automatically released in certain customary circumstances, such as (1) upon any sale or other disposition of all or substantially all
of the assets of the subsidiary (including by way of merger or consolidation) to any person other than Scotts Miracle-Gro or any
“restricted subsidiary” under the applicable indenture; (2) if the subsidiary merges with and into Scotts Miracle-Gro, with Scotts
Miracle-Gro surviving such merger; (3) if the subsidiary is designated an “unrestricted subsidiary” in accordance with the applicable
indenture or otherwise ceases to be a “restricted subsidiary” (including by way of liquidation or dissolution) in a transaction
permitted by such indenture; (4) upon legal or covenant defeasance; (5) upon satisfaction and discharge of the Senior Notes; or
(6) if the subsidiary ceases to be a “wholly owned restricted subsidiary” and the subsidiary is not otherwise required to provide a
guarantee of the Senior Notes pursuant to the applicable indenture. The following 100% directly or indirectly owned subsidiaries
fully and unconditionally guarantee at September 30, 2014 the Senior Notes on a joint and several basis: EG Systems, Inc., dba
Scotts LawnService®; Gutwein & Co., Inc.; Hyponex Corporation; Miracle-Gro Lawn Products, Inc.; OMS Investments, Inc.; Rod
McLellan Company; Sanford Scientific, Inc.; Scotts Temecula Operations, LLC; Scotts Manufacturing Company; Scotts Products
Co.; Scotts Professional Products Co.; Scotts-Sierra Investments LLC; SMG Growing Media, Inc.; Swiss Farms Products, Inc.;
SMGM LLC; SLS Franchise Systems, LLC; and The Scotts Company LLC (collectively, the “Guarantors”).
The following information presents Condensed, Consolidating Statements of Operations, Condensed, Consolidating
Statements of Comprehensive Income and Condensed, Consolidating Statements of Cash Flows for each of the three years ended
September 30, 2014, and Condensed, Consolidating Balance Sheets as of September 30, 2014 and September 30, 2013. The
condensed, consolidating financial information presents, in separate columns, financial information for: Scotts Miracle-Gro on a
Parent-only basis, carrying its investment in subsidiaries under the equity method; Guarantors on a combined basis, carrying their
investments in subsidiaries which do not guarantee the debt (collectively, the “Non-Guarantors”) under the equity method; Non-
Guarantors on a combined basis; and eliminating entries. The eliminating entries primarily reflect intercompany transactions,
such as interest expense, accounts receivable and payable, short and long-term debt, and the elimination of equity investments,
return on investments, and income in subsidiaries. Because the Parent is obligated to pay the unpaid principal amount and interest
on all amounts borrowed by the Guarantors or Non-Guarantors under the new credit facility (and was obligated to pay the unpaid
principal amount and interest on all amounts borrowed by the Guarantors and Non-Guarantors under the previous senior secured
five-year revolving loan facility), the borrowings and related interest expense for the loans outstanding of the Guarantors and Non-
Guarantors are also presented in the accompanying Parent-only financial information, and are then eliminated. Included in the
Parent Condensed Consolidating Statements of Cash Flows for fiscal 2014, fiscal 2013, and fiscal 2012, respectively are $422.8
million, $87.8 million, and $92.9 million of dividends paid by the Guarantors and Non-Guarantors to the Parent. Included in the
Guarantors Condensed Consolidating Statements of Cash Flows for fiscal 2014 are $1.3 million of dividends paid by the Non-
Guarantors to the Guarantors. The dividends paid to the Parent and Guarantors represent return on investments and as such are
classified within cash flows from operating activities.
In the Condensed, Consolidating Statements of Cash Flows for fiscal 2013 and fiscal 2012 (which were previously presented
in our Annual Report on Form 10-K dated November 30, 2013 and are presented herein), the Company reclassified intercompany
102
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
dividends received by Parent from Guarantors from “Net Cash (Used In) Provided By Financing Activities” to “Net Cash (Used
In) Provided By Operating Activities.” In the Condensed Consolidating Balance Sheet as of September 30, 2013 (which was
previously presented in our Annual Report on Form 10-K dated November 20, 2013 and is presented herein), the Company made
a correction to properly reflect the Senior Notes and the credit agreement as Parent debt and the Company made related correcting
adjustments to Parent intercompany assets and the elimination entries. The Company believes these changes are immaterial.
103
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Statement of Operations
for the fiscal year ended September 30, 2014
(in millions)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses:
Selling, general and administrative. . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . .
Other income, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity income in subsidiaries . . . . . . . . . . . . . . . . . . . . . . . .
Other non-operating income . . . . . . . . . . . . . . . . . . . . . . . . .
Costs related to refinancing . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations before income taxes . . .
Income tax (benefit) expense from continuing operations . .
Income from continuing operations . . . . . . . . . . . . . . . . . . . .
Income from discontinued operations, net of tax. . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Net loss attributable to noncontrolling interest . . . . . . . . . . . $
Net income attributable to controlling interest . . . . . . . . . . . $
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
— $ 2,314.0
$
527.3
$
— $ 2,841.3
—
—
—
—
—
—
(193.2)
(21.3)
10.7
52.5
151.3
(14.9)
166.2
—
166.2
0.3
166.5
$
$
$
1,440.5
873.5
532.8
48.2
(12.6)
305.1
(8.9)
—
—
37.4
276.6
95.2
181.4
0.4
181.8
0.3
182.1
369.4
157.9
147.7
2.8
(2.1)
9.5
—
(22.2)
—
0.9
30.8
10.9
19.9
0.4
$
$
$
20.3
$
— $
20.3
$
—
—
—
—
—
—
202.1
43.5
—
(43.5)
(202.1)
—
(202.1)
—
(202.1) $
(0.3) $
(202.4) $
1,809.9
1,031.4
680.5
51.0
(14.7)
314.6
—
—
10.7
47.3
256.6
91.2
165.4
0.8
166.2
0.3
166.5
104
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidated Statement of Comprehensive Income
for the twelve months ended September 30, 2014
(In millions)
Net income
Other comprehensive income (loss), net of tax:
Net foreign currency translation adjustment
Net change in derivatives
Net change in pension and other post retirement
benefits
Total other comprehensive income (loss)
Comprehensive income
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations Consolidated
$
166.2
$
181.8
$
20.3
$
(202.1) $
166.2
(8.2)
4.6
(4.8)
(8.4)
157.8
$
—
1.3
0.7
2.0
$
183.8
$
(8.2)
—
(5.5)
(13.7)
6.6
8.2
(1.3)
4.8
11.7
(190.4) $
$
(8.2)
4.6
(4.8)
(8.4)
157.8
105
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2014
(in millions)
NET CASH PROVIDED BY OPERATING
ACTIVITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets . . . . . . . .
Proceeds from sale of business . . . . . . . . . . . . . . .
Investments in property, plant and equipment . . .
Proceeds from sale and leaseback transaction . . .
Investments in acquired businesses, net of cash
acquired. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash used in investing activities . . . . . . . .
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of
credit and term loans. . . . . . . . . . . . . . . . . . . . . . .
Repayments under revolving and bank lines of
credit and term loans. . . . . . . . . . . . . . . . . . . . . . .
Repayment of 7.25% senior notes . . . . . . . . . . . .
Financing and issuance fees . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchase of common shares . . . . . . . . . . . . . . . . .
Payments on seller notes. . . . . . . . . . . . . . . . . . . .
Excess tax benefits from share-based payment
arrangements. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash received from exercise of stock options . . .
Intercompany financing . . . . . . . . . . . . . . . . . . . .
Net cash used in financing activities . . . . . . .
Effect of exchange rate changes on cash . . . . . . . . . . .
Net increase (decrease) in cash and cash equivalents .
Cash and cash equivalents at beginning of year . . . . .
Cash and cash equivalents at end of year. . . . . . . . . . . $
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
388.8
$
254.5
$
21.7
$
(424.1) $
240.9
—
—
—
—
—
—
3.7
6.6
(81.0)
35.1
(58.9)
(94.5)
—
0.6
(6.6)
—
(55.1)
(61.1)
—
1,596.1
336.7
—
(200.0)
(6.1)
(230.8)
(120.0)
—
—
20.0
148.1
(388.8)
—
—
—
(1,184.7)
—
—
(404.9)
—
(0.8)
5.9
—
(151.1)
(139.5)
—
20.5
2.6
(340.6)
—
—
(19.2)
—
—
—
—
3.0
(20.1)
(1.5)
(61.0)
127.2
—
—
—
—
—
—
—
—
—
—
424.1
—
—
—
—
—
424.1
—
—
—
3.7
7.2
(87.6)
35.1
(114.0)
(155.6)
1,932.8
(1,525.3)
(200.0)
(6.1)
(230.8)
(120.0)
(0.8)
5.9
20.0
—
(124.3)
(1.5)
(40.5)
129.8
— $
23.1
$
66.2
$
— $
89.3
106
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Balance Sheet
As of September 30, 2014
(in millions)
Parent
ASSETS
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
Intercompany assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
878.8
Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,270.9
$ 1,613.8
$
455.0
—
$ (1,281.4) $ 2,058.3
— $
85.8
$
6.1
$
— $
66.2
99.4
—
103.0
37.9
306.5
67.5
6.6
45.9
28.5
—
—
59.0
81.0
146.1
12.4
47.4
—
93.5
299.4
155.6
—
155.6
455.0
$
— $
—
—
—
—
—
—
—
—
(34.3)
(368.3)
(878.8)
89.3
224.0
113.7
385.1
122.9
935.0
437.0
350.9
302.7
32.7
—
91.9
193.3
259.5
544.7
692.4
254.0
—
—
1,491.1
553.7
13.5
—
—
—
(481.8)
(34.2)
(106.5)
(397.0)
(1,019.5)
(248.4)
(13.5)
(261.9) $
$
567.2
$ (1,281.4) $ 2,058.3
Current assets:
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . $
Accounts receivable, net. . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable pledged . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid and other current assets . . . . . . . . . . . . . . . . . . .
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment, net . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible assets, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity investment in subsidiaries . . . . . . . . . . . . . . . . . . . . .
—
—
—
—
—
—
—
—
23.8
368.3
— $
23.1
$
124.6
113.7
282.1
85.0
628.5
369.5
344.3
256.8
14.7
—
—
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities. . . . . . . . . . . . . . . . . . . . . . .
Long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity investment in subsidiaries . . . . . . . . . . . . . . . . . . . . .
Intercompany liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total shareholders’ equity - controlling interest . . . . . . . . . .
Noncontrolling interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
—
16.7
16.7
681.8
5.1
—
—
703.6
553.8
13.5
134.3
161.8
381.9
480.0
235.7
106.5
303.5
1,507.6
92.7
13.5
Total equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
567.3
Total liabilities and shareholders’ equity. . . . . . . . . $ 1,270.9
$
106.2
$ 1,613.8
$
$
107
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Statement of Operations
for the fiscal year ended September 30, 2013
(in millions)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales - impairment, restructuring and other. . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses:
Selling, general and administrative. . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . .
Other income, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from operations . . . . . . . . . . . . . . . . . . . . . . . .
Equity income in subsidiaries . . . . . . . . . . . . . . . . . . . . . . . .
Other non-operating income . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from continuing operations before income
taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax (benefit) expense from continuing operations . .
Income (loss) from continuing operations . . . . . . . . . . . . . . .
Income from discontinued operations, net of tax. . . . . . . . . .
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
— $ 2,280.4
$
493.3
$
— $ 2,773.7
—
—
—
—
—
—
—
(180.9)
(20.4)
52.4
148.9
(12.2)
161.1
—
1,446.7
—
833.7
515.3
11.2
(6.9)
314.1
1.3
—
25.2
287.6
105.8
181.8
0.8
161.1
$
182.6
$
346.6
2.2
144.5
144.3
6.9
(3.1)
(3.6)
—
—
2.0
—
—
—
—
—
—
—
179.6
20.4
(20.4)
(5.6)
(1.7)
(3.9)
0.9
(3.0) $
(179.6)
—
(179.6)
—
(179.6) $
1,793.3
2.2
978.2
659.6
18.1
(10.0)
310.5
—
—
59.2
251.3
91.9
159.4
1.7
161.1
108
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidated Statement of Comprehensive Income
for the twelve months ended September 30, 2013
(In millions)
Net income (loss)
Other comprehensive income (loss), net of tax:
Net foreign currency translation adjustment
Net change in derivatives
Net change in pension and other post retirement
benefits
Total other comprehensive income (loss)
Comprehensive income (loss)
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations Consolidated
$
161.1
$
182.6
$
(3.0) $
(179.6) $
161.1
—
7.2
—
7.2
—
(2.1)
10.6
8.5
$
168.3
$
191.1
$
(5.2)
—
(1.0)
(6.2)
(9.2) $
—
—
—
—
(179.6) $
(5.2)
5.1
9.6
9.5
170.6
109
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2013
(in millions)
NET CASH PROVIDED BY OPERATING
ACTIVITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets . . . . . . . .
Investments in property, plant and equipment . . .
Investment in unconsolidated affiliate . . . . . . . . .
Investments in acquired businesses, net of cash
acquired. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash used in investing activities . . . . . . .
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of
credit and term loans. . . . . . . . . . . . . . . . . . . . . . .
Repayments under revolving and bank lines of
credit and term loans. . . . . . . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . .
Payments on seller notes. . . . . . . . . . . . . . . . . . . .
Excess tax benefits from share-based payment
arrangements. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash received from exercise of stock options . . .
Intercompany financing . . . . . . . . . . . . . . . . . . . .
Net cash used in financing activities . . . . . . .
Effect of exchange rate changes on cash . . . . . . . . . . .
Net decrease in cash and cash equivalents. . . . . . . . . .
Cash and cash equivalents at beginning of year . . . . .
Cash and cash equivalents at end of year. . . . . . . . . . . $
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
69.8
$
245.9
$
114.1
$
(87.8) $
342.0
—
—
—
—
—
0.2
(44.6)
(4.5)
(3.2)
(52.1)
3.4
(15.5)
—
—
(12.1)
—
1,130.4
344.4
—
—
—
—
—
—
—
87.8
—
—
—
—
87.8
—
—
—
3.6
(60.1)
(4.5)
(3.2)
(64.2)
1,474.8
(1,682.1)
(87.8)
(0.8)
2.0
13.3
—
(280.6)
0.7
(2.1)
131.9
(603.6)
—
—
—
—
154.4
(104.8)
0.7
(2.1)
129.3
$
127.2
$
— $
129.8
—
(87.8)
—
—
13.3
4.7
(69.8)
—
—
—
— $
(1,078.5)
(87.8)
(0.8)
2.0
—
(159.1)
(193.8)
—
—
2.6
2.6
110
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Balance Sheet
As of September 30, 2013
(in millions)
Parent
ASSETS
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
Current assets:
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . $
Accounts receivable, net. . . . . . . . . . . . . . . . . . . . . . . . .
Accounts Receivable, pledged . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid and other current assets . . . . . . . . . . . . . . . . . . .
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment, net . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible assets, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity investment in subsidiaries . . . . . . . . . . . . . . . . . . . . .
— $
2.6
$
127.2
$
— $
—
—
—
—
—
—
—
—
22.4
317.1
119.7
106.7
247.2
76.4
552.6
377.9
314.4
244.8
19.5
—
—
86.9
—
77.7
36.6
328.4
44.4
0.7
39.6
26.5
—
—
$ 1,509.2
$
439.6
—
—
—
—
—
—
—
—
(34.0)
(317.1)
(871.7)
Intercompany assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
871.7
Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,211.2
—
$ (1,222.8) $ 1,937.2
129.8
206.6
106.7
324.9
113.0
881.0
422.3
315.1
284.4
34.4
—
92.4
137.7
279.7
509.8
478.1
238.8
—
—
1,226.7
$
5.1
$
— $
—
—
—
(73.0)
(34.0)
(173.3)
(798.7)
(1,079.0)
(143.8)
53.8
80.3
139.2
10.2
47.8
—
146.6
343.8
95.8
439.6
710.5
$ (1,222.8) $ 1,937.2
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt . . . . . . . . . . . . . . . . . . . . . . . . . . $
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities. . . . . . . . . . . . . . . . . . . . . . .
Long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity investment in subsidiaries . . . . . . . . . . . . . . . . . . . . .
Intercompany liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
— $
—
16.0
16.0
473.0
11.7
—
—
87.3
83.9
183.4
354.6
67.9
213.3
173.3
652.1
Total liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
500.7
1,461.2
Total shareholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . .
710.5
Total liabilities and shareholders’ equity. . . . . . . . . $ 1,211.2
48.0
$ 1,509.2
$
111
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Statement of Operations
for the fiscal year ended September 30, 2012
(in millions)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales — product registration and recall matters . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses:
Selling, general and administrative. . . . . . . . . . . . . . . . .
Impairment, restructuring and other . . . . . . . . . . . . . . . .
Product registration and recall matters . . . . . . . . . . . . . .
Other income, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity income in subsidiaries . . . . . . . . . . . . . . . . . . . . . . . .
Other non-operating income . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from continuing operations before income
taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax (benefit) expense from continuing operations . .
Income (loss) from continuing operations . . . . . . . . . . . . . . .
Income (loss) from discontinued operations, net of tax. . . . .
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Parent
Subsidiary
Guarantors
— $ 2,270.7
1,464.8
—
0.4
—
805.5
—
Non-
Guarantors
499.8
$
348.7
—
151.1
Eliminations
$
Consolidated
— $ 2,770.5
1,813.5
—
0.4
—
956.6
—
—
—
—
—
—
(126.4)
(24.5)
56.5
94.4
(12.1)
106.5
—
106.5
$
550.8
7.9
7.8
(1.1)
240.1
1.6
—
25.4
213.1
80.9
132.2
(5.8)
126.4
152.5
(0.8)
—
(1.7)
1.1
—
—
4.4
—
—
—
—
—
124.8
24.5
(24.5)
(3.3)
(1.0)
(2.3)
0.7
(1.6) $
(124.8)
—
(124.8)
—
(124.8) $
$
703.3
7.1
7.8
(2.8)
241.2
—
—
61.8
179.4
67.8
111.6
(5.1)
106.5
112
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidated Statement of Comprehensive Income
for the twelve months ended September 30, 2012
(In millions)
Net income (loss)
Other comprehensive income (loss), net of tax:
Net foreign currency translation adjustment
Net change in derivatives
Net change in pension and other post retirement
benefits
Total other comprehensive income (loss)
Comprehensive income (loss)
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations Consolidated
$
106.5
$
126.4
$
(1.6) $
(124.8) $
106.5
—
0.1
—
0.1
$
106.6
$
—
(1.0)
(1.2)
(2.2)
124.2
$
2.3
—
(9.5)
(7.2)
(8.8) $
—
—
—
—
(124.8) $
2.3
(0.9)
(10.7)
(9.3)
97.2
113
Table of Contents
THE SCOTTS MIRACLE-GRO COMPANY
Condensed, Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2012
(in millions)
NET CASH PROVIDED BY OPERATING ACTIVITIES . . . $
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets . . . . . . . . . . . . . . .
Investments in property, plant and equipment . . . . . . . . . .
Investment in acquired businesses, net of cash acquired . .
Net cash used in investing activities . . . . . . . . . . . . . .
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and
term loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repayments under revolving and bank lines of credit and
term loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchase of Common Shares . . . . . . . . . . . . . . . . . . . . . . .
Excess tax benefits from share-based payment
arrangements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash received from exercise of stock options . . . . . . . . . .
Intercompany financing . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash used in financing activities. . . . . . . . . . . . . .
Effect of exchange rate changes on cash . . . . . . . . . . . . . . . . . .
Net (decrease) increase in cash and cash equivalents . . . . . . . .
Cash and cash equivalents at beginning of year . . . . . . . . . . . .
Cash and cash equivalents at end of year . . . . . . . . . . . . . . . . . $
Parent
Subsidiary
Guarantors
Non-
Guarantors
Eliminations
Consolidated
72.9
$
163.6
$
9.8
$
(92.9) $
153.4
—
—
—
—
—
0.7
(61.2)
(6.7)
(67.2)
—
(8.2)
(0.3)
(8.5)
853.4
830.6
— (1,016.2)
(92.9)
—
(75.4)
(17.5)
—
17.6
2.4
(72.9)
—
—
—
6.6
—
151.0
(98.1)
—
(1.7)
4.3
(678.4)
—
—
—
—
(153.4)
(1.2)
2.6
2.7
126.6
—
—
—
—
—
—
92.9
—
—
—
—
92.9
—
—
—
— $
2.6
$
129.3
$
— $
0.7
(69.4)
(7.0)
(75.7)
1,684.0
(1,694.6)
(75.4)
(17.5)
6.6
17.6
—
(79.3)
2.6
1.0
130.9
131.9
114
Table of Contents
Column A
Classification
Schedule II—Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2014
Column B
Balance
at
Beginning
of Period
Column C
Column D
Column E
Column F
Reserves
Acquired
Additions
Charged
to
Expense
(In millions)
Deductions
Credited
and
Write-Offs
Balance
at End of
Period
Valuation and qualifying accounts deducted from the assets
to which they apply:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allowance for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . $
Income tax valuation allowance. . . . . . . . . . . . . . . . . . . . . . .
$
9.5
51.5
— $
—
$
6.6
(1.5)
(8.6) $
(1.7)
7.5
48.3
Schedule II—Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2013
Column A
Classification
Column B
Balance
at
Beginning
of Period
Column C
Column D
Column E
Column F
Reserves
Acquired
Additions
Charged
to
Expense
(In millions)
Deductions
Credited
and
Write-Offs
Balance
at End of
Period
Valuation and qualifying accounts deducted from the assets
to which they apply:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allowance for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . $
Income tax valuation allowance. . . . . . . . . . . . . . . . . . . . . . .
$
10.5
48.4
— $
—
$
5.5
(4.0)
(6.5) $
7.1
9.5
51.5
Schedule II—Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2012
Column A
Classification
Column B
Balance
at
Beginning
of Period
Column C
Reserves
Acquired
Column D
Additions
Charged
to
Expense
(In millions)
Column E
Deductions
Credited
and
Write-Offs
Column F
Balance
at End of
Period
Valuation and qualifying accounts deducted from the assets
to which they apply:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allowance for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . $
Income tax valuation allowance. . . . . . . . . . . . . . . . . . . . . . .
$
12.9
44.3
— $
—
$
19.1
(0.6)
(21.5) $
4.7
10.5
48.4
115
Table of Contents
Exhibit
No.
3.1(a)
3.1(b)
3.2
4.1(a)
4.1(b)
4.1(c)
4.1(d)
The Scotts Miracle-Gro Company
Index to Exhibits
Description
Initial Articles of Incorporation of The Scotts Miracle-
Gro Company as filed with the Ohio Secretary of State
on November 22, 2004
Certificate of Amendment by Shareholders to Articles
of Incorporation of The Scotts Miracle-Gro Company
as filed with the Ohio Secretary of State on March 18,
2005
Code of Regulations of The Scotts Miracle-Gro
Company
Indenture, dated as of January 14, 2010, among The
Scotts Miracle-Gro Company, the Guarantors (as
defined therein) and U.S. Bank National Association,
as trustee
First Supplemental Indenture, dated as of January 14,
2010, among The Scotts Miracle-Gro Company, the
Guarantors (as defined therein) and U.S. Bank National
Association, as trustee
Second Supplemental Indenture, dated as of September
28, 2011, among The Scotts Miracle-Gro Company, the
Guarantors (as defined therein) and U.S. Bank National
Association, as trustee
Location
Incorporated herein by reference to the Current Report
on Form 8-K of The Scotts Miracle-Gro Company (the
“Registrant”) filed March 24, 2005 (File No. 1-11593)
[Exhibit 3.1]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed March 24, 2005 (File
No. 1-11593) [Exhibit 3.2]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed March 24, 2005 (File
No. 1-11593) [Exhibit 3.3]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed January 14, 2010
(File No. 1-11593) [Exhibit 4.1]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed January 14, 2010
(File No. 1-11593) [Exhibit 4.2]
Incorporated herein by reference to the Registrant's
Annual Report on Form 10-K for the fiscal year ended
September 30, 2011 (File No. 1-11593) [Exhibit 4.1(c)]
Third Supplemental Indenture, dated as of September
30, 2013, among The Scotts Miracle-Gro Company, the
Guarantors (as defined therein) and U.S. Bank National
Association, as trustee
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
4.1]
4.1(e)
Form of 7.25% Senior Notes due 2018
Indenture, dated as of December 16, 2010, by and
among The Scotts Miracle-Gro Company,
the
Guarantors (as defined therein) and U.S. Bank National
Association, as trustee
First Supplemental Indenture, dated as of September
28, 2011, by and among The Scotts Miracle-Gro
Company, the Guarantors (as defined therein) and U.S.
Bank National Association, as trustee
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed January 14, 2010
(File No. 1-11593) [Included in Exhibit 4.2]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed December 16, 2010
(File No. 1-11593) [Exhibit 4.1]
Incorporated herein by reference to the Registrant's
Annual Report on Form 10-K for the fiscal year ended
September 30, 2011 (File No. 1-11593) [Exhibit 4.2(b)]
Second Supplemental Indenture, dated as of September
30, 2013, among The Scotts Miracle-Gro Company, the
Guarantors (as defined therein) and U.S. Bank National
Association, as trustee
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
4.2]
Third Supplemental Indenture, dated as of February 25,
2014, among The Scotts Miracle-Gro Company, the
Guarantors (as defined therein) and U.S. Bank National
Association, as trustee
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended March 29, 2014 (File No. 1-11593) [Exhibit 4.1]
4.2(e)
Form of 6.625% Senior Notes due 2020
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed December 16, 2010
(File No. 1-11593) [Included in Exhibit 4.1]
116
4.2(a)
4.2(b)
4.2(c)
4.2(d)
Table of Contents
4.2(f)
4.3
10.1(a)
10.1(b)
10.2
10.3
10.4(a)†
10.4(b)†
Registration Rights Agreement, dated
as of
December 16, 2010, by and among The Scotts Miracle-
Gro Company, the Guarantors (as defined therein) and
Merrill Lynch, Pierce, Fenner & Smith Incorporated,
as representative of the several initial purchasers named
therein
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed December 16, 2010
(File No. 1-11593) [Exhibit 4.3]
Agreement to furnish copies of instruments and
agreements defining rights of holders of long-term debt
*
Amended and Restated Agreement and Plan of Merger,
dated as of May 19, 1995, among Stern’s Miracle-Gro
Products, Inc., Stern’s Nurseries, Inc., Miracle-Gro
Lawn Products Inc., Miracle-Gro Products Limited,
Hagedorn Partnership, L.P., the general partners of
Hagedorn Partnership, L.P., Horace Hagedorn,
Community Funds, Inc., and John Kenlon, The Scotts
Company and ZYX Corporation
First Amendment to Amended and Restated Agreement
and Plan of Merger, made and entered into as of
October 1, 1999, among The Scotts Company, Scotts’
Miracle-Gro Products, Inc. (as successor to ZYX
Corporation and Stern’s Miracle-Gro Products, Inc.),
Miracle-Gro Lawn Products
Inc., Miracle-Gro
Products Limited, Hagedorn Partnership, L.P.,
Community Funds, Inc., Horace Hagedorn and John
Kenlon, and James Hagedorn, Katherine Hagedorn
Littlefield, Paul Hagedorn, Peter Hagedorn, Robert
Hagedorn and Susan Hagedorn
the “Borrower”;
Third Amended and Restated Credit Agreement, dated
as of December 20, 2013, by and among The Scotts
Miracle-Gro Company as
the
Subsidiary Borrowers (as defined in the Third
Amended and Restated Credit Agreement); JPMorgan
Chase Bank, N.A., as Administrative Agent; Bank of
America, N.A., as Syndication Agent; CoBank, ACB,
BNP Paribas, Crédit Agricole Corporate and
Investment Bank, Coöperatieve Centrale Raiffeisen-
Boerenleenbank B.A., “Rabobank Nederland,” New
York Branch, Citizens Bank of Pennsylvania, and Wells
Fargo Bank, N.A., as Documentation Agents; and the
several other banks and other financial institutions from
time to time parties to the Third Amended and Restated
Credit Agreement (collectively, the “Lenders”)
Third Amended and Restated Guarantee and Collateral
Agreement, dated as of December 20, 2013, made by
The Scotts Miracle-Gro Company, each domestic
Subsidiary Borrower under the Third Amended and
Restated Credit Agreement, and certain of its and their
domestic subsidiaries, in favor of JPMorgan Chase
Bank, N.A., as Administrative Agent
The Scotts Miracle-Gro Company Amended and
Restated 1996 Stock Option Plan (effective as of
October 30, 2007)
Specimen form of Stock Option Agreement for Non-
Qualified Stock Options granted to employees under
The Scotts Company 1996 Stock Option Plan (now
known as The Scotts Miracle-Gro Company Amended
and Restated 1996 Stock Option Plan)
117
Incorporated herein by reference to the Current Report
on Form 8-K of The Scotts Company, a Delaware
corporation, filed June 2, 1995 (File No. 0-19768)
[Exhibit 2(b)]
Incorporated herein by reference to the Current Report
on Form 8-K of The Scotts Company, an Ohio
corporation, filed October 5, 1999 (File No. 1-13292)
[Exhibit 2]
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed December 26, 2013
(File No. 1-11593) [Exhibit 4.1]
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed December 26, 2013
(File No. 1-11593) [Exhibit 4.2]
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2007 (File No. 1-11593) [Exhibit 10(d)
(4)]
Incorporated herein by reference to the Current Report
on Form 8-K of The Scotts Company, an Ohio
corporation, filed November 19, 2004 (File No.
1-11593) [Exhibit 10.7]
Table of Contents
10.5(a)†
10.5(b)†
10.6(a)†
10.6(b)†
10.6(c)(i)†
10.6(c)(ii)†
10.6(c)(iii)†
10.6(c)(iv)†
10.6(c)(v)†
The Scotts Miracle-Gro Company Amended and
Restated 2003 Stock Option and Incentive Equity Plan
(effective as of October 30, 2007)
Specimen form of Award Agreement for Directors used
to evidence grants of Nonqualified Stock Options made
under The Scotts Miracle-Gro Company 2003 Stock
Option and Incentive Equity Plan (now known as The
Scotts Miracle-Gro Company Amended and Restated
2003 Stock Option and Incentive Equity Plan)
[post-2003 version]
The Scotts Miracle-Gro Company Long-Term
Incentive Plan (reflects amendment and restatement of
plan formerly known as The Scotts Miracle-Gro
Company 2006 Long-Term Incentive Plan) [effective
as of January 17, 2013]
Specimen form of Award Agreement for Nonemployee
Directors used to evidence grants of Time-Based
Nonqualified Stock Options made under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan
(now known as The Scotts Miracle-Gro Company
Long-Term Incentive Plan)
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Amended and Restated 2006 Long-Term
Incentive Plan (now known as The Scotts Miracle-Gro
Company Long-Term Incentive Plan) [January 23,
2009 through January 19, 2012 version]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Amended and Restated 2006 Long-Term
Incentive Plan (now known as The Scotts Miracle-Gro
Company Long-Term Incentive Plan) [January 20,
2012 through January 17, 2013 version]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grant of
Deferred Stock Units made on January 20, 2012 to
Adam Hanft under The Scotts Miracle-Gro Company
Amended and Restated Long-Term Incentive Plan
(now known as The Scotts Miracle-Gro Company
Long-Term Incentive Plan)
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Long-Term Incentive Plan [January 18,
2013 through January 30, 2014 version]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units which may be made under The
Scotts Miracle-Gro Company Long-Term Incentive
Plan [post-January 30, 2014 version]
118
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2007 (File No. 1-11593) [Exhibit 10(j)
(3)]
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2005 (File No. 1-11593) [Exhibit 10(v)]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed January 24, 2013
(File No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed February 2, 2006
(File No. 1-11593) [Exhibit 10.3]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended March 28, 2009 (File No. 1-11593) [Exhibit
10.1]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2011 (File No. 1-11593) [Exhibit
10.4]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2011 (File No. 1-11593) [Exhibit
10.5]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.3]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
10.8]
Table of Contents
10.6(c)(vi)†
10.6(d)(i)†
10.6(d)(ii)†
10.6(d)(iii)†
10.6(d)(iv)†
10.6(d)(v)†
10.6(e)†
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made on May 1, 2014 under The
Scotts Miracle-Gro Company Long-Term Incentive
Plan
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Amended and Restated 2006 Long-Term
Incentive Plan (now known as The Scotts Miracle-Gro
Company Long-Term Incentive Plan) [Deferral of Cash
Retainer — January 22, 2010 through January 20, 2011
version]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Amended and Restated 2006 Long-Term
Incentive Plan (now known as The Scotts Miracle-Gro
Company Long-Term Incentive Plan) [Deferral of Cash
Retainer — January 21, 2011 through January 19, 2012
version]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Amended and Restated 2006 Long-Term
Incentive Plan (now known as The Scotts Miracle-Gro
Company Long-Term Incentive Plan) [Deferral of Cash
Retainer — January 20, 2012 through January 17, 2013
version]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units made under The Scotts Miracle-
Gro Company Long-Term Incentive Plan [Deferral of
Cash Retainer — January 18, 2013 through January 30,
2014 verison]
Specimen form of Deferred Stock Unit Award
Agreement for Nonemployee Directors (with Related
Dividend Equivalents) used to evidence grants of
Deferred Stock Units which may be made under The
Scotts Miracle-Gro Company Long-Term Incentive
Plan [Deferral of Cash Retainer — post-January 30,
2014 version]
Specimen form of Award Agreement used to evidence
grants of Restricted Stock Units, Performance Shares,
Nonqualified Stock Options, Incentive Stock Options,
Restricted Stock and Stock Appreciation Rights made
under The Scotts Miracle-Gro Company 2006 Long-
Term Incentive Plan (now known as The Scotts
Miracle-Gro Company Long-Term Incentive Plan)
[pre-October 30, 2007 version]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended March 29, 2014 (File No. 1-11593) [Exhibit
10.11]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended January 2, 2010 (File No. 1-11593) [Exhibit
10.1]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended January 1, 2011 (File No. 1-11593) [Exhibit 10.4]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2011 (File No. 1-11593) [Exhibit
10.6]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.2]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
10.9]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2005 (File No. 1-11593) [Exhibit
10(b)]
119
Table of Contents
10.6(f)(i)†
10.6(f)(ii)†
10.6(f)(iii)†
10.6(f)(iv)†
10.6(f)(v)†
10.6(g)(i)†
10.6(g)(ii)†
10.6(g)(iii)†
10.6(h)(i)†
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2011 (File No. 1-11593) [Exhibit
10.2]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.5]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended March 29, 2014 (File No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
10.10]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
10.11]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2011 (File No. 1-11593) [Exhibit
10.1]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.6]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended March 30, 2013 (File No. 1-11593) [Exhibit
10.8]
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2007 (File No. 1-11593) [Exhibit 10(t)
(3)]
Specimen form of Restricted Stock Unit Award
Agreement for Employees (with Related Dividend
Equivalents) used to evidence grants of Restricted
Stock Units made under The Scotts Miracle-Gro
Company Amended and Restated 2006 Long-Term
Incentive Plan (now known as The Scotts Miracle-Gro
Company Long-Term Incentive Plan) [January 20,
2012 through January 17, 2013 version]
Specimen form of Restricted Stock Unit Award
Agreement for Employees (with Related Dividend
Equivalents) used to evidence grants of Restricted
Stock Units which may be made under The Scotts
Miracle-Gro Company Long-Term Incentive Plan
[post-January 17, 2013 version]
Form of Restricted Stock Unit Award Agreement for
Employees (with Related Dividend Equivalents) used
to evidence grant of Restricted Stock Units made on
April 1, 2013 to Lawrence A. Hilsheimer under The
Scotts Miracle-Gro Company Long-Term Incentive
Plan
Form of Restricted Stock Unit Award Agreement for
Employees (with Related Dividend Equivalents) used
to evidence grant of Restricted Stock Units made on
December 11, 2013 to James Hagedorn under The
Scotts Miracle-Gro Company Long-Term Incentive
Plan
Specimen form of Restricted Stock Unit Award
Agreement for Employees (with Related Dividend
Equivalents) used to evidence grants of Restricted
Stock Units made on January 31, 2014 to Barry W.
Sanders and Denise S. Stump under The Scotts Miracle-
Gro Company Long-Term Incentive Plan
Specimen form of Performance Unit Award Agreement
for Employees (with Related Dividend Equivalents)
used to evidence grants of Performance Units made
under The Scotts Miracle-Gro Company Amended and
Restated 2006 Long-Term Incentive Plan (now known
as The Scotts Miracle-Gro Company Long-Term
Incentive Plan) [January 20, 2012 through January 17,
2013 version]
Specimen form of Performance Unit Award Agreement
for Employees (with Related Dividend Equivalents)
used to evidence grants of Performance Units which
may be made under The Scotts Miracle-Gro Company
Long-Term Incentive Plan [post-January 17, 2013
version]
Specimen form of Performance Unit Award Agreement
for Employees (with Related Dividend Equivalents)
used to evidence grants of Performance Units made on
January 18, 2013 to James Hagedorn under The Scotts
Miracle-Gro Company Long-Term Incentive Plan
Specimen form of Nonqualified Stock Option Award
Agreement for Employees used to evidence grants of
Nonqualified Stock Options made under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan
(now known as The Scotts Miracle-Gro Company
Long-Term Incentive Plan) [October 30, 2007 through
October 8, 2008 version]
120
Table of Contents
10.6(h)(ii)†
10.6(h)(iii)†
10.6(h)(iv)†
10.7(a)†
10.7(b)(i)†
10.7(b)(ii)†
10.7(b)(iii)†
10.7(c)†
10.7(d)†
Specimen form of Nonqualified Stock Option Award
Agreement for Employees used to evidence grants of
Nonqualified Stock Options made under The Scotts
Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan (now known as The Scotts
Miracle-Gro Company Long-Term Incentive Plan)
[January 20, 2010 through January 19, 2012 version]
Specimen form of Nonqualified Stock Option Award
Agreement for Employees used to evidence grants of
Nonqualified Stock Options made under The Scotts
Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan (now known as The Scotts
Miracle-Gro Company Long-Term Incentive Plan)
[January 20, 2012 through January 17, 2013 version]
Specimen form of Nonqualified Stock Option Award
Agreement for Employees used to evidence grants of
Nonqualified Stock Options which may be made under
The Scotts Miracle-Gro Company Long-Term
Incentive Plan [post-January 17, 2013 version]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended January 2, 2010 (File No. 1-11593) [Exhibit
10.4]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 31, 2011 (File No. 1-11593) [Exhibit
10.3]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.7]
The Scotts Company LLC Amended and Restated
Executive Incentive Plan (effective as of January 30,
2014)
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed February 5, 2014
(File No. 1-11593) [Exhibit 10.1]
form of Employee Confidentiality,
Specimen
for
Noncompetition, Nonsolicitation Agreement
employees participating in The Scotts Company
Executive/Management Incentive Plan (now known as
The Scotts Company LLC Amended and Restated
Executive Incentive Plan) [2005 version]
form of Employee Confidentiality,
Specimen
Noncompetition, Nonsolicitation Agreement
for
employees participating in The Scotts Company LLC
Executive/Management Incentive Plan (now known as
The Scotts Company LLC Amended and Restated
Executive Incentive Plan) [post-2005 version]
Confidentiality,
Employee
Noncompetition,
Nonsolicitation Agreement, dated as of December 12,
2013, by and between The Scotts Company LLC, all
companies controlled by, controlling or under common
control with The Scotts Company LLC, and James
Hagedorn
Form of Retention Award Agreement evidencing the
payment of a cash bonus on April 12, 2013 and the grant
of Restricted Stock Units on May 8, 2013 under The
Scotts Miracle-Gro Company Amended and Restated
2006 Long-Term Incentive Plan (now known as The
Scotts Miracle-Gro Company Long-Term Incentive
Plan) to Thomas Coleman (executed by The Scotts
Company LLC on May 14, 2013 and by Thomas
Coleman on May 16, 2013)
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2008 (File No. 1-11593) [Exhibit 10.2
(b)(i)]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended July 1, 2006 (File No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed December 17, 2013
(File No. 1-11593) [Exhibit 10.2]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended March 29, 2014 (File No. 1-11593) [Exhibit
10.2]
Executive Officers of The Scotts Miracle-Gro
Company who are parties to form of Employee
Confidentiality, Noncompetition, Nonsolicitation
Agreement for employees participating in The Scotts
Company LLC Amended and Restated Executive
Incentive Plan incorporated in this Annual Report on
Form 10-K as Exhibit 10.7(b)(ii)
*
10.8(a)(i)†
The Scotts Company LLC Executive Retirement Plan,
As Amended and Restated as of January 1, 2011
(executed December 22, 2010)
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended January 1, 2011 (File No. 1-11593) [Exhibit 10.3]
121
Table of Contents
10.8(a)(ii)†
First Amendment to The Scotts Company LLC
Executive Retirement Plan, as Amended and Restated
as of January 1, 2011 (effective as of January 1, 2011)
10.8(a)(iii)†
Second Amendment to The Scotts Company LLC
Executive Retirement Plan, as Amended and Restated
as of January 1, 2011 (effective as of January 1, 2012)
10.8(a)(iv)†
Third Amendment to The Scotts Company LLC
Executive Retirement Plan, as Amended and Restated
as of January 1, 2011 (effective as of January 1, 2013)
10.8(a)(v)†
Fourth Amendment to The Scotts Company LLC
Executive Retirement Plan, as Amended and Restated
as of January 1, 2011 (effective as of January 1, 2014)
Form of Executive Retirement Plan Retention Award
Agreement between The Scotts Company LLC and
each of Barry W. Sanders, Denise S. Stump and Michael
C. Lukemire (entered into on November 4, 2008)
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.8]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.9]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended December 29, 2012 (File No. 1-11593) [Exhibit
10.10]
Incorporated herein by reference to the Registrant’s
Quarterly Report on Form 10-Q for the quarterly period
ended December 28, 2013 (File No. 1-11593) [Exhibit
10.5]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed October 15, 2008
(File No. 1-11593) [Exhibit 10.2]
Summary of Compensation
for Nonemployee
Directors of The Scotts Miracle-Gro Company
(effective as of May 1, 2014)
*
Executive Severance Agreement, dated as of December
11, 2013, by and between The Scotts Company LLC
and James Hagedorn
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed December 17, 2013
(File No. 1-11593) [Exhibit 10.1]
Consulting Agreement, dated as of February 7, 2014,
between The Scotts Miracle-Gro Company and Dr.
Michael Porter
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended March 29, 2014 (File No. 1-11593) [Exhibit 10.8]
Separation Agreement and Release of All Claims, by
and between The Scotts Company LLC (executed on
January 21, 2014) and James R. Lyski (executed on
January 22, 2014)
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed January 23, 2014
(File No. 1-11593) [Exhibit 10.1]
Consulting Agreement, dated February 7, 2014,
between The Scotts Miracle-Gro Company and Adam
Hanft [expired on August 1, 2014]
Incorporated herein by reference to the Registrant's
Quarterly Report on Form 10-Q for the quarterly period
ended March 29, 2014 (File No. 1-11593) [Exhibit 10.9]
Separation Agreement and Release of All Claims,
entered into by and between The Scotts Company LLC
(executed on April 15, 2014) and Lawrence A.
Hilsheimer (executed on April 17, 2014)
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed April 17, 2014 (File
No. 1-11593) [Exhibit 10.1]
10.11(a)†
The Scotts Company LLC Executive Severance Plan,
adopted on May 4, 2011
10.11(b)†
Form of Tier 1 Participation Agreement under The
Scotts Company LLC Executive Severance Plan
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed May 10, 2011 (File
No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed May 10, 2011 (File
No. 1-11593) [Exhibit 10.2]
10.11(c)†
Executive Officers of The Scotts Miracle-Gro
Company who are parties to form of Tier 1 Participation
Agreement under The Scotts Company LLC Executive
Severance Plan incorporated in this Annual Report on
Form 10-K as Exhibit 10.11(b)
*
122
10.8(b)†
10.9†
10.10(a)†
10.10(b)†
10.10(c)†
10.10(d)†
10.10(e)†
Table of Contents
10.12(a)
10.12(b)
10.12(c)
10.13
10.14
10.15(a)
10.15(b)
10.15(c)
12
14
21
23
24
Amended and Restated Exclusive Agency and
Marketing Agreement, effective as of September 30,
1998, between Monsanto Company and The Scotts
Company LLC (as successor to The Scotts Company,
an Ohio corporation)
Letter Agreement, dated March 10, 2005, amending the
Amended and Restated Exclusive Agency and
Marketing Agreement, dated as of September 30, 1998,
between Monsanto Company and The Scotts Company
LLC (as successor to The Scotts Company, an Ohio
corporation)
Letter Agreement, dated March 28, 2008, amending the
Amended and Restated Exclusive Agency and
Marketing Agreement, dated as of September 30, 1998,
between Monsanto Company and The Scotts Company
LLC
Purchase Agreement, dated December 13, 2010, among
The Scotts Miracle-Gro Company, the subsidiary
guarantors named therein and Merrill Lynch, Pierce,
Fenner & Smith Incorporated, as representative of the
several initial purchasers named therein
Share and Business Sale Agreement, dated February
23, 2011, by and among The Scotts Company LLC, as
Seller, each of the Share Sellers and Business Sellers
(as defined
therein), Israel Chemicals Ltd., as
Purchaser, each of the Share Purchasers and Business
Purchasers (as defined therein) and The Scotts Miracle-
Gro Company, as Seller Guarantor
Master Accounts Receivable Purchase Agreement,
dated as of November 15, 2012, by and among The
Scotts Miracle-Gro Company, The Scotts Company
LLC, The Bank of Nova Scotia, Suntrust Bank, RB
Receivables LLC and Mizuho Corporate Bank, Ltd., as
Administrative Agent and as a Bank
First Amendment, dated as of October 25, 2013, to the
Master Accounts Receivable Purchase Agreement,
dated as of November 15, 2012, among The Scotts
Miracle-Gro Company, The Scotts Company LLC, The
Bank of Nova Scotia, Suntrust Bank, RB Receivables
LLC and Mizuho Bank, Ltd., as Administrative Agent
and as a Bank
Second Amendment, dated as of August 29, 2014, to
the Master Accounts Receivable Purchase Agreement,
dated as of November 15, 2012, among The Scotts
Miracle-Gro Company, The Scotts Company LLC, The
Bank of Nova Scotia, Suntrust Bank, RB Receivables
LLC and Mizuho Bank, Ltd., as Administrative Agent
and as a Bank
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2005 (File No. 1-11593) [Exhibit 10(x)]
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2009 (File No. 1-11593) [Exhibit 10.17
(b)]
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2008 (File No. 1-11593) [Exhibit 10.18
(b)]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed December 16, 2010
(File No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed March 1, 2011 (File
No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended
September 30, 2012 (File No. 1-11593) [Exhibit 10.16]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed October 31, 2013
(File No. 1-11593) [Exhibit 10.1]
Incorporated herein by reference to the Registrant’s
Current Report on Form 8-K filed September 4, 2014
(File No. 1-11593) [Exhibit 10.1]
Computation of Ratio of Earnings to Fixed Charges
*
The Scotts Miracle-Gro Company Code of Business
Conduct & Ethics (as revised effective January 18,
2012)
Incorporated herein by reference to the Registrant's
Current Report on Form 8-K filed January 24, 2012
(File No. 1-11593) [Exhibit 14.1]
Subsidiaries of The Scotts Miracle-Gro Company
Consent of Independent Registered Public Accounting
Firm — Deloitte & Touche LLP
Powers of Attorney of Executive Officers and Directors
of The Scotts Miracle-Gro Company
*
*
*
123
*
*
*
*
*
*
*
Table of Contents
31.1
31.2
32
Rule 13a-14(a)/15d-14(a) Certifications
Executive Officer)
(Principal
*
Rule 13a-14(a)/15d-14(a) Certifications
Financial Officer)
(Principal
*
Section 1350 Certifications
Officer and Principal Financial Officer)
(Principal Executive
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema
101.CAL
XBRL Taxonomy Extension Calculation Linkbase
101.DEF
XBRL Taxonomy Extension Definition Linkbase
101.LAB
XBRL Taxonomy Extension Label Linkbase
101.PRE
XBRL Taxonomy Extension Presentation Linkbase
*
†
Filed or furnished herewith.
Management contract, compensatory plan or arrangement.
124
Rule 13a-14(a)/15d-14(a) Certifications
(Principal Executive Officer)
CERTIFICATIONS
I, James Hagedorn, certify that:
Exhibit 31.1
1.
I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the fiscal year ended
September 30, 2014;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize
and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: November 25, 2014
By:
/s/ JAMES HAGEDORN
Printed Name: James Hagedorn
Title: Chief Executive Officer and Chairman of the Board
Rule 13a-14(a)/15d-14(a) Certifications
(Principal Financial Officer)
CERTIFICATIONS
I, Thomas Randal Coleman, certify that:
Exhibit 31.2
1.
I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the fiscal year ended
September 30, 2014;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize
and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: November 25, 2014
By:
/s/ THOMAS RANDAL COLEMAN
Printed Name: Thomas Randal Coleman
Title: Executive Vice President and Chief Financial Officer
SECTION 1350 CERTIFICATIONS*
Exhibit 32
In connection with the Annual Report on Form 10-K of The Scotts Miracle-Gro Company (the “Company”) for the fiscal year
ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned James Hagedorn, Chief Executive Officer and Chairman of the Board of the Company, and Thomas Randal
Coleman, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to Section 1350 of Chapter
63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best
of their knowledge:
1)
2)
The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the consolidated financial condition
and results of operations of the Company and its subsidiaries.
/s/ JAMES HAGEDORN
Printed Name: James Hagedorn
Title: Chief Executive Officer and Chairman of the
Board
/s/ THOMAS RANDAL COLEMAN
Printed Name: Thomas Randal Coleman
Title: Executive Vice President and Chief Financial Officer
November 25, 2014
November 25, 2014
*
THESE CERTIFICATIONS ARE BEING FURNISHED AS REQUIRED BY RULE 13a-14(b) UNDER THE
SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”) AND SECTION 1350 OF CHAPTER 63 OF
TITLE 18 OF THE UNITED STATES CODE, AND SHALL NOT BE DEEMED “FILED” FOR PURPOSES OF
SECTION 18 OF THE EXCHANGE ACT OR OTHERWISE SUBJECT TO THE LIABILITY OF THAT SECTION.
THESE CERTIFICATIONS SHALL NOT BE DEEMED TO BE INCORPORATED BY REFERENCE INTO ANY
FILING UNDER THE SECURITIES ACT OF 1933 OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT THAT
THE COMPANY SPECIFICALLY INCORPORATES THESE CERTIFICATIONS BY REFERENCE.
EXECUTIVE TEAM
Jim Hagedorn
Chief Executive Officer and
Chairman of the Board
Barry Sanders
President and Chief Operating Officer
Randy Coleman
Executive Vice President and
Chief Financial Officer
Mike Lukemire
Executive Vice President,
North American Operations
Ivan Smith
Executive Vice President,
General Counsel,
Corporate Secretary and
Chief Compliance Officer
Denise Stump
Executive Vice President,
Global Human Resources and
Chief Ethics Officer
Mike Carbonara
President, East, Canada and
Puerto Rico Regions
Mike French
Senior Vice President,
Global Asset Utilization
Michel Gasnier
President, International Region
Jim Gimeson
Senior Vice President
Chief Operating Officer,
Scotts LawnService
Scott Hendrick
Senior Vice President,
Chief Transformation Officer and
Chief Information Officer
Phil Jones
Senior Vice President,
North American Sales
Jim King
Senior Vice President,
Chief Communications Officer
Pete Supron
Senior Vice President,
Business Development
Dave Swihart
Senior Vice President,
Global R&D and Sourcing
Jim Tates
President, West, Mexico and
Latin America Regions
Mark Wilhelmi
President, Scotts LawnService
BOARD OF DIRECTORS
Alan H. Barry
Former President and Chief Operating Officer
Masco Corporation
Manufacturer of products for
home improvement and construction
Member of Audit and Nominating & Governance Committees
Board member since 2009
Brian D. Finn
Former Chief Executive Officer
and Chairman of the Board
Asset Management Finance Corporation
Private investment firm
Member of Audit and Finance Committees
Board member since 2014
Jim Hagedorn
Chief Executive Officer and Chairman of the Board
The Scotts Miracle-Gro Company
Board member since 1995
Adam Hanft
Founder and Chief Executive Officer
Hanft Projects LLC
Strategic consultancy firm
Member of Innovation & Technology Committee
Board member since 2010
Michelle A. Johnson
Chief Executive Officer
StudentsFirst
Chair of Compensation & Organization Committee
Member of Nominating & Governance Committee
Board member since 2014
Stephen L. Johnson
President and Chief Executive Officer
Stephen L. Johnson and Associates
Strategic Consulting, LLC
Chair of Nominating & Governance Committee
Member of Compensation & Organization and
Innovation & Technology Committees
Board member since 2010
Thomas N. Kelly Jr.
Former Executive Vice President,
Transition Integration
Sprint Nextel Corporation
Global communications company
Chair of Innovation & Technology Committee
Member of Compensation & Organization
and Audit Committees
Board member since 2006
Katherine Hagedorn Littlefield
General Partner
Hagedorn Partnership, L.P.
Private investment partnership
Chair of Finance Committee
Member of Innovation & Technology Committee
Board member since 2000
James F. McCann
Chief Executive Officer
and Chairman of the Board
1-800-Flowers.com
Online florist and gift shop
Member of Audit and Finance Committees
Board member since 2014
Nancy G. Mistretta
Retired Partner
Russell Reynolds Associates
Executive search firm
Chair of Audit Committee
Member of Finance Committee
Board member since 2007
Michael E. Porter, Ph.D.
Bishop William Lawrence University Professor
Harvard Business School
Member of Finance Committee
Board member since 2013
John R. Vines
Founder and Chief Executive Officer
John R. Vines Associates LLC
Member of Nominating & Governance Committee
Board member since 2013
WWW.SCOTTSMIRACLEGRO.COM
14111 SCOTTSLAWN ROAD
MARYSVILLE, OHIO 43041
937.644.0011
OUR VISION: TO HELP PEOPLE OF ALL AGES EXPRESS
THEMSELVES ON THEIR OWN PIECE OF THE EARTH
OUR MISSION: ScottsMiracle-Gro is committed to
helping consumers around the world by providing them
with innovative solutions to create beautiful and healthy
lawns and gardens. We will be responsible stewards of
our planet. We will provide a dynamic workplace for our
associates to succeed and grow their careers. In return,
we will be rewarded with an improved market presence
and profitable growth that enhances shareholder value.